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ABSTRACT  
Introduction and aims: The bladder urothelium is generally considered to be poorly 
permeable blood-urine barrier. However, recent studies have shown that the 
urothelium expresses transmembrane water channels, aquaporins (AQPs). Currently 
13 AQPs (AQP0, AQP1, AQP2, AQP3, AQP4, AQP5, AQP6, AQP7, AQP8, AQP9, 
AQP10, AQP11, AQP12) subtypes have been identified in mammalian tissues, and 
from these subtypes, AQPs 1-4, AQP7, AQP9 and AQP11 have been found in the 
urothelium of various species indicating that AQPs could regulate urothelial cell 
volume and osmolarity, determine the final composition of urine. However, the exact 
function of AQPs, their cellular regulation and distribution under different osmotic 
conditions in bladder urothelium remain to be elucidated. Therefore, this study aimed 
to i) investigate the expression of AQPs in pig urinary bladder, ii) the potential role of 
AQPs in mediating water transport across pig bladder urothelium in response to 
osmotic stress iii) investigate the effect of hypotonic and hypertonic solution on AQP3 
intracellular localisation 
Methods: Bladders obtained from (~6 months old) female pigs, as well as tissues used 
as positive control were obtained from the local abattoir and used to investigate AQPs. 
PCR was carried out on mRNA isolated from bladder mucosa and on urothelium cell 
suspensions, as well as tissues used as positive control to identify AQPs 1-11. 
Localisation of AQPs was determined using immunohistochemistochemical method 
on paraffin embedded mucosa sections. Movement of deuterium oxide (D2O) fluxes 
across the bladder urothelium/suburothelium (mucosa) membranes were assessed 
using an Ussing chamber system. AQP3 intracellular localisation in urothelial cells 
after exposure to changes in tonicity was asses using immunoflourescence.   
Results: AQPs 1, 3, 9, 11 mRNA expression was found in the mucosa of pig bladder, 
AQP 3, 9, 11 expression was also found specifically in urothelium. 
Immunohistochemistry showed AQP1 labelling in the endothelium of lamina propria 
blood vessels. AQPs 3 and 11 were expressed throughout the urothelium and AQP9 
immunoreactivity was detected in upper region of the urothelium. Ussing chamber 
experiment shows gradual increase in D2O concentration on the basolateral side of 
the mucosa over time when osmotic gradient was created between the apical and 
basolateral side of the mucosa tissue section with a known D2O concentration on the 
apical side. D2O diffusion rate was halted when tissue was treated with HgCl2. The 
average diffusion rate for D2O in absence of HgCl2 and in the presence of HgCl2 was 
calculated using Newman-keuls test. AQP3 immunoreactivity was detected around the 
nucleus in untreated urothelial cells, however, after exposure to hypertonic and 
hypotonic solutions for 4 and 5 hours, AQP3 immunoreactivity was detected mainly in 
the cell membrane. 
Conclusions. Four different AQPs subtypes were identified in adult pig bladder, 
suggesting that AQPs may play a regulatory role in urothelial cell volume and water 
transport across the urothelium. Water movement was detected across pig bladder 
urothelium which was significantly inhibited by HgCl2, demonstrating a possible role of 
AQPs in mediating transcellular movement of water across bladder urothelium. 
Immunofluorescent staining revealed cytoplasmic localisation of AQP3 in untreated 
 
 
urothelial cells and its translocation to the cell membrane under osmotic stress. AQPs 
in the urinary bladder urothelium may play a regulatory role in urothelial cell volume 
and modifying the final urine composition depending on the overall fluid homeostasis.
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Chapter 1 
 
Introduction and Main Aims  
1 
 
1.1 Anatomy of the Urinary Bladder  
 
The urinary bladder is a hollow viscus and a highly distensible organ that consists of 
a main portion (body) that collects urine, a funnel-shaped extension (neck) that 
connects with the urethra and single tube through which the urine passes to reach the 
external environment. The opening between the bladder and urethra is closed by two 
rings of muscle called sphincters (Figure 1.1B). The internal sphincter is a continuation 
of the bladder wall and consists of smooth muscle and immediately adjacent is the 
external sphincter made up of voluntary, mainly slow-twitch striated-muscle fibers 
(Silverthorn 2010; Boron and Boulpaep, 2012).  
The bladder lies in contact with the posterior surface of the lower part of the anterior 
abdominal wall (Figure 1.1A) (Mahadevan, 2016). The anatomical position, size and 
shape of the bladder and the relationship of the bladder with nearby structures are 
determined by the degree to which the bladder is distended by the contained urine 
and also by the state of the adjacent viscera (Hickling et al., 2015).  In the adult, the 
empty urinary bladder lies entirely within the true pelvic cavity, occupying the anterior  
part of the pelvic cavity, behind the pubic symphysis and pubic bones (Figure 1.1B). 
As the bladder distends it ascends above the level of the pelvic brim and thus into the 
abdomen.  
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Urinary bladder
Urinary bladder body
Ureteric orifices
Trigone
Urethra
External sphincter
A
B
Figure 1.1 Anatomy of the urinary bladder in the human body 
A) The Urinary bladder is found to the peritoneum, sitting on the pelvic floor. In females its inferior 
surface lays on the pubic symphysis and the posterior wall is in contact with the vagina and uterus. 
B) The bladder has four parts: body, which is bounded anteriorly by the apex and 
the fundus posteriorly, neck, inferiorly located in the region of the internal urethral orifice, emerges 
from the union of the right and left inferolateral surfaces. The fundus of the bladder contains three 
openings which form the trigone of the bladder; the internal urethral orifice and the two ureteric 
orifices (Kenhub, 2020). 
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1.2 The Function of the Urinary Bladder  
 
The primary functions of a healthy urinary bladder are to act as a reservoir allowing 
storage of urine whilst maintaining a low intravesical pressure during filling and also to 
expel urine periodically in a highly coordinated manner when deemed possible (Hill et 
al., 2015). The high compliance of the bladder wall allows it to expand to hold a volume 
of about 500ml, and also ensures that the ureters are not forced to transport urine into 
a pressurised compartment, with the associated risk of retrograde flow (Kohler et al., 
2001). Moreover, prevention of reflux into the ureter is helped by the nature of the 
uretero-vesical junction whereby the ureters do not merely penetrate the bladder wall 
but make a J-shaped function thus forming a non-return valve (Lescay and Tuma, 
2018). The ability of the urinary bladder to store and periodically release urine are 
dependent on central nervous control, peripheral autonomic and somatic neural 
pathways.  
 
1.3 Innervation of Bladder and Control of the Micturition Reflex 
 
The micturition cycle is divided to two phases, urine storage and voiding. The bladder 
and urethra function reciprocally to maintain the cycle. The control of the micturition 
cycle is dependent upon neural circuits located in the brain, spinal cord and peripheral 
ganglia. The bladder has dense innervation of autonomic parasympathetic (pelvic), 
thoracolumbar sympathetic (hypogastric) and somatic (pudendal) nerves (Reviewed 
in De Groat, 1997 and Andersson and Arner, 2004), which often have opposing 
functions. During the storage phase, stretch receptors in the bladder send signals via 
sensory neurons to the brain through the pelvic nerves. One first senses the urge for 
voluntary bladder emptying at a volume of ∼150 ml and senses fullness at ∼500 ml. 
4 
 
Nevertheless, until it is socially acceptable to void, efferent impulses from the brain, 
inhibit presynaptic parasympathetic neurons in the sacral spinal cord that would 
otherwise stimulate the smooth muscle cells of the bladder wall. Voluntary contraction 
of the external urethral sphincter, which are controlled by the somatic motor neurons, 
also contributes to storage (Silverthorn 2010; Boron and Boulpaep, 2012). The voiding 
phase begins with a voluntary relaxation of the external urinary sphincter, followed by 
the internal sphincter. When a small amount of urine reaches the proximal (posterior) 
urethra, afferents signal the cortex that voiding is imminent. The micturition reflex now 
continues as pontine centres in the brain which no longer inhibit the parasympathetic 
preganglionic neurons leading to bladder smooth muscle contraction and expulsion of 
urine. At the same time, the cortical centres inhibit the external sphincter muscles. 
Voluntary urination also involves the voluntary contraction of abdominal muscles, 
which further raises bladder pressure and thus contributes to voiding and complete 
bladder emptying (Silverthorn 2010; Boron and Boulpaep, 2012).  
 
1.4 The Structure of the Bladder Wall 
 
The bladder wall is organized into three different layers (from outside to inside); the 
serosa/adventitia, detrusor muscle, and mucosa comprising of lamina propria (LP) and 
the urothelium (Figure 1.2A). 
The serosa/adventitia forms a partial covering for the bladder dome. The superior part 
of the bladder is lined by the peritoneal membrane – the bladder itself is therefore an 
extraperitoneal organ. The serosa is a protective layer that will indeed allow the 
bladder to expand relatively independently of other lower abdominal organs. In 
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addition, the serosa serves as a protective barrier for the urinary bladder detrusor 
muscle (Mutsaers, 2003; Fry and Vahabi, 2016). 
The main component of the bladder wall consists of smooth muscle called the detrusor 
muscle (Figure 1.2A). The detrusor muscle is composed of three different layers: the 
longitudinal inner layer which becomes circular in the middle followed by outer 
longitudinal layer. This muscle is well defined around the neck of the urinary bladder 
whilst in the rest of the bladder wall the detrusor muscle runs more randomly with little 
orientation. (Dixon and Gosling, 1987; Sam and Lagrabge, 2018). 
The LP, is the suburothelial layer separating the urothelium and underlying detrusor 
muscle (Figure 1.2B). It is separated from the overlying urothelium by a basement 
membrane and is composed of an extracellular matrix with elastic fibres, capillaries, 
lymphatics, immune cells, afferent and efferent nerve endings, fibroblasts, adipocytes, 
interstitial cells, and indistinct smooth muscle layer, known as the muscularis mucosae 
(Drumm et al., 2014). 
The urothelium, is a transitional epithelium and lines the inner surface of the renal 
pelvis, the ureters, the urinary bladder and the urethra and forms a barrier to urine and 
the underlying tissues or the suburothelium and detrusor layers (Bolla and Jetti, 2019). 
The urothelium is composed of at least three layers; a basal cell layer attached to a 
basement membrane, an intermediate layer and apical layer composed of large 
hexagonal cells called the umbrella cells (Figure 1.2B) (Birder and Andersson, 2013). 
The apical umbrella cells have a diameter of 60-120 µM and are roughly cuboidal in 
an empty bladder, but they become squamous-like in morphology as the bladder fills. 
The intermediate layer is formed from two to three layers of polygonal cells which have 
a diameter of 20 µM, and the basal layer is made up from two to three layers of small 
cuboidal cells, each with a diameter of 5-10µM (Keshtkar et al., 2007; Bolla and jetti, 
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2019). In a relaxed urinary bladder, the urothelium is five to seven layers of cell thick. 
When the urinary bladder fills with urine, it greatly expands stretching the bladder wall. 
In the distended bladder, the urothelium becomes two to three layers thick without any 
structural impairment 
  It was generally assumed that the urothelium is just a passive barrier against urine 
solutes, pathogens and noxious compounds. Many studies have now demonstrated 
that the urotheium has additional and important physiological roles (Apodaca et al., 
2007; Birder and de Groat, 2007).  
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Figure. 1.2 The structure of the bladder wall and schematic drawing of the bladder mucosa.  A) an overview of a 
cross sectioned bladder and a diagram of different layers of urinary bladder wall demonstrating the mucosal layer that 
lines the bladder and consist of urothelium and lamina propria (LP), the detrusor muscle and the adventitia layer that 
covers the outer surface of the bladder B) Mucosa section with urothelial cells and its properties. The LP is located 
between the basal membrane and the detrusor muscle. (Adapted from Chunhui et al., 2014) 
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1.5 The Sensory Function of the Urothelium  
 
Emerging evidence indicates that the urothelium has specialized sensory properties 
and is capable of detecting mechanical or chemical stimuli (such as changes in 
bladder pressure or tension, and tonicity of urine) and releasing a number of signalling 
molecules (Apodaca et al., 2007; Birder and de Groat, 2007).  
 Urothelial cells express a variety of ‘sensor molecules’ (i.e. receptors and ion 
channels), similar to those found on sensory neurons, such as receptors for bradykinin 
purines (P2X and P2Y), norepinephrine (α and β), acetylcholine (nicotinic and 
muscarinic receptors), protease-activated receptors, amiloride-sensitive and 
mechanosensitive Na+ channels, and a number of transient receptor potential (TRP) 
channels.  (Birder and de Groat, 2007; Apodaca et al., 2007; Birder et al., 2014; 
Gonzales et al., 2014)  
Moreover, several substances are released from urothelial cells following mechanical, 
chemical and thermal stimulation such as neurotrophins, neuropeptides, ATP, 
acetylcholine, prostaglandins, prostacyclin, nitric oxide (NO) and cytokines (Birder and 
Andersson., 2013; Burnstock, 2013; Gonzales et al., 2014; Merrill et al., 2016) and 
these molecules are able to communicate in a reciprocal manner with other cell types 
including bladder nerves, smooth muscle cells, interstitial cells and inflammatory cells 
which ultimately alter bladder function (Birder and Andersson., 2013). These 
observations open new exciting avenues for identifying new pharmacologic 
interventions that aim to target urothelial cell receptors and ion channels or 
neurotransmitter release mechanisms, leading to new strategies for the clinical 
management of bladder disorders.
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1.6 The Barrier Function of the Urothelium  
 
 Urothelium serves as a tight barrier between the urine and underlying layers of the 
bladder wall and allows storage of urine volume while preventing the unregulated 
fluxes of substances between urine and blood (Khandelwal et al., 2009). Epithelial 
tightness is commonly assessed by measurement of transepithelial electrical 
resistance (TEER) with epithelial displaying TEER >500 Ω.cm2 classified as tight 
(Adam et al., 2010). TEER is a widely acknowledged quantitative technique used to 
measure the integrity of epithelial dynamics in cell culture models of endothelial and 
epithelial monolayers as well as intact tissues (Srinivasan et al., 2015). 
According to Frömter and Diamond (1972), the urinary bladder epithelium is a tight 
epithelium, based on the TEER ranges observed throughout various mammalian 
urothelial TEER measurements. The umbrella cell layer, which is in close contact to 
the urine content of the bladder, is primarily responsible for urothelium permeability 
barrier function and has TEER that ranges between 10,000 and >75,000 Ω.cm2 
(Khandelwal et al., 2009). This extremely high transepithelial resistance is as a result 
of a high apical plasma membrane transcellular resistance in addition to the 
paracellular resistance of tight junctions (Lewis et al., 1976; Negrete et al., 1996; 
Khandelwal et al., 2009).  The transepithelial resistance of the blood–brain barrier, 
which protects the brain from harmful materials circulating in the blood, ranges from 
1,000 to 2,000 Ω.cm2 (Butt et al., 1990), whereas transepithelial resistances of 
epidermal and intestinal barrier are even smaller, around 400 and 100 Ω.cm2, 
respectively (Soler et al., 1999; Schulkze et al., 2009; Kirschner et al., 2009). Based 
on the measurement of epithelial in different parts of the body, urothelial blood–urine 
barrier can be therefore considered the tightest and most impermeable barrier in the 
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body. Urothelial cells, more specifically umbrella cells, have several features that 
contribute to the high resistance of the urinary bladder urothelium.  
 
1.6.1 The Specific Features of the Umbrella Cells in Aiding 
Urothelial Barrier Function 
 
The bladder urothelium allows storage of urine for prolonged periods of time whilst 
limiting the passage of water, electrolytes and highly permeable molecules such as 
ammonia, as well as preventing noxious compounds entering the systemic circulation 
(Hicks, 1975; Apodaca, 2004). Several features of the apical surface of terminally 
differentiated mammalian urothelial umbrella cells aid the bladder in maintaining 
normal barrier function as the bladder fills and empties. These features include a 
number of tight-junction proteins such as zona occludens-1, occludins, claudins 
(Figure 1.2B), glycosaminoglycan (GAG), as well as specialised lipids and uroplakin 
proteins (Figure 1.2B) expressed by the umbrella cell apical membrane (Apodaca, 
2004; Khandelwal et al., 2009; Birder, 2010). These features allow the urothelium to 
respond to mechanical stretching as a result of an increase in intravesical pressure 
during bladder filling whilst maintaining an effective barrier.  
 
1.6.1.1 The Urothelium and the GAG layer 
 
The GAG layer is located on the surface of the urothelial and is composed of 
dermantan, heparin, and the glycosaminoglycans, chondroitin sulfate and hyaluronic 
acid (Klingler, 2016). The GAG layer provides a protective barrier to prevent 
unregulated permeability of water and solutes. Dysfunction of the GAG leads to 
increased permeability into the deep layers of the urothelium and bladder. 
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1.6.1.2 The Urothelium and Tight Junction Proteins 
 
Tight junctions are located between the surface of urothelial cells and are made up of 
a dense network of cytoskeletal elements, cytoplasmic proteins, as well as several 
transmembrane proteins (Figure 1.3A) (Gonzalez et al., 2003). The cytoplasmic 
proteins, which include zonula occludens-1 (ZO-1) are believed to form a framework 
that links the tight junction-associated transmembrane proteins to the peri-junctional 
actin cytoskeleton (Matter & Balda, 2003). Transmembrane proteins that are 
associated with the tight junctions include junctional-associated membrane protein 1 
(Padura et al., 1998), the Coxsackie and adenovirus-associated receptor (Cohen et 
al., 2001, Walter et al., 2002), the IG8 antigen (Nasdala et al., 2002), as well as the 
tetraspan proteins including occludin (∼65 kDa) and the claudins (∼22 kDa) (Furuse 
et al., 1993; Furuse et al., 2001). The occludins and claudins form continuous dividing 
fibrils of transmembrane particles that completely surround the apical aspect of the 
adjacent surface of each cell (Figure 1.3B), forming a multifaceted barrier, which 
demonstrates ion and molecular size selectivity (Tsukita et al., 2002; Acharya et al., 
2003). The tight junctions between the surface epithelial cells play a major role in 
blocking transepithelial ion flux efficiently so that the epithelium can maintain the very 
high transepithelial resistances (Lewis et al., 1976; Wang et al., 2003; Acharya et al., 
2003).   
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Figure 1.3 The zone of attachment between adjacent urothelial cells A) The zone of attachment between two urothelial 
cells consists of tight junction (TJs), desmosomes (Ds) and adhered junctions (AJs). B) An overview of the structure of a tight 
junction located between umbrella cells. TJ consist of three members of transmembrane proteins: junction adhesion 
molecules (JAMs), claudins and occluding, TJs; Tight junctions, AJs; Adherens junctions, Ds; desmosomes, GAG; 
glycosaminoglycan layer (Adapted from Abrams et al., 2017).   
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1.6.1.3 The Urothelium and Uroplakins 
 
Another urothelium feature that plays a key role in maintaining tight barrier function of 
urothelium is the presence of uroplakin (Figure 1.2B). The urothelial umbrella apical 
surface is entirely covered by folded plaques that are made from uroplakins (Birder 
and Andersson, 2013). The uroplakins have important functions including maintaining 
the urothelial barrier, in part by preventing proteins as well as ionic and non-ionic 
substances from gaining access to the suburothelial area and systemic circulation 
(Acharya et al., 2004; Apodaca, 2004). Currently, four types of uroplakins have been 
identified in humans – UPIa, UPIb, UPII, UPIII (Lee, 2011). UPIa, Ib and III are 
glycoproteins; the sugar residues are important elements in the process of uroplakin 
synthesis and are necessary for their proper function (Lee, 2011). The role of 
uroplakins in the urinary bladder remains to be fully elucidated. It has been 
demonstrated that deletion of the UPII gene leads to a total absence of urothelial 
plaques, leading to an increased movement of water and solutes of the urine across 
the urothelium (Wu et al., 2009; Kong et al., 2009). The absence of UPII and UPIIIa 
also results in the inappropriate development of umbrella cells. These abnormal and 
underdeveloped umbrella cells undergo hypertrophy that causes urine leakages 
through the urothelium barrier as well as vesicoureteral reflux (Hu et al., 2002; Kong 
et al., 2004; Hu et al., 2007; Lee, 2011). Therefore, the presence of uroplakins is key 
in prevention movement of ion, solutes and water across the urothelium. 
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1.7 Transport Functions of the Urothelium  
 
Although the urothelium forms a tight barrier, it has been known for many years that 
the there is a bidirectional movement of water and solutes across this tissue under 
various osmotic conditions and that the composition of urine changes during passage 
from the renal pelvis to the bladder (Fellows and Turnbull, 1971; Fellows and Turnbull, 
1972; Nelson et al., 1975; Hilson et al., 1990; Negrete et al., 1996). For example, 
Turnbull and Fellows (1972) investigated Na+ and water transport across the luminal 
surface of rabbit urinary bladder urothelium and demonstrated that Na+ permeability 
increased when bladders were filled with hypertonic solutions. Moreover, there was 
apparent net movement of water from the blood stream into the lumen of the bladder 
(Fellows and Turnbull, 1972). Another study also discovered that during hibernation 
season in bears, the urinary bladder absorbs heavy water deuterium oxide (D2O) and 
urea back into the systemic circulation (Nelson et al., 1975).  
Other studies have measured water and Na+ permeability across the bladder wall in 
dogs (Rapoport et al., 1960; Hakim et al., 1965), rats (Hicks, 1965) and humans 
(Fellow and Marshall 1972). These studies collectively have reported a significant net 
transport (both lumen to blood and blood to lumen) of urinary constituents, primarily 
water and Na+ along their respective blood/urine gradients (Levinsky and Berliner 
1959; Rapoport et al., 1960; Turnbull and Fellows 1972; Hohlbrugger, 1987: Walser 
et al., 1988), These studies also concluded that the movement of these solutes and 
water across the urothelium may not simply rely on passive diffusion but that their 
active transport is facilitated by transporters and channels. 
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 1.7.1 Transcellular and Paracellular Pathways 
 
Permeability of water and solutes across the urothelium occurs by two main pathways; 
the paracellular pathway which involves tight junctions located in the intracellular 
space of urothelial cells (Figure 1.4) and the transcellular pathway which consists of 
both the apical and basolateral plasma membranes of the terminally differentiated 
umbrella cells (Figure 1.4)  (Carattino et al., 2013).  
Paracellular transport of solutes is mainly achieved through diffusion and osmosis 
where solutes move down their concentration gradients (Bruewer and Nusrat, 2013). 
This process is heavily influenced by the zone of attachment between flanking 
urothelial cells (Khandelwal et al., 2009).  
The two main barriers involved in transcellular permeability are the apical and 
basolateral membranes of the umbrella cells (Figure 1.4), with the apical surface of 
urothelial cells demonstrating the highest TEER of up to 150,000 Ω cm2, compared to 
the basolateral surface with a TEER of 1,500 Ω cm2 (Clausen et al., 1979; Lewis and 
Kleine, 2000). Whilst paracellular transport of water and solutes is mainly passive, 
transcellular transport can be both passive and active. Transcellular transport is 
directional and energy-dependent and is mediated by transporters and channels 
(Lewis and Kleine, 2000). 
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Figure 1.4 Paracellular and transcellular pathways of the urothelium. The paracellular pathway is composed of the intercellular 
space where tight junctions (TJs) are located. The transcellular pathway, demonstrates movement of solutes across the apical and 
basolateral plasma membrane of the umbrella cells. The apical plasma membrane contains urothelial plagues and glycosaminoglycan 
(GAG) layer. DFV, discoical fusiform vesicles; TJ, tight junction; GAG, glycosaminoglycan layer (Adapted from Abrams et al., 2017).    
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1.8 Mechanisms for Ion, Solute and Water Transport Across the 
Urothelium 
 
A variety of ion transport mechanisms have been defined in the urothelium. Na+, K+ 
and Ca2+ channels, as well as other non-specific cation channels located on the apical 
surface of the plasma membrane (Lasic et al., 2015). The basolateral plasma 
membrane, on the other hand, expresses Cl- channels, Na+/H+ and Cl-/HCO3- 
exchangers, ATPase-dependent pumps as well as Na+ and K+ channels (Lasic et al., 
2015). Other channels that are also expressed by the umbrella cells include 
hemmicannels of connexions and pannexin channels (Taruno, 2018; Epifantseva and 
Shaw, 2019). Na+/H+ and Na+ transporters are known to be responsible for Na+ and 
fluid transport across the epithelium of various tissues (Garty and Palmer, 1997). 
Studies have also demonstrated that Na+ and K+ channels channels are involved in 
cell volume recovery of urothelial cells during changes in intra- and extracellular 
osmolarity (Lewis and Donaldson,1990).  
One of the most studied transport channels is the epithelial Na+ channel (ENaC). 
ENaCs are expressed on the apical surface of the terminally differentiated umbrella 
cells (Figure 1.5). ENaCs facilitate transurethelial Na+ flux along with Na+/K+-ATPase 
dependent active transport on the basolateral membrane to provide the net 
electrochemical gradient that promotes Na+ absorption. During bladder filling, stretch 
of on the urothelium cells can also stimulate K+ and Cl- secretion (Khandewal et al., 
2009).  
Other ion channels that have also been demonstrated in the urothelium include non-
selective TRP channels, permeable to Ca2+, Mg2+ and Na+ (Figure 1.5). (Blanchard et 
al., 2016). Another family of non-selective cation channels include the purinergic 
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receptors (P2X) which are activated by the binding of extracellular ATP and have a 
high permeability to Ca2 +, Na+, and K+. (North, 2016).  
Solutes such as urea and creatinine are also constantly reabsorbed from urine (or 
secreted depending on the local environment). Although simple diffusion across the 
urothelium can be considered for some of these solutes, the magnitude of the quantity 
of flux and its rapidity of movement indicates that the transport is facilitated or active 
in nature (Abrahams et al., 2017). For example, two subfamilies of urea transporters 
(UT)s,  UT-A and UT-B,  have been identified in the urothelium (Li et al., 2012; Li et 
al., 2014; Walpole et al., 2014). These transporters are believed to be involved in 
absorption of urea across the urothelium which leads to alteration of cell volume and 
osmolality (Li et al., 2012; Li et al., 2014; Walpole et al., 2014). 
In addition to ion and solutes, isotopic movement of heavy water (deuterium oxide, 
D2O) or isotopically labelled water across mammalian urothelial has been reported 
(Spector et al., 2002). The mechanism responsible for the bulk movement of water, 
was under debate until the discovery of aquaporin (AQP) water channels in the bladder 
(Rubenwulf et al., 2009; Spector et al., 2002; Rubenwulf et al., 2012). The focus of this 
study is to look at the expression and function of AQP water channels in pig bladder 
urothelium.  
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Figure 1.5 A model for ionic, water and solutes homeostasis in urothelial cells.  
Distribution of water and ions in cells involve both active and passive transport mechanisms across the plasma membrane. Movement 
of solutes and ions across urothelial cells are believed to be accommodated by the Influx of water by osmosis and/or through 
constitutively expressed AQP, leading to cell swelling which induces influx of ions and solutes such as extracellular calcium entry 
through TRP channels, activation of Na + K+ pump (or ATPase), potassium channels, chloride channels ect, and as a result triggers 
AQP translocation or water influx. Water subsequently enters or exits the cell to maintain cellular homeostasis. Major channels known 
to be present on urothelial cells which are involve in maintaining cell homeostasis including volume, osmolarity and pH is shown in the 
above image. ENAC: Epithelial Sodium Channel, TRP = Transient Receptor Potential, AQP: Aquaporin, Na+: sodium, K+: Potassium, 
Ca2+: Calcium, Cl- : Chloride, Na+ H+ : Sodium Hydrogen exchanger, Na+ K+ : Sodium Potassium pump, Cl-/ HCO3- : Chlorde 
Bicarbonate exchanger. Since AQPs facilitate solutes such as urea accros cell membrane, Urea Transporter (UT) which transport 
urea, is believed to work synergistically with AQP channels in facilitating urea transport across uorothelial cells. ENAC is believed to 
respond to hormonal changes such as aldesteron in regulating Na+ and as a result triggers water transport through AQP channels 
(Adapted from Franco et al., 2006, Day et al., 2014) 
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1.9 AQP Water Channels (Structure and Function) 
AQPs, also known as major intrinsic protein (MIPs), are highly conserved ubiquitous 
integral membrane channels that primarily facilitate the transport of water across cell 
membranes in various living organisms (Abascal et al., 2014). AQPs mediate water 
transport across biological membranes in response to osmotic gradients created by 
active transport of ions and solutes (Patil et al., 2016). Selectivity of AQPs to water 
and small solutes is determined by their structure, conformational change and 
conserved motifs. There are currently 12 different AQPs (AQPs 0-11) identified in 
mammals which are divided into three subfamilies: (i) the classical or orthodox AQPs 
(AQP1, AQP2, AQP4, AQP5, AQP8) which are responsible for bidirectional movement 
of water, various ions (CI-, K+) and gases (CO2, NH3, NO, O2) across the epithelial 
barriers even though in general, gas permeability is not limited by the intrinsic cell 
membrane permeability but by diffusion in so-called ‘unstirred layers’ outside the 
membrane (Geers and Gros, 2000) (ii) Aquaglyceroporins (AQP3, AQP7 AQP9 and 
AQP10), which facilitate the movement of water as well as small solutes such as 
glycerol, urea, ammonia, and metalloids , and (iii) S-aquaporins or unorthodox 
superaquaporins (AQP11 and AQP12), which have been identified in animals but their 
exact role in epithelial barriers remains to be determined (Papadopoulos and 
Verkman, 2013; Ishibashi et al., 2014; Madeira et al., 2016). All AQPs share the same 
structural features which consist of six membrane-spanning helical domains (M1, M2, 
M4, M5, M6 and M8) and two half spanning helices (M3, M7) that surround the 
cytoplasmic and extracellular vestibules, with the NH2 and COOH terminals located 
within the cytoplasm (Figure 1.6) (Verkman, 2011; Nesverova et al., 2019). Four AQP 
monomers (each is approximately 30kDa in size) are assembled to form tetramers in 
membranes (Figure 1.6) (Verkman et al., 2014). All AQP channels are characterised 
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by two asparagine-proline-alanine (NPA) sequences (that are important for the 
formation of a water-permeating pore)  located at loops B and E, that shape short 
hydrophobic helices participated in substrate selectivity, a single alanine-glutamate-
phenylalanine-leucine (AEFL) and histidine-tryptophanvaline-phenylalanine-tyrosine-
tryptophan-glycine-proline (HW[V/I][F/Y]WXGP) sequences that are both responsible 
for water permeability and membrane targeting (Figure 1.6) (Jiang, 2009; Guan et al., 
2010; Monsang et al., 2019). The difference between AQPs and aquaglyceroporins is 
the narrowest constriction point of the channel which is also known as selectivity filter 
(SF). The radius of the SF in classical AQPs is ~1.1 Å which is slightly smaller than 
the radius of a molecule of water (~1.4 Å), whereas the radius of the pore for 
aquaglyceroporins is slightly larger (~1.7 Å) than a molecule of water (Fu D et al., 
2000; Tajkhorshid et al., 2002). The SF region is more polar in water selective AQPs 
and contains conserved histidine whereas in aquaglyceroporins, this region is more 
hydrophobic with two conserved aromatic residues, usually a tryptophan and a 
tyrosine (Savage et al., 2010; Verkman et al., 2011). The difference in the SF region 
of AQPs and aquaglyceroporin contributes to the selectivity of these two different types 
of channels to water and larger solutes.  
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Figure 1.6 The secondary, tertiary, and quaternary structures of Aquaporin proteins  
(A) Aquaporin structure contains six -helices linked together by three extracellular and two intracellular loops. Loops B and E contain 
asparagine-proline-alanine (NPA) motifs which makes the smallest diameter of AQP pore. In addition, loop E -helices from each 
monomer also contains aromatic/arginine (ar/R) motifs which play an important role in H+ exclusion. (B) All six α-helices assemble in a 
closely connected tertiary monomer structure with both ar/R motifs located internally and interacting at opposite sides of the pore and 
both NPA motifs interacting within the membrane.  A route for water passage exists in the transmembrane pore formed through the 
centre of the individual monomer three-dimensional barrel. (C) Individual AQPs monomers homotetramerise to create a five-pore 
quaternary structure. The function of the central pore located within the individual monomer, formed by the space between all four 
monomers, remains largely unknown (Adapted from Halsey et al., 2018). 
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1.10 AQPs’ Regulation  
 
Water is a unique substance and its properties such as being polar allows liquid water 
to act as a "universal solvent that is able to dissolve many ionic and polar covalent 
compounds, make it the most central molecule in biology” (Perez and Riveros, 2017). 
Regulation of the osmotic potential within a cell is fundamental and the water flux 
across biological membranes is mediated by intrinsic membrane proteins acting as 
water channels. Eukaryotes have evolved to fine-tune water transport through these 
water channels (AQPs) by three main regulatory mechanisms: (1) at the 
transcriptional/translational level (Matsumura et al., 1997); (2) by translocation to the 
membrane in response to a trigger (Nedvetsky et al., 2009); (3) by conformational 
change or “gating” (Walz et al., 2009). These regulatory mechanisms can be achieved 
through phosphorylation, glycosylation or ubiquitination of AQPs (Leitch et al., 2001; 
Hendriks et al., 2004; Kamsteeg et al., 2006; Buck et al., 2004; Willermain et al., 2014; 
Duan and Walther, 2015; Nesverova et al., 2019). Phosphorylation of AQPs is the 
most efficient and studied form of post translational modification of AQP as it allows 
rapid modification of AQPs membrane water permeability in a reversible manner.  
  
1.10.1 Phosphorylation of AQPs 
 
Phosphorylation of proteins is one of the most important post-translational 
modifications that allows proteins to be regulated reversibly. About 30% of mammalian 
proteins are phosphorylated and phosphorylation significantly alters protein activity, 
protein: protein interactions and protein trafficking (Cohen, 2000; Audagnotto and 
Peraro, 2017). Effects of phosphorylation are cell specific and thus, enable proteins to 
be regulated according to the functions of a particular cell type (Cohen, 2000; 
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Nesverova et al., 2019). In eukaryotes, AQP phosphorylation allows water flow across 
cellular membranes to be tightly regulated in response to various external and internal 
signals which are further described in Table 1 (Conner et al., 2013). Trafficking and 
gating serves as a fast regulatory mechanism by increasing the abundance of AQPs 
located in the plasma membrane through shuttling of AQP protein, or by increasing 
water flow through the channel (Kreida and Horsefield, 2015).  
 
1.10.2 Glycosylation of AQPs 
 
Glycosylation is another form of post translational modification in eukaryotes (Lis and 
Sharon. 1993). Glycans, also referred to as polysaccharide, are mostly attached to 
secreted proteins as well as membrane proteins. Processing of the glycan occurs in 
the ER lumen before the protein has been fully synthesised and folded and the protein 
is subsequently transported to the Golgi apparatus where it is further processed 
(Jamieson and Palade, 1968; Atkinson and Lee, 1984). Several AQPs are shown to 
have consensus sequences for N-linked glycosylation and are monoglycosylated in 
native tissues (e.g; AQP1, AQP3, AQP9, AQP11and AQP10) (Chen et al., 2015). For 
example, in 50% of purified erythrocytes, AQP1 monomers are glycosylated with 
polylactosaminyl oligosaccharide at residue N42 in the first extracellular loop (loop A) 
(van Hoek et al., 1994; Verkman and Mitra 2000; Boury-Jamot et al., 2006). However, 
the specific functions altered by AQP glycosylation have not been identified. (Helenius, 
2001; Spector et al., 2002). Existing reports have suggested that glycosylation of 
AQPs is not required for water transport function, tetramerization nor for transport from 
the endoplasmic reticulum to the Golgi complex (Hendriks et al., 2004). Instead, the N-
linked glycan is important for exit from the Golgi complex and sorting of AQP2 to the 
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plasma membrane (Hendriks et al., 2004; Buck et al., 2004). AQP glycosylation may 
be key in AQP maturation and arrangement in the membrane. 
 
1.10.3 Ubiquitination of AQPs 
Another less studied form of AQP post translational regulation is ubiquitination. 
Ubiquitination of membrane proteins is a common way of mediating internalization and 
promotion of protein degradation by the lysosomal pathway (Piper and  Luzio, 2007; 
Kazazic et al., 2009;  Vina-Vilaseca et al., 2011).  AQPs have been demonstrated to 
be ubiquitinated for proteasome degradation (Leitch et al., 2001; Kamsteeg et al., 
2006; Willermain et al., 2014). For example, AQP2 phosphorylation sites S256 and 
S269 play an important role in the translocation of this protein to the membrane. 
Prevention of S256 phosphorylation causes ubiquitination where ubiquitin protein 
attaches to AQP2 protein, leading to internalisation of AQP2 irrespective of the S269 
phosphorylation status (Kamsteeg et al., 2006). Also, phosphorylation at S261 is 
involved in AQP2 ubiquitination and degradation (Nedvetsky et al., 2010; Tamma et 
al., 2011). AQP1 has also been demonstrated to be ubiquitinated for proteasome 
dependent degradation however, under hypertonic conditions, AQP1 ubiquitination 
decreases and protein stability markedly increases thereby contributing to overall 
protein induction (Leitch et al., 2001). 
 
1.10.4 Primary Signals that Stimulate AQP Regulation 
 
Regulation of AQPs through phosphorylation, glycosylation and ubiquitination can be 
triggered by a number of stimuli including hormones such as vasopressin, adrenaline, 
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oestrogen, aldosterone (Oliveira et al., 2005; Boone and Deen, 2008; Kwon et al., 
2013; Jung and Kwon 2016; Vukicevic et al., 2016;), changes in tonicity (Hoffert et al., 
2000, Matsuzaki et al., 2001; Kultz, 2001; Tamas, 2003; Arima et al., 2003, Cahalan 
et al., 2004; Hasler et al., 2005, Loitto et al., 2007) and activation of TRP ion channels 
(Benfenati, et al., 2007; Benfenati et al., 2010; Jo et al., 2015) and possible ENaC 
channels. These primary signals initiate signalling cascades with the ultimate goal of 
regulation AQP function, depending on the specific need and requirement of the 
tissue. Although the intracellular signalling pathways used for the control of AQP 
function have not been conclusively established, a few intracellular signalling 
components in the regulation of the different types of AQPs have been described  
(Table 1.2). These include cytoskeletal proteins, Ca2+, protein kinase A (PKA), protein 
kinase C (PKC), protein kinase G (PKG), and phosphatidylinositol 3-kinase (Table 1.2) 
(Tietz et al., 2006; Carmosino et al., 2007; Garcia et al., 2001; Ishikawa et al., 2002; 
Gunnarson et al., 2008; Nesverova et al., 2019). Specific primary signals involved in 
AQPs regulation have been described in Table 1.1 Studies that have reported on the  
function, localisation and known intracellular signalling components/pathways for each 
subtypes of AQPs identified are further discussed in the subsequent sections. 
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Primary signals Translocation AQP Experimental system Reference 
Vasopressin PM
WP
AQP2 
AQP4 
Native kidney tissue 
Xenopus oocytes 
(Christensen et al., 2009) 
(Moeller et al., 2009)
Histamine PM AQP4 Human gastric cells (Carmosino et al., 2007)
Isoprenaline PM 
PM 
AQP3 
AQP7 
Human adipocytes 
Human adipocytes 
(Rodriguez et al., 2011b) 
(Rodriguez et al., 2011b) 
Hypertonicity PM 
PM 
PM 
PM
PM 
PM 
AQP1 
AQP2 
AQP3 
AQP4 
AQP5 
AQP9 
Human neutrophils 
Collecting duct cells 
MDCK cells 
Rat astrocytes Lung 
epithelial cells Rat 
astrocytes 
(Loitto et al., 2007) 
(Hasler et al., 2005) 
(Matsuzaki et al., 2001) 
(Arima et al., 2003) 
(Hoffert et al., 2000) 
(Arima et al., 2003) 
Glutamate PM/WP AQP4 Astrocytes (Gunnarson et al., 2008) 
Lipopolysaccharide PM AQP5 Lung epithelial cells (Ohinata et al., 2005)
Hypotonicity PM 
PM 
PM
AQP1 
AQP3 
AQP8
HEK293/astrocytes 
Keratinocytes 
Amnion epithelial cells 
(Conner et al., 2010) 
(Garcia et al., 2011)
(Qi et al., 2009)
Vasoactive intestinal 
polypeptide PM AQP5
Duodenum (Brunner’s 
gland)
(Parvin et al., 2005)
Secretin PM AQP1 Cholangiocytes (Marinelli et al., 1997) 
Adrenaline PM 
PM 
AQP3 
AQP5 
Caco-2 epithelial cells 
Rat parotid cells
(Yasui et al., 2008) 
(Ishikawa et al., 1999) 
Acetylcholine PM AQP5 Rat parotid cells (Ishikawa et al., 1998b) 
Table 1.1 Examples of primary signals involved in in AQP regulation 
Primary signals that initiate AQP regulation in different cell lines and mammalian tissues are listed PM; aquaporin translocation to 
the plasma membrane. WP; water permeability. The experimental system used to determine the AQP translocation is included for 
each primary signal.  Adapted from (Conner et al., 2013) 
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Intracellular 
component 
AQP Effect Experimental system Residue Reference 
PKA
AQP0 
AQP2 
AQP4 
AQP5 
AQP5
AQP6 
AQP7 
WP 
PM
PM 
PM 
PM 
Uknown
Putative 
Collecting duct
Kidney tissue
Human gastric cells 
MDCK 
Brunner’s gland 
MDCK 
n/a 
S235 
S256 
-
S152
-
-
-
(Reichow and Gonen, 
2008) (Christensen et al., 
2000) (Carmosino et al., 
2007) (Karabasil et al., 
2009) (Parvin et al., 
2005) 
(Beitz et al., 2006) 
(Kishida et al., 2000) 
PKC 
AQP0
AQP1 
AQP3 
AQP3 
AQP4 
AQP4 
AQP9 
PM 
PM 
PM 
PM 
PM 
PM 
PM 
RK13 epithelial cells 
HEK293 cells 
Caco-2 epithelial cells 
Caco-2 epithelial cells 
Astrocytes 
Xenopus oocytes
Human neutrophils 
S235 
T157/T23
9 T514 
S660 
S111
S180 
S11/S222 
(Golestaneh et al., 2008) 
(Conner et al., 2012)
(Yasui et al., 2008) 
(Yasui et al., 2008) 
(Gunnarson et al., 2008) 
(Moeller et al., 2009) 
(Karlsson et al., 2011) 
PKG AQP5 PM Rat parotid cells - (Ishikawa et al., 2002) 
Actin
AQP1 
AQP4 
AQP5
AQP5 
PM 
PM
PM
PM 
Cholangiocytes
Astrocytes 
Salivary gland cells 
Rat parotid
-
-
-
-
(Tietz et al., 2006) 
(Nicchia et al., 2008)
(Tada et al., 1999) 
(Ishikawa et al., 1999) 
Microtubule 
+ cAMP
AQP1 
AQP5
AQP8 
AQP5 
PM 
PM
PM
PM
HEK293 cells 
MDCK cells 
Hepatocytes 
Lung epithelial cells
-
-
-
-
(Conner et al., 2010) 
(Karabasil et al., 2009) 
(Garcia et al., 2001) 
(Yang et al., 2003)
Ca2+/ 
Calmodulin
AQP1 
AQP5 
AQP6 
PM
PM
PM
HEK293 cells 
Rat parotid cells 
CHO-K1 cells 
-
-
-
(Conner et al., 2012) 
(Ishikawa et al., 1998a, 
Ishikawa et al., 1999, 
Rabaud et al., 2009) 
TRP channels AQP1 PM HEK293 cells - (Conner et al., 2012) 
RAC1 AQP9 PM Human neutrophils - (Karlsson et al., 2011) 
Dynein AQP1 PM Cholangiocytes - (Marinelli et al., 1997) 
Kinesin AQP1 PM Cholangiocytes - (Marinelli et al., 1997) 
Table 1.2 Examples of intracellular signalling components involved in AQP regulation  
A summary of the intracellular signalling components involved regulating AQP function. The arrows indicate the direction of the 
effect. Arrows going down indicate internalisation of AQPs from the membrane as a result of intracellular signalling. Arrows 
pointing up indicate translocation of AQPs to the membrane and the amino acid residue that the component acts upon is also 
included where known (Conner et al., 2013) 
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1.10.4.1 AQP0 Localisation, Function and Regulation  
 
The major intrinsic protein (MIP), also known as AQP0 – was initially identified in 1984 
as a water channel and gap junction protein (Gorin et al., 1984). AQP0 is involved in 
cell-to-cell adhesion of fibre cells and has also been found in kidney collecting ducts 
and other tissues.  Mutations in AQP0 have been associated with individuals suffering 
from cataracts (Berry et al., 2000). Studies have demonstrated  that the C-terminus of 
AQP0 contains numerous phosphorylation sites; S229 for casein II (Ball et al., 2004), 
S231 for PKC and S235 for PKA (Schey et al., 2000) and that phosphorylation of these 
sites is important for gating and translocation of AQP0 to the membrane in various 
cell. 
 
1.10.4.2 AQP1 Localisation, Function and Regulation 
 
From the 13 identified AQPs, AQP1 was the first protein for which water transport 
across its channel was assesed. Also it was the first AQP for which the structure was 
determined (Murata et al., 2000). Since the discovery of AQP1 in erythrocytes, it has 
been found in a wide range of tissues, including kidneys, eyes, lungs, muscles and 
brain tissue (Maunsbach et al., 1997; Stamer et al., 2003; Au et al., 2008 Tomassoni 
et al., 2010; Gao 2013;).  No studies have reported AQP1 regulation through gating 
but it has been shown that changes in tonicity causes trafficking of AQP1 to the 
membrane in HEK293 cells, mediated by PKC (Conner et al., 2010). It was shown that 
trafficking was mediated by Ca2+ influx through transient receptor potential-
canonical  1 (TRPC1) channels, resulting in activation of CaM and PKC, with 
subsequent phosphorylation of AQP1 (Conner et al., 2010). Two phosphorylation sites 
with a consensus region for PKC have been identified in AQP1; T157, located in loop 
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D, and T239 of the C-terminus and they are thought to mediate hypotonicity-induced 
translocation of AQP1. Phosphorylation of these sites lead to increase water 
permeability in Xenopus oocytes (Zhang et al., 2007; Tomita et al., 2017). PKA also 
phosphorylates AQP1 in vitro in rat kidney homogenates, and studies carried out in 
oocytes demonstrated that cAMP and arginine vasopressin (AVP), both known 
activators of PKA, increase AQP1 membrane abundance (Han and Patil, 2000). The 
combination of PKA and PKC phosphorylation of AQP1 is not needed for AQP1 
translocation to the membrane. This was demonstrated when after inhibition of PKA 
in HEK293 cells, AQP1 was still trafficked to the plasma membrane.  (Zhang et al., 
2007). 
 
1.10.4.3 AQP2 Localisation, Function and Regulation 
 
AQP2 was identified soon after the discovery of AQP1, in particular in the renal 
collecting duct (Fushimi et al., 1993).  AQP2 has been identified in a variety of human 
tissues, including the lungs (Verkman;1998) and  intestine (Zhu et al.,2016), but is best 
studied in terms of its function in the collecting duct where it plays a key role in 
regulating urine volume and concentration, mediated by vasopressin (antidiuretic 
hormone, ADH). Vasopressin is a peptide hormone that controls plasma osmolality 
through the regulation of renal water excretion/reabsorption facilitated by AQPs Lee 
and kwon et al., 2007). When plasma osmolality increases, as would occur in whole 
body dehydration for example, vasopressin is secreted from the posterior pituitary 
gland.  In the collecting duct, vasopressin binds to G-protein coupled vasopressin V2 
receptors on the basolateral membrane which leads to an increase of intracellular 
cAMP and subsequent phosphorylation of AQP2 by PKA. PKA-mediated 
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phosphorylation triggers the translocation of AQP2 residing in storage vesicles to the 
apical membrane, causing increased osmotic water transport across the epithelium of 
the collecting duct, leading to reabsorption of filtered water back to the blood 
(Vukicevic et al., 2016). When the levels of vasopressin, which has a short half-life of 
about 15 mins, are reduced, AQP2 undergoes endocytosis; a fraction of the protein is 
ubiquitinated and degraded, and the water permeability of the membrane is reduced 
back to the initial situation (Kamsteeg et al., 2006). 
 
1.10.4.4 AQP3 Localisation, Function and Regulation 
 
AQP3 was initially identified in the basolateral membrane of the collecting duct in the 
kidney. (Ma et al., 1994, Ishibashi et al., 1994, Echevarria et al., 1994). AQP3 belongs 
to the aquaglyceroporin family, indicating that it transports not only water, but also 
glycerol, urea, and other solutes. AQP3 has been identified in various tissues including 
keratinocytes in the basal layer of the epidermis in human skin (Sougrat et al., 2002). 
As with many AQPs, the exact role of AQP3 have not been identified, however, a few 
studies have provided possible roles for AQP3 (Spector et al., 2002; Jamot et al., 2006; 
Thiagarajah et al., 2017; Rubenwulf et al., 2012). Molecular studies have found that 
deletion of the AQP3 gene in mice causes a reduction in skin elasticity, slower wound 
healing, reduced glycerol contents and dry skin (Hara et al., 2002). Another study also 
revealed that AQP3 null mice causes AQP2 to be down-regulated. Although the 
mechanism of AQP2 down regulation in the absence of AQP3 is not fully known, a 
possible suggestion could be proposed. AQP2 is found on the apical surface of 
collecting ducts to allow reabsorption of water while AQP3 is found on the basolateral 
surface to allow excretion of water from the cell. Both AQP proteins operate in an 
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organised manner to reabsorb water as well as restoring the cell volume of collecting 
duct principal cells, also known as regulatory volume decrease (RVD). It could be 
hypothesised that, in AQP3 null mice, RVD, a process where cells are restored to their 
original cell volume, cannot be achieved. Therefore, the increase in cell volume as a 
result of AQP2 water permeability leadis to cell stretch, initiating an inhibitory 
mechanism that causes AQP2 to be downregulated as an attempt to prevent the 
increase in cell volume. AQP3 regulation has not been fully established, however, 
aldosterone hormone (Kwon et al., 2002), isoprenaline (Rodriguez et al., 2011), 
adrenaline (Yasui et al., 2008) and tonicity (Matsuzaki et al., 2001; Garcia et al., 2011) 
have been has been proposed to regulate AQP3 expression and function. Epinephrine 
was found to promote translocation of AQP3 from the cytoplasmic fraction to the 
plasma membrane. This increased trafficking of AQP3 was suppressed by 
phospholipase C and PKC inhibitors and a phorbol ester accelerated the trafficking of 
AQP3 to the membrane fraction (Yasui et al., 2008). 
 
1.10.4.5 AQP4 Localisation, Function and Regulation 
 
AQP4 was first cloned from rat lung (Hasegawa et al., 1994) and rat brain (Jung et al., 
1994a). Since then, AQP4 has also been found in numerous tissues including kidney 
(Kim et al., 2001). AQP4 is particularly highly expressed in astrocytic glial cells of the 
brain with a role in maintaining osmotic potential across the blood brain barrier 
(Passantes-Morales and Cruz Rangel, 2010). Various isoforms for AQP4 have been 
identified but the isoform identified in the brain is several amino acids longer and it 
transports water at higher rates. Subsequent publications reported more possible 
splice variant of the gene (Yang et al., 1995; Lu et al., 1996). AQP4 knock-out in 
33 
 
astrocytic end-feet are protected from cytotoxic brain oedema (Tang and Yang, 2016) 
and AQP4 antibodies are thought to be key to the onset of neuromyelitis optica (Chan 
et al., 2012). In addition, the water flux through AQP4 aids in rapid clearance of K+ 
thereby contributing to the recovery of normal extracellular K+ concentration after 
neuronal activation (Amiry-Moghaddam et al., 2003). AQP4 is also regulated by 
vasopressin, however, unlike AQP2, vasopressin does not result in AQP4 
translocation from internal stores to the plasma membrane. Vasopressin caused 
AQP4 to be internalised from the cell surface in xenopus oocytes (Gunnarson et al., 
2008; Moeller et al., 2009).  
 
1.10.4.6 AQP5 Localisation, Function and Regulation 
 
AQP5 is highly expressed in various tissues including salivary, sweat and lacrimal 
glands, as well as lungs and airways, and plays a key role in secretion of isotonic fluids 
(Kitchen et al., 2015). AQP5 has been demonstrated to function together with TRP 
vanilloid 4 (TRPV4) to control regulatory volume decrease (a process that allows the 
cells to return to its initial volume) in saliva. AQP5 has the closest homologues to AQP2 
and therefore they share similar regulatory mechanisms (Frick et al., 2013). AQP5 has 
been found to be regulated by cAMP and a PKA-dependent pathway in several cell 
types. Two consensus PKA sites for phosphorylation have been identified in AQP5; 
S156 in loop D and T259 in the C-terminus (Woo et al., 2008). The PKA consensus 
site T259 plays a crucial role in AVP-mediated membrane targeting. Both these sites 
have been shown to be able to be directly phosphorylated by PKA and S156 was 
shown to be preferentially phosphorylated in tumour cells (Woo et al., 2008). 
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1.10.4.7 AQP6 Localisation, Function and Regulation 
 
AQP6 was first cloned from rat kidney and was initially referred to as WCH3 (Ma et 
al., 1993). AQP6 has been identified in kidney but in contrast to other renal aquaporins, 
AQP6 is located in intracellular vesicles suggesting that AQP6 is less likely to be 
involved in water reabsorption. Instead, studies found that acidic pH could serve as 
the activating mechanism of AQP6 and it could function as an acid-base regulator 
(Yasui et al., 1999a). Similar to AQP2, AQP6 is retained within intracellular vesicles 
and studies have found that residues at the N-terminal sequence are required for 
cytosolic retention (Conner et al., 2013). For example, substitution of the N-terminal 
sequence on AQP1 for AQP6 N-terminal resulted in intracellular retention of the 
AQP1/AQP6-N-terminus (Conner et al., 2013). A possible PKA phosphorylation site is 
also found at the C-terminal but no role has been reported for this site. (Beitz et al., 
2006). 
 
 1.10.4.8 AQP7 Localisation, Function and Regulation 
 
AQP7 belongs to the aquaglyceroporins, similar to AQP3 AQP9 and AQP10. AQP7 
was first cloned from rat testis (Ishibashi et al., 1997a) and was found to transport 
glycerol. AQP7 expression is also found in both skeletal (Yang et al., 2000; Skowronski 
et al.,2007) and cardiac muscle (Butler et al., 2006; Skowronski et al., 2007). 
In humans it was first found expressed in adipose tissue (Kuriyama et al., 1997). In 
adipocytes, AQP7 supplied the glycerol needed for gluconeogenesis (Lena and 
Lebeck, 2018). In addition, adult AQP7 null mice have a severe increase in body fat 
mass indicating a role in obesity (Hara-Chikuma et al., 2005). In the kidney, AQP7 has 
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also been shown to reabsorb glycerol (Skowronski et al., 2007). PKA has been 
proposed to be involved in AQP7 translocation in which cells? (Kishida et al., 2000), 
however, experimental evidence for this is currently lacking.  
 
1.10.4.9 AQP8 Localisation, Function and Regulation 
  
AQP8 has been found in various tissues including colon, placenta, liver, heart (Ma et 
al., 1997), testis (Ishibashi et al., 1997b) and pancreas (Koyama et al., 1997). As with 
many of the identified AQPs, AQP8 regulation still remains to be fully established in 
the different tissues in which it has been identified. However, studies have provided 
evidence of intracellular components involved in AQP8 trafficking. For example, AQP8 
has been shown to be trafficked from intracellular vesicles to the plasma membrane 
in response to cAMP stimulation in isolated hepatocytes (Garcia et al., 2001). Although 
AQP8 exhibits similar structure and conserved NPA sequences compared to other 
AQPs, studies shows that AQP8 lacks the conserved regions essential for 
phosphorylation via PKA or PKC (Conner et al., 2013). This observation is significant 
in providing the possibility of an intermediate protein that is independent of the PKA 
pathway, being involved in phosphorylation of AQP8.  
 
 
1.10.4.10 AQP9 Localisation, Function and Regulation 
 
AQP9 is expressed in kidney, liver, leucocytes, lung, spleen, brain and testis (Lindskog 
et al., 2016). Similar to AQP3 and AQP7, AQP9 it belongs to the aquaglyceroporin 
family and has been shown to transport solutes such as urea and glycerol in addition 
to water (Ishibashi et al., 1998; Tsukaguchi et al., 1998). In liver, AQP9 mediates the 
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uptake of glycerol and also participate in the mechanisms of energy sensing in the 
brain (Badaut et al., 2004). PKC is a possible regulator for AQP9. AQP9/PKC binding 
or phosphorylation sites have been identified as serine residues 11 and 222 (Loitto et 
al., 2007). AQP9 has also been shown to be phosphorylated in human neutrophils. 
PKC-mediated phosphorylation at serine 11 triggered by hyperosmolarity caused 
trafficking of AQP9 to the plasma membrane which contributed to RVD or a regulatory 
volume increase (RVI). Of interest, a S11A mutation ablated AQP9 translocation to 
the plasma membrane (Karlsson et al., 2011).  
 
 1.10.4.11 AQP10 Localisation, Function and Regulation 
  
Little is known about AQP10 expression, regulation and function. AQP10 belongs to 
the aquaglycerolporins localised in human adipose tissue, small intestine, male 
reproductive system and skin (Li et al., 2006). In the small intestine, two isoforms of 
AQP10 were identified and both isoforms have been proposed to play different roles 
in the proximal portion of human small intestine (Li et al., 2006; Laforenza et al., 2015) 
In adipose tissue, AQP10 is expressed along with AQP7 and it is believed to have 
similar role as AQP7 in maintaining normal or low glycerol content inside the 
adipocytes, thus protecting human from obesity (Laforenza et al., 2016). Currently, no 
studies have been reported on AQP10 regulation in mammals.  
 
1.10.4.12 AQP11 Localisation, Function and Regulation 
 
AQP11 is considered as an S-aquaporin or unorthodox superaquaporin. These have 
been identified in animals but not fungi, bacteria or plants, and their exact role in 
epithelial barriers remains to be determined (Madeira et al., 2016; Ishibashi et al., 
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2014; Papadopoulos and Verkman, 2013). AQP11 null mice develop polycystic 
kidneys (Ishibashi, 2009). Also, Muller cells expressing AQP11 shows the AQP11 is 
important during osmotic stress conditions in the rescue from cell shrinking in 
extracellular hypertonic conditions (Deeg et al., 2016). Immunohistochemical studies 
have shown AQP11 localisation in intracellular organelles kidney proximal tubes 
(Morishita et al., 2005). The ability of AQP11 to mediate water transport was 
investigated in oocytes and reconstituted liposomes. However, these experimental 
studies showed contrasting data. Oocytes showed no water transport (Gorelick et al., 
2006), while transport was observed in artificial liposomes (Yakata et al., 2007). The 
exact intracellular signalling pathway or signalling components involved in AQP11 
activity has currently not been revealed.  
 
1.10.4.13  AQP12 Localisation, Function and Regulation 
 
Similar to AQP11, AQP12 belongs to the S-aquaporins or unorthodox 
superaquaporins. AQP12 is poorly characterised and little is known about its role. A 
key signature feature of all identified AQPs is the tandem repeats of highly conserved 
pore-forming amino acid residues named NPA boxes (Morishita et al. 2004). The NPA 
boxes of the new subfamily, of which AQP12 belongs, however, are very different with 
an overall homology of less than 20% (Morishita et al. 2004). Further, little is known 
about the functions and physiological relevance of AQP12. AQP12 was selectively 
localised in the acinar cells of the pancreas and this along with its location in 
intracellular organelles suggests a role in digestive enzyme secretion such as  
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AQP Year Found Permeable to Location Putative Functional Roles 
0 1984 Water Lens fibre gap junctions Water regulation, structural 
function 
1 1987 Water Kidney (proximal renal 
tubule), eye, CNS, lung, 
erythrocytes 
Water homeostasis, fluid 
reabsorption
2 1993 Water Kidney collecting duct
Water homeostasis, 
reabsorption from urine
3 1994 Water, glycerol, urea Skin, kidney, lung, eye, small 
intestine, colon 
Water homeostasis in renal 
collecting duct, glycerol/lipid 
metabolism 
4 1994 Water Brain, lung, muscle, stomach
Glial cells, (astrocytes), renal 
collecting duct
Water regulation, cerebral 
oedema
5 1995 Water Salivary-, lacrimal- and sweat 
gland, lung, eye. 
Facilitates isotonic secretions 
6 1993 Water, anions Renal collecting duct Intracellular water/ion 
regulation
7 1997 Water, glycerol, urea, arsenite Adipocytes, kidney, liver, testis Glycerol/lipid metabolism
8 1997 Water Liver, kidney, testis, pancreas, 
heart, colon, placenta, small 
intestine
Water homeostasis
9 1998 Water, glycerol, urea, small 
solutes, arsenite
Kidney, liver, leucocytes, lung, 
spleen, brain, testis 
Water/ small molecule 
homeostasis, glycerol 
metabolism
10 2001 Water, glycerol, urea Small intestine (duodenum, 
jejunum), kidney 
Water regulation
11 2000/2005 Water Kidney, testis, brain, 
pancreas, leucocytes, smooth 
muscle , liver
Unknown
12 2000/2005 Unknown Pancreas Unknown
Table 1.3 Expression, localisation, function and discovery of AQP 0-12 
This table present the different types pf AQPs identified in mammalian cells, their subcategories, function and their 
discovered roles (where known) in different tissues. Adapted from Conner et al., 2012 
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1.11  AQPs and the Urinary Bladder 
The notion that the kidney is not exclusively responsible for determining the final 
concentration of urine has existed for many years. Several studies have demonstrated 
that the composition of urine sampled at the renal pelvis is different from samples 
taken from the bladder (Englund 1956; Levinsky and Berliner 1959; Cahill et al., 2003; 
Shafik et al. 2004; Shafik et al. 2005), suggesting that for the duration that urine is 
present in the bladder, the urothelium contributes to modifying urine composition.  
AQPs (and aquaglyceroporins) have been identified in the urothelium of various 
species such as rats, hibernating bears and humans (Spector et al., 2002; Rubenwulf 
et al., 2009; Rubenwulf et al., 2012), indicating that AQPs might generally be involved 
in modification of urine concentration. Changes to the extracellular osmolarity of 
urothelial cells are also a form of stress, which results in release of transmitters such 
as ATP, acetylcholine and Nitric oxide (NO) (Birder and Andersson, 2013). Release of 
these transmitters has a significant effect on the contractile function of the bladder and 
transduction mechanisms underlying the activation of afferent fibres during bladder 
filling (Vlaskovska et al., 2001; Yu and de Groat, 2010). However, the exact role of 
AQPs in mediating the sensory and contractile functions of the bladder wall, and the 
mechanisms by which their expression and function in the urothelium is regulated, 
remains unclear. A better understanding of the role of AQPs in modulating water and 
solute movement across the bladder urothelium should aid in the development of novel 
therapeutic interventions for the treatment of conditions, such as nocturia. 
1.12  Pathologies Associated with Urothelium Barrier Dysfunction 
As with many other organs, the cause of bladder disorders cannot be attributed to one 
single source. However, there is emerging evidence to support the involvement of 
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bladder urothelium abnormalities in a variety of these disorders (Curhan et al., 1999; 
Held et al., 1990; Johansson and Fall, 1990; Tomaszewski et al., 2001). One of these 
abnormalities is nocturia. Nocturia is a lower urinary tract (LUT) disorder that is 
currently defined by the International Continence Society (ICS) as waking up from the 
main period of sleep one or more times to void (Bergman et al., 2015). Morbidity 
associated with nocturia, mainly due to its impact on sleep, includes increased 
prevalence of depressive symptoms in men and woman, tiredness, mood changes, 
cognitive dysfunction with poor concentration and performance (Jin and Moon, 2008; 
Kupelian et al., 2012; Dani et al., 2016).  
The prevalence of nocturia increases with age (Kim et al., 2010), so another important 
associated morbidity is an increased risk of falls and fractures in the elderly (Friedman 
and Weiss, 2013). These complications collectively result in direct, indirect and 
intangible costs to health-care systems that are often overlooked. Direct annual costs 
of nocturia, including those associated with falls and fractures, were estimated to be 
approximately $1.5 billion in the United States (US) and €1 billion in the largest fifteen 
European countries (Larsen, 2014). Loss or impairment of work productivity, which is 
categorized as an indirect impact of nocturia, was calculated to cost $62.5 billion and 
€29 billion annually in US and in the 15 largest European countries respectively (Oelke 
et al., 2014). Intangible costs, such as behavioural modifications, feelings of loss of 
control and poor mood, prove difficult to be evaluated as they affect the quality of life 
of patients and are not immediately equivalent to an economic cost (Larsen, 2014). In 
view of these financial and social impacts of nocturia, it is important to research and 
develop better treatments and management options for this condition.  
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 1.12.1 Aetiology and Pathophysiology of Nocturia 
Nocturia is considered as one of the hallmarks symptoms of lower urinary tract (LUT) 
disorders such as overactive bladder (OAB) syndrome and benign prostatic 
hyperplasia (BPH) (Kerrebroeck and Andersson, 2014). Treatment options provided 
for patients with LUTs  disorders such as OAB and BPH do not significantly improve 
nocturia (Smith and Wein., 2011), indicating that although nocturia is hallmark for 
LUTs, it is a condition in its own right with various aetiologies unrelated to bladder or 
prostate disorders. Thus, treatment regimens should be designed to treat nocturia and 
not other LUT disorders in the hope of improving nocturia. While bladder outlet 
obstruction (BOO) or prostate enlargement may cause nocturia in some patients, in 
many non-urological factors play a major role. Hormonal imbalance, uncompensated 
heart disease, sleep disorder and lifestyle choices, such as fluid intake before bed 
time, are a few examples of non-urological factors (Van Kerrebroeck et al., 2002). In 
addition to bladder storage disorders, other urological causes may be related to kidney 
disorders that leads to overproduction of urine throughout the day or during sleep 
(global or nocturnal polyuria) (Kerrebroeck and Andersson, 2014).  
 
 1.12.2 Urological Causes of Nocturia  
The general accepted categories for the classification of nocturia includes nocturnal 
polyuria (NP), reduced bladder capacity (RBC), global (24 hour) polyuria (GP) and a 
combinations of these conditions. Under the category of RBC, altered salt/water 
reabsorption from the bladder is a possible cause (Weiss et al., 1998).  
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1.12.3 Nocturnal polyuria Nocturnal polyuria (NP) 
NP is excessive urine production at night (33% of total daily urine output) caused by 
water diuresis, solute diuresis or both, and it affects up to 82% of patients with nocturia 
(Young et al., 2015). Lifestyle and behavioural choices such as excessive fluid intake 
in the evening (diuretic beverages; alcohol, caffeine) (Figure 1.7) or a defect in 
vasopressin secretion and function causes NP. Alternatively, the condition may be 
idiopathic (Kerrebroeck and Andersson, 2014). The primary causes of solute diuresis 
include congestive heart failure, sleep apnoea, renal insufficiency, autonomic 
neuropathy, venous insufficiency and neurological disease (Kujubu 2009).  
 
1.12.4 Global polyuria (GP) 
GP is defined as a continuous overproduction of urine (more than 40ml/kg over a 24 
hr period) and may result from several different pathologies (Kerrebroeck and 
Andersson, 2014). GP usually occurs as a result of polydipsia (Figure 1.7) which in 
turn leads to increased urine production. This form of urine production is not limited to 
sleep hours and occurs during the day and the night-time (Jin and Moon, 2008). 
Polydipsia may simply be behavioural or secondary to dehydration due to a poorly 
controlled disorder such as diabetes mellitus (DM) or diabetes insipidus (DI) (Jin and 
Moon, 2008; Kerrebroeck and Andersson, 2014). 
1.12.5 Reduced Bladder Capacity (RBC)  
RBC is usually due to bladder storage problems caused by benign prostatic 
hyperplasia (BPH), overactive bladder (OAB), interstitial cystitis or bladder pain 
syndrome (Hofmeester et al., 2014). RBC is a feature of neurogenic bladder, which 
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may be due to conditions such as Parkinson’s disease, multiple sclerosis, spinal cord 
injury, or stroke (Figure 1.7). Voiding disorders associated with OAB lead to urine 
retention that affects the functional storage capacity and leads to increased urinary 
frequency (Hajdinjak and Leskovar, 2013). Patients with RBC could also be presented 
with NP. Thus, in order to improve the condition, treatment options for patients with 
RBC usually take into account the possibility of existing NP (van Kerrebroeck and 
Anderson, 2014).  
 
1.12.6 Non-urological Causes of Nocturia (sleep impairment) 
Sleep disorders such as insomnia, restless leg syndrome and narcolepsy can also 
cause nocturia (Figure 1.7). Neurological and psychiatric conditions such as 
depression, anxiety and chronic pain disorder may also cause secondary sleep 
disorders associated with nocturia (Jin and Moon, 2008; Ancoli-Isreal et al., 2011). 
Increased alcohol consumption and drugs such as cardiac glycosides and lithium use 
can contribute to sleep impairment that in turn leads to nocturia (Wyman et al., 2009).  
 
1.12.7 Circadian Clock Disorders  
A circadian clock is an internal self-sustained molecular oscillator that is responsible 
for controlling behavioural, physiological and metabolic daily rhythms in mammals (Ko 
and Takahashi, 2006). The bladder has been identified to be influenced by circadian 
genes and it has been demonstrated that the voiding micturition cycle of an organism 
is caused by adaptation to the day-night cycle of the environment (Figure 1.7) (Kim et 
al., 2016). Men with bladder obstruction, that causes reduced voiding volume and 
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shorter voiding time in the afternoon compared to mornings and overnight, have a 
dysregulated circadian clock (van Kerrebroeck and Anderson, 2014). Considering 
nocturia as a circadian disorder that simply leads to voiding at the wrong time, warrants 
a different approach into the investigation in the pathophysiology of nocturia. 
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clock
Sleep 
impairment 
Global 
polyuria
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polyuria
alcohol, diuretic 
beverages, 
caffeine, defect 
vasopressin
benign prostatic hyperplasia, 
overactive bladder, interstitial 
cystitis, bladder pain 
syndrome
Restless leg syndrome, 
narcolepsy, obstructive sleep 
apnoea, sleep disruption 
Improper adaptation 
to the day-night cycle 
of the environment
Polydipsia, diabetes 
mellitus, diabetes 
insipidus 
Figure 1.7 Urological and non urological causes of nocturia.  
The general accepted categories for nocturia is devided into five classification: nocturnal polyuria (NP), reduced bladder 
capacity (RBC), global (24 hour) polyuria (GP) and a combinations of these conditions where the causes are non urological, 
such as circadian clock disorder, sleep imparment. The figure presented above demonstrates the different causes of nocturia.  
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1.13 Treatment Options for Nocturia 
The current available treatments for nocturia include alpha-blockers, 5-alpha 
reductase inhibitors and anti-muscarinics, which are not generally effective because 
these drugs do not primarily manage nocturia, but rather target other LUT disorders 
such as OAB, BHP that are associated with nocturia (Friedman and Weiss, 2013). 
Desmopressin, a synthetic analogue of vasopressin, is a key compound for the 
treatment of nocturia, as it increases renal reabsorption of water via AQP2, thereby 
reducing the fluid load delivered to the LUT (Cvetković and Plosker, 2005; 
Rezakhaniha et al., 2011; Friedman and Weiss, 2013). However, desmopressin is 
highly specific in its function and thus cannot effectively be used in the treatment of 
certain types of nocturia including the type caused by reduced functional bladder 
capacity (Weiss, 2013). Thus, better treatment options are desirable, as many people 
have nocturia that is refractory to available licensed options.  
A new concept of bladder absorption to avoid nocturia has been reported. It has been 
demonstrated that during the “sleep-flat pattern,” the bladder reaches its functional 
capacity shortly after sleep onset and is maintained steadily at the functional capacity 
until wake time in the morning (Watanabe et al., 2016). In the process, a temporary 
reduction in bladder volume occurs without micturition, which further supports the 
notion that water is absorbed from the bladder. Therefore, there is increasing evidence 
that the bladder plays an active role in both solute and fluid reabsorption and is able 
to modify the final composition of urine. Since AQPs have been identified in the bladder 
urothelium, their exact role in mediating water transport across the bladder wall needs 
to be further explored in order to target these proteins for increasing bladder capacity 
during sleep and treatment of nocturia. 
47 
 
In this study, the possibility of a new approach to moderate the balance between fluid 
accumulation and bladder reservoir function by investigating the role of the bladder 
urothelium in mediating transmural water transport was evaluated 
 
1.14 The Use of Animal Models to Study Bladder Pathologies 
 
Animals have been used for medical and scientific research for a long time. The 
anatomical and physiological resemblance between human and animals, 
predominantly mammals, have allowed researchers to conduct the majority of 
scientific research involving the study of mechanisms and in the assessment of novel 
therapies in animal models before application to humans (Sinoussi and Montagutelli, 
2015). However, not all results obtained on animals can be directly translated to 
humans. This observation is emphasised by the variation in the complex network of 
hormones, circulating factors such as epidermal growth factor, as well as cross-talk 
between cells in the different species, particularly in small rodents such as rat and 
mouse (Sinoussi and Montagutelli, 2015). The use of animal models to study lower 
urinary tract dysfunction can be challenging due to the fact that bladder symptoms 
cannot be determined in an animal. Therefore surrogate physiological and behavioural 
observations have to be utilised. To date, a variety of animals, mainly small rodents, 
along with cell culture models, have been used to study lower urinary tract 
pathophysiology. However, extrapolating findings generated using small laboratory 
animals to the physiology of urine storage and voiding in large animals is difficult. 
Studies have evaluated the urodynamic properties of pig in vivo, demonstrating 
comparable urodynamic (Sibley, 1984; Crowe and Burnstock, 1989; Mills et 
al., 2000b; Moore and Brading, 2007) and structural (Dixon and Gosling, 1983; Teufl 
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et al., 1997) characteristics to humans, and potential clinical relevance. We have also 
developed a novel perfused model using isolated pig urinary bladder to study the 
integrative physiology of the bladder. 
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1.15  Hypothesis, Aims and Objectives of the Study 
 
1.15.1 Hypothesis  
The overall hypothesis of this study is that pig urinary bladder expresses AQP 
channels and these channels are responsible for absorption of water across the 
bladder urothelium in response to different osmotic conditions 
1.15.2 Aims of the study 
The adult pig bladder offers a viable animal model as it has comparable structural and 
physiological properties to the human bladder. Based on existing data, the expression 
and function of AQPs in pig urinary bladder has not been investigated. Therefore, the 
overall aims of this study were to investigate whether AQPs are expressed in pig 
bladder urothelium and explore their role in mediating water flux across the urothelium 
under various osmotic condition 
1.15.3 The overall objectives of this study  
 To identify the different subtypes of AQPs in pig urinary bladder using 
polymerase chain reaction (PCR) 
 To identify the localisation of AQP substypes in the different layers of pig urinary 
bladder using PCR and immunohistochemistry and western blot  
 To determine whether the identified AQPs are functional in pig urinary bladder 
using Ussing chamber  
 To determine whether changes in osmolarity affect the rate of water movement 
of across pig mucosa section using using chamber  
  To determine whether AQPs are translocated to the membrane in respond to 
changes in osmolarity using immunoflourescense  
50 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2 
 
Investigating the Expression of AQP’S in  
Urothelial and Sub-urothelial Layers of Pig 
Urinary Bladder 
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2.1 Introduction  
 
The presence of AQPs has now been reported in the urinary bladder of various species 
and it is hypothesised that AQPs are involved in modifying the final concentration of 
urine (Rubenwulf et al., 2009; Spector et al., 2002; Rubenwulf et al., 2012). Studies 
have now confirmed the presence of AQPs in human (Rubenwolf et al., 2009), rat 
(Spector et al., 2002) and American black bears urothelium (Spector et al., 2015)  
2.1.1 AQPs in Human Urinary Bladder 
 
AQPs have been identified in human bladder. AQP3, AQP4, AQP7 AQP9 and AQP11 
were constitutively expressed at the transcript level in freshly isolated human urothelial 
cells and a normal human urothelial (NHU) cell line (Rubenwolf et al., 2009). 
Immunolableling demonstrated an intense production of AQP3 protein in the basal cell 
layer. AQP4 and AQP7 showed less intense cytoplasmic expression throughout the 
urothelium. No immunoreactivity was found with the antibody against AQP9 whereas 
AQP11 protein production could not be assessed due to the lack of suitable antibodies 
(Rubenwolf et al., 2009). The expression of both “orthodox” aquaporins and 
aquaglyceroporins may be of significance with regards to physiological function of 
these channels in human urothelial cells.  
2.1.2 AQPs in Rat Urinary Bladder 
 
In rat bladder AQP1, AQP2 and AQP3 have been identified. It was shown that AQP1 
was expressed in endothelial cells of capillaries and small arteries, whereas AQP2 
and AQP3 were expressed in cell membranes of rat urothelium with the exception of 
the apical surface of umbrella cells. AQP2 was also present in the cytoplasm of 
urothelial cell. (Spector et al., 2002). It was further demonstrated that dehydration 
52 
 
induced upregulation of AQP2 and AQP3 but not AQP1, suggesting that changes to 
urine osmolarity can directly impact AQP2 and AQP3 expression and function. AQP1 
was not affected by the hydration status of the animal, which is in keeping with a study 
showing that in vascular endothelium, renal cortex and inner and outer medulla, AQP-
1 is not regulated by hydration status or circulating AVP (Terris et al., 1996). 
 
2.1.3 AQPs in American Black Bears Urinary Bladder 
 
Studies with American black bears, which undergo winter hibernation, have shown 
that these animals do not urinate for months. However, despite continuous production 
of urine during the hibernation state, these animals do not become uraemic and blood 
urea levels remain constant (Nelson et al., 1973). In subsequent studies, radioactively-
labelled urea and deuterium oxide (D2O), were instilled into the bladder of these 
animals during the hibernation period and it was observed that both D2O and urea 
could be detected in the plasma, demonstrating reabsorption of these compounds 
across the bladder wall (Nelson et al., 1975). Of interest, a recent study with 
hibernating American black bears reported AQP1 protein production in suburothelial 
capillaries and arterioles and AQP3 in the basolateral membrane of basal and 
intermediate cells (Spector et al., 2015) which further supports an association between 
the presence of AQPs and their potential involvement in mediating urea and D2O 
reabsorption across the bladder urothelium.  
Although not many studies have investigated the expression of AQPs and their 
function in the urinary bladder, these studies collectively provide strong evidence for 
a complex role of the urinary bladder urothelium in regulating osmolality and 
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composition of the urine with the possibility of contributing to the overall fluid 
homeostasis in the body.  
 
2.1.4 Potential Regulatory Mechanism Mediating AQP Expression 
and Function in Bladder Urothelium.  
 
Some of the potential receptors and channels responsible for mediating AQP function 
and expression in various tissues were described in chapter 1. As there are numerous 
potential primary signals involved in regulating AQP function, the expression profile of 
only a few of these proteins were investigated in this study.  
 
2.1.4.1 Transient receptor potential (TRP) Channels and AQPs 
 
Studies have shown that TRP channels regulate AQP channels (Benfenati et al., 2011; 
Jo et al., 2015; Kitchen et al., 2015). In astrocytes, regulatory volume decrease (RVD), 
a mechanism for volume control that serves to prevent detrimental swelling in 
response to hypo-osmotic stress, is mediated by interaction between AQP4 and 
TRPV4 (Benfenati et al., 2011). Also, hypotonicity-induced calcium influx through 
TRPC1 has also been shown to be important for translocation of AQP1 (Conner et al., 
2012). In addition, calcium influx through TRPV4 mediates AQP5-dependent 
regulatory volume decrease in acinar cells (Kitchen et al., 2015). TRP channels may 
therefore be important in regulating AQP function. Therefore the presence of TRP 
channels in pig urinary bladder was investigated. 
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2.1.4.2 Estrogen Receptors and AQPs 
 
Estrogen receptor (ER) has been demonstrated to regulate AQP function. An estrogen 
response element (ERE) has been identified in the promoter region of the AQP1, 
AQP3, AQP2 and AQP5 genes (Zou et al., 2011; Jiang et al., 2015; Cui et al., 2018). 
AQPs expression appears to be influenced (up or downregulation of AQPs) by the 
changes in estrogen levels during menstrual cycle in human epithelial endometrial 
cells (Cui et al., 2018). AQP3 expression in the mid- and late-secretory phases of the 
human endometrium is significantly higher than in other phases. Progesterone up-
regulates AQP3 by directly targeting the promoter of the AQP3 gene (Cui et al., 2018). 
As female pigs were used throughout this study, changes in AQPs expression and 
function in the urinary bladder could be expected depending on the phase of estrus 
cycles of the pigs. Therefore, the presence of ERs was also investigated in pig 
urothelium.   
 
2.1.4.3 ENaC Channels and AQPs 
 
Another type of channel that is hypothesized to regulate AQP function indirectly are 
ENaC channels. Numerous studies have reported AQP involvement in regulatory 
volume decrease (Liu et al., 2006; Benfenati et al., 2007; Day et al., 2014) a 
mechanism that involves the transport of water and ions including Na+ to regulate 
intracellular and extracellular osmolarity. According to the proposed RVD mechanism 
by Day et al., (2014) ENaC are involved in this process (Day et al., 2014) 
Therefore, identifying the presence of these channels and receptors in pig urinary 
bladder mucosa could suggest a possible regulatory mechanism involved in AQP 
expression and function. 
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2.2 Aims and Objectives  
 
The aim of this study was to investigate the expression of AQPs in the urothelial and 
sub-urothelial layers of pig urinary bladder and to determine the expression of some 
of the potential channels and receptors reported to be involved in AQP expression, 
trafficking and function.  
2.2.1 Specific objectives 
 
 Accurate qualitative mapping of aquaporin channels in the pig bladder tissues 
using PCR molecular technique  
 Accurate qualitative mapping of aquaporin channels in the different layers of 
pig bladder tissues using  immunological techniques 
 Accurate qualitavie mapping of possible AQP regulators in different layers of 
the pig urinary bladder using PCR molecular technique 
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2.3 Materials and Methods  
 
2.3.1 Tissue Preparation 
 
Bladders, kidney (cortex, medulla and pelvis), stomach antrum, lung, liver, duodenum, 
rectum and testis  from ∼6-months old female pigs (Sus scrofa domestica), were 
obtained from a local abattoir (with permission of Langford Abattoir, University of 
Bristol, Bristol, UK), immediately after the animals were killed.  
Pig bladders were used to investigate AQP expression. Kidney (cortex, medulla and 
pelvis), stomach antrum, lung, liver, duodenum, rectum and testis, collectively referred 
to as positive control tissue, were used to validate AQP primers. 
Kidney and liver samples were also obtained from 8-week female Wistar rats (210-
223g) euthanised for other studies (University of Bristol, Bristol, UK). Rat kidney and 
liver were placed in 10% neutral buffered formailne (Formaldehyde, 37%, 900ml 
deionized water, NaH2PO4; 4.0g/L, Na2HPO4; 6.5g/L) and used as positive controls for 
validation of AQP antibodies used immunohistochemical experiments.  
The animals used in this experiment for AQP studies using molecular and 
immunohistochemical techniques were in accordance with UK Government 
regulations (Animals Scientific Procedures Act 1986). This study did not require a UK 
Home Office project license, because no regulated procedures were carried out.  
Tissues were placed in ice-cold Krebs solution containing (mM): NaCl, 118.4; 
NaHCO3, 24.9; KCl, 4.7; CaCl2, 1.9; MgSO4, 1.1; KH2PO4, 1.15; glucose, 11.7; 95% 
O2/5% CO2, pH 7.4. The warm ischaemia time (time between sacrificing the animal 
and placing the required organs in cold buffer) was kept to 15-30 min. Samples of 
bladder and kidney from pigs and rats were also placed in 10 % neutral-buffered 
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formalin (37% formaldehyde solution, Nacl 0.8 g, KH2PO4 0.4 g, K2HPO4 0.65 g, 
Distilled water 90ml) for immunohistochemistry. From each bladder, mucosa samples 
(urothelium and lamina propria; 30-50 mg) were obtained by blunt dissection from the 
lateral wall of the dome using the natural plane of division between the lamina propria 
and the underlying smooth muscle layer. In addition, 30-50 mg of urothelial cell 
suspension (consisting of basal, intermediate and umbrella cells) in lysis buffer 
(Promega, UK) was obtained by gentle scraping of a separate luminal part of the 
mucosa with a scalpel. 30-50 mg of the positive control tissues were obtained by blunt 
dissection ensuring that each sample consists of all the different layers of the tissue.  
All procedures were performed at room temperature (RT) with tissues bathed in Krebs 
solution. Mucosa samples and those from positive control tissues, were washed four 
times in phosphate buffered saline (PBS) composed of 137 mM NaCl, 2.7 mM KCl, 8 mM 
Na2HPO4, and 2 mM KH2PO4 (with the exception of urothelium cells which were 
suspended in lysis buffer) prior to RNA extraction. All chemicals were from Promega 
(UK).  
 
2.3.2 RNA Isolation and Reverse Transcription PCR 
 
Bladder mucosa and urothelial samples from 25 different pigs as well as positive 
control tissue samples of different organs from one pig were homogenised at 12000 x 
g with TissueRuptor (Qiagen, UK) for 30 sec to 1 min in 500 µl RNA lysis buffer 
(Promega, UK). Total RNA was extracted from tissue samples using Promega SV total 
RNA isolation kit (Promega, UK) according to the manufacturer’s instructions, 
including the removal of trace genomic DNA which was part of the RNA extraction 
process.  
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Homogenised samples were centrifuged at 13,000 x g for 5 min followed by aspiration 
of clear lysate. Chloroform (200 µl) was added to clear lysate and centrifuged at 900 
x g for 10 min at 4 ̊C. Ethanol (100% , 200 µl) was then added to 400 µl clear lysate 
and vortexed immediately. The lysate was transferred to a pre-assembled spin basket 
and centrifuged at 13,000 x g for 1 min. The RNA was subsequently bound to the silica 
membrane in the spin basket column and was then washed twice with 700 µl and 500 
µl of RNA washing solution, respectively for 1 min at RT at 13,000 x g. Spin basket 
columns containing silica bound RNA was treated with Promega DNase treatment 
solution containing 24 µl yellow core buffer, 3 µl of MnCl2 (0.09 M), 3 µl of DNase-1 
enzyme for 30 min at RT. The DNase treatment was then inactivated by addition of 50 
µl DNase stop solution to the spin basket column containing silica bound RNA to 
terminate the reaction. Two additional washings were performed using 600 µl and 400 
µl of RNA washings solutions at each 13,000 x g for 1 min and 5 min. Total RNA 
sample was eluted from the spin basket column using 20-30 µl nuclease free water. 
RNA integrity and concentration was determined using a NanoDrop-1000 
spectrophotometer (Thermofisher, UK). The ratio of absorbance at 260 nm and 280 
nm was used to assess the purity of RNA and a ratio above 1.80 was the acceptable 
to avoid sample contamination with DNA and protein. 
 
2.3.3 Complementary DNA (cDNA) Synthesis  
 
Total RNA (1 µg) was reverse transcribed to single-stranded cDNA using GoScript™ 
enzyme along with oligo dT primers in two separate steps as per manufacturer’s 
instructions (Promega, UK). In the first step, 1 µg of total RNA was added to a reaction 
mixture containing 0.5 µg Oligo (dT)15 Primer and nuclease free water (NFW) to reach 
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a final volume of 10 µl. The reaction mixture was heated at 70 ºC using a heating block 
for 5 min and immediately chilled on ice for 5 min. The reaction mixture was 
subsequently centrifuge for 10 seconds in a micro-centrifuge and then stored on ice.  
A second reaction mixture containing 4 µl of GoScript™ 5X Reaction Buffer, 1.5 µl of 
1.5 mM MgCl2, 1.5 µl of 0.5 mM PCR Nucleotide Mix, 1.5 µl of 20 units Recombinant 
RNasin®, 1.5 µl of GoScript™, 1 µl of Reverse Transcriptase and NFW to reach a final 
volume of 20 µl, was prepared and added to the initial mixture on ice to reach a final 
volume of 30 µl. The total mixture was heated at 25ºC for 5 min and 42ºC for 1 hr for 
annealing and extension, respectively. The reaction was terminated at 70ºC for 15 
min. The transcribed RNA to single-strand cDNA was used for the polymerase chain 
reaction (PCR).  
 
2.3.4 Polymerase Chain Reaction (PCR) 
 
Primers specific for pig AQP1-11, smooth muscle myosin heavy chain (SMMHC), ER 
1, TRPC4, TRPV4, Claudin-2, Claudin-4, ENaCs, vWF, Uroplakin were designed 
using the primer-3 design tool (http://primer3.ut.ee/).  
To ensure that the urothelial samples obtained from the pig bladder were pure and did 
not contain cells from the sub-urothelial or smooth muscle layers cell, smooth muscle 
specific genes vWF and SMMHC were designed to test for the presence of smooth 
muscle cells in extracted urothelial cell samples using PCR. Primers for endothelial 
specific gene vWF was also designed to use as a control measure for cross 
contamination of sub urothelial blood vessels in extracted urothelium cell samples. 
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Uroplakin primers served to determine the presence of umbrella cells in extracted 
urothelial samples.  
To ensure that the urothelial samples obtained from the pig bladder contain all the 
relevant layers, uroplakin and Claudin primers were designed as urothelial specific cell 
gene.  
Primers were also designed to amplify potential AQPs regulatory channels and 
receptor TRPC4, TRPV4, AG-2R and ER 1. 
To optimise PCR conditions for the primers, pig bladder tissue samples were 
subjected to gradient PCR using annealing temperatures of 53ºC, 54ºC , 55ºC , 56ºC 
, 56.5ºC , 57ºC , 58.2ºC , 59.4ºC, 60ºC , 61ºC with all the different primers. The PCR 
reaction mixture contained 3 µl of 1 µg cDNA, 12.5 µl GoTaq® G2 Hot Start Colorless, 
3 µl of 0.8 mM of forward and reverse primers and NFW to reach a final mixture volume 
of 30 µl. This mixture was used in the following PCR conditions: 5 min denaturation at 
94 °C; 35 cycles of 94 °C for 30 s; annealing temperature for 1 min (different annealing 
temperatures, Table 2.1); 1 min at 70 °C and a 5 mins final extension at 70 °C. cDNA 
samples were first amplified using Glyceraldehyde 3‐phosphate dehydrogenase 
(GAPDH) forward and reverse primers (Table 2.1) to confirm successful reverse 
transcription (positive control). Absence of genomic DNA contamination was 
confirmed using RNA samples in PCR reaction (negative control). Sterile water 
reaction was also included instead of cDNA template as an additional negative control. 
Following confirmation of the presence of amplifiable cDNA, samples were amplified 
using primers specified in Table 2.1. The PCR products were loaded onto 2% (w/v) 
agarose gels containing 1 µl of 0.4 μg ethidium bromide. Electrophoresis was carried 
out at 100 V for approximately 40 min. The bands were visualised using the Syngene 
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gel imaging and analysis system (Cambridge, UK). The PCR products were identified 
by comparison with DNA ladder covering the range of 100-1000 bp. The PCR products 
were purified using the Wizard® SV Gel and PCR Clean-Up System (Promega, UK). 
The separated DNA bands were excised from the gel and transferred into 1.5 ml 
Eppendorf tubes. Membrane binding solution (MBS) was added to the excised gel at 
ratio of 10 µl MBS to 10 mg of excised gel. The mixture was incubated at 65 ºC for 10 
min to dissolve the gel in the MBS, transferred into a minicolumn-collection tube 
system and centrifuged at 12000 x g for 1 min. The DNA in the column was washed 
by adding 700 µl of membrane wash solution to the column followed by centrifugation 
at 12000 x g for 5 min. Elution of DNA from the column into new DNase-free tube was 
performed by adding 40 µl of nuclease-free water followed by centrifugation at 12000 
x g for 1 min. The purified PCR products were sent for sequencing at the concentration 
of 10 ng/µl and the primers concentration was 10 pmol/µl per sequencing reaction 
(Eurofins MWG, Ebersberg, Germany). Sequence data were verified by comparison 
with the genome database using BLAST from the NCBI website 
(http://blast.ncbi.nlm.nih.gov/blast.cgi).  
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Name of 
primer/Accession 
number 
  
Forward primer (5’-3’) 
  
  
Reverse   primer (5’-3’) 
  
  
Base 
pairs 
  
  
Annealin
g 
temperat
ure 
(ᵒC) 
AQP 1 
(NM_214454.1) 
AGCTGCCAGATCAGTGTCCT 
  
CCAGTGGTCCTGGAAGTTGT 
  
375  60.9 
AQP  2 
(NM_001128476.1) 
GCTGCCATGTCTCCTTTCTC TCATGGAGCAGCCAGTGTAG 318  59.04 
AQP  3 
(NM_001110172.1) 
GGGACCCTTATCCTCGTGAT 
  
AGAAGCCATTGACCATGTCC 
  
394   58.2 
AQP  4 
(NM_001110423.1) 
TTGCTTTGGACTCAGCATTG 
  
TGACATCAGTCCGTTTGGAA 
  
332  57.5 
AQP  5   
(NM_001110424.1) 
GAAGGAGGTGTGCTCTCTGG CGTGTTGTTGTTGAGCGAGT 373  59.5 
AQP  6 
(NM_001128467.1) 
TGGATGACTGTCAGCAAAGC CCTCAGGTATGACCCCGTAA 316  58.3 
AQP  7 
(NM_001113438.1) 
AGAGTTCTTGGCCGAGTTCA ACCGGTCACTGTCAGCTTTC 346 59.6 
  
AQP  8 
(NM_001112683.1) 
GCCTGTCGGTCATTGAGAAT GGATGATCTCTGCCACCACT 333  58.6 
AQP  9 
(XM_005659551.1) 
TGCATTTGCAGACCAGGTAG 
  
CTGGTTTGTCCTCCGATTGT 
  
380  58.7 
AQP  10 
(NM_001128454.1) 
TTGTGCTCATGCTCTTCACC GGATAGGTGGCAAAGATGGA 355  57.7 
AQP  11 
(NM_001112682.1) 
CGCTTTCGTCTTGGAGTTTC 
  
GGAGCAGATGGCCTCTATCA 
  
388  58.4 
GAPDH 
(XM_005658673.2) 
CACGTTGGGGGTGGGGACAC  ACCCAGAAGACTGTGGATGG  171  60.0 
Uroplakin 2 
(XM_005667407.1) 
TGTCCCCTGCGTTAACTGAG TTCGAGGAAGCGTGGACATT  315 59.6 
Table 2.1. List of pig specific primer sequences, gene accession numbers and the expected 
product size. The corresponding annealing temperatures for pig specific AQPs, SMMHC, 
transporters, ER-1, TRPC4, TRPV4, Claudin-2, Claudin-4, ENaC α, β, γ uroplakin, vWF and 
GAPDH. The primers were based on mRNA sequences accessed from 
DDBJ/EMBL/GenBank database and the primers designed using Primer 3 software. The 
purpose of the gene amplification was to determine the presence of AQPs, SMMHC, 
transporters, ER-1, TRPC4, TRPV4, Claudin-2, Claudin-4, ENaC α, β, γ uroplakin, vWF and 
GAPDH in the tissue sampe collected. 
 
63 
 
TRPV4  
(XM_013986922.1) 
GCCTGTGTATTCCTCGCTCT CTGGTAGTAAGCGGTGAGGG 241 59.5 
TRPC4  
(NM_001145868.1) 
AGCCCCAAGTCTCTCTGGTA CTCTGATCATAGCGGCCACA 187 59.5 
Oestrogen receptor 1 
(NM_214220.1) 
GTGTCCAGCTACCAACCAGT GATCATCTGGTCGGCTGTCA 289 56.6 
Claudin-4 
(XM_013995522.1) 
GCCTTCCTTCCAGCTCCTAG  GATGTTGCTGCCGATGAAGG  160 59.5 
Claudin-2 
(NM_001161638.1) 
ATCTTCATGGGATCCTGCGG CTTGGCTTTGGGTGGTTGAC 239 59.6 
Von Willebrand factor 
(NM_001246221.1) 
TCCAGAACAACGACCTCACC  TCCTGGAAAATGTCGCTGGT 205 59.6 
Smooth muscle 
myosin heavy chain 
(XM_013991919.1) 
GACCTCGTTCGTTCCCTCAA  CCGGGTTTGGTTTTGTCCTG 156  59.6 
Epithelial sodium 
channel SCNN1B 
transcript variant X1 
(NC _010452) 
TTCAGGCCTGTATTCGCTCC TTGTACTGGGTGTCGTTGCA 214 59.8 
Epithelial sodium 
channel SCNN1A 
(NM_213758.2) 
AGGACGGGAGGTAGGATCAG TGGCCTCTCTGTTGCTTCTC 236 59.8 
Epithelial sodium 
channel SCNN1G 
(XM_003124543) 
CTGTCTCAACACCAACACGC ACGGCGGGAAAATCTAGCTT 195 59.7 
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2.3.5  Immunohistochemistry 
 
Fixed bladder and kidney samples from pigs and rats in 10 % neutral buffered 
formaline were processed and embedded in paraffin. Tissue sections (3 μm) were 
placed on (3-aminopropyl) triethoxysilane coated slides and placed in a 60 °C oven 
overnight prior to immunohistochemical staining to aid adhesion. Sections were 
dewaxed in clearance (2 x 5 min) and dehydrated in 100 % ethanol (2 x 3 min). 
Endogenous peroxidase activity was blocked by incubation in 0.3 % H2O2 prepared in 
100% methanol for 30 mins at ∼20 °C. Citrate buffer (10 mM sodium citrate, 0.05% 
Tween 20, pH 6.0) was used for antigen retrieval of tissue sections by bringing the 
citrate buffer to the boil twice in a 750 W microwave and allowing to cool for 5 min and 
15 min respectively. Slides were subsequently washed (2 x 3 min) in phosphate 
buffered saline (PBS (mM): NaCl, 154; NaH2PO4.12H2O, 1.86; Na2HPO4.2H2O, 7.48; 
pH 7.1) and blocked with 10% horse serum in PBS (20 min) to block non-specific 
binding sites, followed by incubation with the specific primary antibody (AQP1, 3, 9 
and 11 polyclonal antibodies, used at 1:1000-1:1500 (Table 2.2) dilutions in PBS, 
(Almone Laboratories, Israel) overnight at 4°C. Negative controls replaced the primary 
antibody with the relevant peptide (Alomone Laboratories, Isreal). Relevant peptide is 
where primary antibody (Table 2.2) was mixed with the control peptide (1∶4 ratio) in 1 
ml Tris buffer saline (TBS) and was incubated for an hour at RT before applying to 
tissue sections overnight at 4 °C. Subsequent to overnight incubation, the slides were 
washed in PBS (2 x 3 min) and a biotinylated antibody raised to mouse IgG was 
applied (prepared as per Vectastain ABC kit instructions) (20 min). The slides were 
washed again in PBS (2 x 3 min) followed by application of avidin biotin complex in 
PBS (as per Vectastain ABC kit instructions) (20 mins). Slides were washed in PBS (2 
x 3 min), developed with DAB/H2O2 in distilled water (as per DAB substrate kit 
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instructions) for 10 min and then washed in running water for 10 min. Sections were 
counterstained with Harris’s haematoxylin (25% Gill haematoxylin) (30 s) and washed 
in running tap water (10 min). Finally, the sections were dehydrated in 100% ethanol 
(2 x 3 min), cleared in 100% clearene (2 x 5 min) and mounted in Clearium® Mounting 
Media. Sections were examined at x40 magnificationusing a Nikon Eclipse 50i 
microscope (Nikon Instruments Inc., USA). 
 
2.3.6    Immunoblotting  
2.3.6.1 Preparation of Protein Lysate 
Mucosa and urothelial (50-100 mg) from the urinary bladder of 3 different pigs were 
homogenised in 1 ml of RIPA lysis buffer (400 μl of 5 M NaCl; 200 μl of 1M Tris-HCl; 
two tablets of 1x protease inhibitor (Sigma, UK); 2 ml of 10% SDS; 17 ml of distilled 
water) with TissuesRuptor (Qiagen, USA) 
2.3.6.2 Protein Concentration Determination by the Bradford Assay 
 
For protein estimation, a stock dye of Coomassie blue G was prepared (330 mg 
Coomassie blue G dye dissolved in 100 ml of phosphoric acid/ethanol (2:1) mixture). 
This was diluted to a working solution from 1.5 ml stock dye 4 ml phosphoric acid, 1.9 
ml ethanol and 92.6 ml water. Appropriate dilutions of 0.2, 0.4, 0.6, 0.8, 1.0 and 1.2 
μg/μl bovine serum albumin (BSA) in deionised water were prepared and 5 µl of diluted 
sample was pipetted into 96 triplicate wells. Unknown concentration protein samples 
were diluted between 1:5 and 1:50 in deionised water. Working solution of Coomassie 
blue G dye (200 µl) was pipetted into each well and the absorbance was measured at 
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OD620nm with a Fluostar Optima plate reader (BMG Labtech, Aylesbury, UK). The 
OD620nm is directly proportional to protein concentration over this range of standards, 
a standard curve (Figure 2.1) was constructed and using linear regression the 
concentration of protein in the samples was calculated using their OD620nm. 
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Figure 2.1 Bradford assay standard curve of BSA concentration versus absorbance.  
The concentration of protein (µg /µl) was determined using the equation y=0.3188x+0.1786 generated from the BSA 
standards prepared with an R2 value of 0.982, where y is absorbance and x is concentration. The calibration curve is 
needed to calculate samples concentration.  
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2.3.6.3 SDS-polyacrylamide gel electrophoresis  
 
Protein lysate prepared from bladder mucosa and urothelium (20µg) was added to 
loading dye NuPAGE LDS Sample Buffer (4x bromophenol blue dye in 200 mM Tris, 
pH 6.8; 4x SDS-glycerol containing 40% glycerol and 8% SDS; 5% β-
mercaptoethanol) (Life Technologies, Paisley, UK). Diluted samples were denatured 
by heating at 95 °C for 5 min and protein separated by electrophoresis alongside 
Spectra Multicolour Broad Range Protein Ladder (Fisher Scientific UK Limited, 
Loughborough, UK) on a NuPAGE 4–12 % Bis–Tris precast gel (Life Technologies, 
Paisley, UK) using the NuPAGE MES SDS Running Buffer (Life Technologies, 
Paisley, UK) in a XCell SureLock transfer tank for 1 h at 100 V. Proteins on the gel 
were subsequently transferred onto a polyvinylidene difluoride (PVDF) membrane in 
trans-Blot SD wet transfer (Biorad, Hertfordshire, UK) using XCell SureLock™ 
system. 
Once the transfer was complete, the PVDF membrane was washed twice in 1X TBS-
tween (TBST) (50 mM Tris-HCl, 150 mM NaCl; pH 7.4; 0.1% (v/v) Tween 20) for 5 
min, then blocked in 5 % (w/v) non-fat dried milk powder in 1X TBST 1 hour and 
incubated overnight at 4 ºC with primary antibodies diluted in 5 % milk and 1X TBST 
(Table 2.2). The membrane was then washed 6 x 5 min in TBST and incubated at RT 
for 45 mins with anti-rabbit horseradish peroxidase (HRP) conjugated secondary 
antibody (Vector Laboratories) (dilution 1:5000) in 5 % (w/v) non-fat milk dissolved in 
1X TBST. The blot was then subjected to a further wash cycle with TBST and then 
incubated with 2 ml of HRP substrate for 1 min. Immunolabelled proteins was 
visualisation using Luminata Forte Western HRP Substrate (Millipore) applied for 2 
min, followed by exposure to Amersham Hyperfilm ECL (GE Healthcare, UK). 
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Table 2.2. Primary antibodies and their respective concentrations.  
Primary antibodies used to probe for AQP1, AQP3, AQP9, AQP11 in immunoblot and 
immuhistochemistry. Different concentration were used to improve specificity. Peptide 
control was four fold the initial diluted antibody. The listed antibodies were obtained 
from Alomone Laboratories (Jerusalem, Israel) 
 
 
Primary antibody Dilution ( 5% 
milk and 
TBST) IHC 
Dilutions (in 
5% milk and 
TBST) WB 
Species 
(polyclonal) 
Reactivity and peptide 
sequence  
Anti- AQP1 
(AQP-001) 
(Kim et al., 2013) 
1:1000  1:200 Rabbit Mouse, human, rat 
(C)KVWTSGQVEEYDLDADDIN 
Peptide 
control (PC) 
1:1000+ 
4000 pc 
 
Peptide 
control (PC) 
1:1000+ 800 
pc 
 
Anti- AQP3 
(AQP-003) 
(Zheng and 
Bollinger,2003) 
1:1000  1: 200 Rabbit Mouse, human, rat  
(C)STEAENVKLAHMKHKEQI 
Peptide 
control (PC) 
1:1000+ 
4000 pc 
 
Peptide 
control (PC) 
1:1000+ 800 
pc 
 
Anti- AQP9 
(AQP-009) 
(Sales et al., 
2016) 
1:1000  1: 300 Rabbit Mouse, rat  
(C)EKDGAKKSLMQRLALK 
Peptide 
control (PC) 
1:1000+ 
4000 pc 
 
Peptide 
control (PC) 
1:1000+ 1200 
pc 
 
Anti- AQP11 
(AQP-011) 
(Yasui et al., 
1999) 
1:1500 1:500 Rabbit Mouse,rat   
(C)SLSLTKYHFDER 
Peptide 
control (PC) 
1:1000+ 
6000 pc 
 
Peptide 
control (PC) 
1:1000+ 2000 
pc 
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2.4 Results  
 
2.4.1 Amplification of Urothelial Specific genes to Determine Cross 
Contamination of Mucosa in Urothelial Samples  
 
 
RT-PCR was used to investigate the expression of various urothelial specific genes 
such as Claudin-2, Claudin-4 (tight junction proteins) and uroplakin 2 to ensure that all 
the cell layers of the urothelium were indeed present in the collected urothelial cell 
suspensions as these are urothelial specific genes.    
SMMHC and vWF served as a control measure for urothelial extraction technique to 
confirm the absence of smooth muscle cells contamination in urothelial sample. 
GAPDH as a housekeeping gene was used to confirm successful RNA isolation and 
reverse transcription. 
Claudin-4, but not Claudin-2, was expressed in both urothelial and mucosa samples 
(Figure 2.2). Uroplakin and GAPDH was expressed in both mucosa and urothelial 
samples (Figure 2.2). SMMHC and vWF expression was identified in the mucosa 
samples only (Figure 2.2). Urothelial samples containing SMMHC and vWF was 
excluded from the experiment. 
The presence of vWF and SMMHC in mucosa sample but not in urothelial sample 
suggest successful urothelial extraction technique. The presence of Claudin 4 and 
Uroplakin suggest the presence of umbrella cells in extracted urothelial sample. The 
experiment was repeated 25 times to ensure that variabilities such as diet, age, 
variation in different pigs had no influence on the expression of AQPs present in pig 
urinary bladder. Sterile water replaced cDNA template as a negative control. Samples 
of interest, control samples and negative control samples were run on the same gel 
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but in different lanes. For the purpose of the thesis, the relevant bands from the 
different lanes are joined together to illustrate PCR product at the expected size. 
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Figure 2.2: Expression of vWF, Claudin-4, Claudin-2, SMMHC, GAPDH and uroplakin mRNA in pig urinary bladder. Expression of 
vWF Claudin-4, Claudin-2, SMMHC, GAPDH and uroplakin transcripts in a representative pig bladder mucosa and corresponding 
urothelium found at the expected size. The negative controls is substitution of reverse transcriptase with nuclease‐free water in the 
amplification process.  bp= base pair (-) C = negative control, representative image of n=25.  
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2.4.2 Amplification of AQPs 1, 3, 9 and 11 mRNA in Adult Pig 
Bladder 
 
 
RT-PCR demonstrated the expression of AQP1 in the mucosa but not the urothelium 
of the pig bladder (Figure 2.3).  In addition, AQP3, AQP9 and AQP11 were expressed 
in the mucosa and the urothelium of pig bladder with only a faint band for AQP9 in 
the mucosa (Figure 2.3). The expression of 
AQP2, AQP4, AQP5, AQP6, AQP7, AQP8, AQP10 and AQP11 could not be 
detected in either mucosa or urothelium preparations of the pig bladder (n=3) (Figure 
2.3).   
RT-PCR demonstrated the expression of all 11 AQP subtypes in different pig tissues 
(Figure 2.4). This demonstrates that the absence of expression of AQP2, AQP4-8, 
AQP10, 11 in the pig bladder does not represent a failure of the protocol to amplify 
any mRNA for these particular AQP subtypes.   
Sterile water replaced cDNA template as a negative control. Samples of interest, 
control samples and negative control samples were run on the same gel but in different 
lanes. For the purpose of the thesis, the relevant bands from different lanes are joined 
together to illustrate PCR product at the expected size. 
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Figure 2.3: AQP mRNA expression of AQPs in pig bladder urothelium and mucosa   
Expression of AQP1-11 transcripts in a representative pig bladder mucosa and the corresponding urothelium sample; the red 
arrow in AQP9 mucosa demonstrate a faint band. The negative controls are where nuclease-free water substituted reverse 
transcriptase in the amplification process. (representative image of n=25) 
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Figure 2.4: AQP transcript expression in positive control tissues  
Expression of AQP1-11 transcripts in positive control tissues: pig kidney, stomach, 
lung, testis, rectum, liver and duodenum. The negative controls are where nuclease-
free water substituted reverse transcriptase in the amplification process. bp= base pair 
(-)C = negative control (representative image of n=3).   
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2.4.3 Amplification of TRPC4, TRPV4, ER-1 ENaC-α ENaC-β ENaC-γ, 
Transcripts in Adult Pig Bladder 
 
 
TRPC4, TRPV4, ER-1 ENaC-α ENaC-β ENaC-γ were investigated to determine their 
presence in pig bladder as they could serve as potential regulatory channels, 
receptor for AQP regulation. 
RT-PCR demonstrated the expression of TRPV4, ER-1 ENaC-β and ENaC-γ in the 
mucosa and urothelium of the pig bladder (Figure 2.5). Faint band for TRPC4 was 
found in the mucosa only and a faint band for ENaC-α was expressed in the urothelium 
only (Figure 2.5). (n=3). Sterile water replaced cDNA template as a negative control. 
Samples of interest, control samples and negative control samples were run on the 
same gel but in different lanes. For the purpose of the thesis, the relevant bands from 
different lanes are joined together or pasted to illustrate PCR product at the expected 
size. 
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Figure 2.5 Expression of TRPC4, TRPV4, ER-1 ENaC-α ENaC-β ENaC-γ, AG-2R transcripts in pig urinary bladder.  
Expression of TRPC4, TRPV4, ER-1 ENaC-α ENaC-β ENaC-γ, AG-2R GAPDH and uroplakin transcripts in a representative pig bladder mucosa 
and the corresponding urothelium sample. Red arrows demonstrate faint bands. The negative controls are where nuclease‐free water 
substituted reverse transcriptase in the amplification process.  bp= base pair (-)C = negative control (representative image of n=3) 
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2.4.4  Immunihistochemical Detection of AQP1, 3, 9 and 11 protein 
in Adult Pig Bladder from Tissue Extract 
 
The presence of AQP1, 3, 9 and 11 proteins in adult pig bladder was investigated 
using Western blotting and antibodies specific for AQP1, 3, 9 and 11. Immunoblotting 
of AQP proteins showed band for AQP1 in the samples prepared from mucosa layer 
at expected size around 28 kDa (Figure 2.10), AQP3 was also detected in both 
mucosa and isolated urothelial extracts at around 28 kDa (Figure 2.10). Additional 
bands were detected on the immunoblot for AQP3 with protein sizes of around 55 kDa, 
65 kDa and 70 kDa which could be phosphorylated forms of AQP3 (Yasui et al., 2008).  
A band for AQP9 was  found in the urothelial protein extract 35 kDa (Figure 2.10) and 
AQP11 was also detected in both urothelium and mucosa layer with urothelium at 
around 40 kDa (Figure 2.10). All the repeats are n=1. Protein quantification was not 
performed due to the low n number. In addition, the purpose of the immunoblot was to 
determine the size of AQP protein.  
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Figure 2.6 Investigation of AQP1, 3, 9, 11 protein in pig urinary bladder mucosa and 
urothelium. 
The presence of AQP1, AQP3, AQP9 and AQP11 protein was detected in pig bladder mucosa and 
urothelium on immunoblots with anti AQP1, AQP3, AQP9 and AQP11 specific rabbit polyclonal 
antibodies at  1:200, 1:200, 1:300 and 1:500 dilution repectively. 20µg sample protein was loaded in 
each well of SDS-polyacrylamide gel. A) AQP1 was detected in the mucosa layer at 28 kDa, B) AQP3 
was detected at 28 kDa, in mucosa and urothelium, C) AQP9 was detected around 35 kDa in 
urothelium only, D) AQP11 was detected at around 40 kDa in pig in mucosa and urothelium. n=1.  
 
 
 
M
uc
os
a
U
ro
th
el
iu
m
B
AQP3
10
50
35
60
70
kDa
C
AQP9 25
35
D
AQP11
35
50
A
AQP1 25
10
35
80 
 
2.4.5  Immunoperoxidase Labelling of AQP1, 3, 9 and 11 in Adult 
Pig Bladder Extracts 
 
AQP1, AQP3, AQP9 and AQP11 expression was detected in different regions of the 
urothelium and lamina propria in 12 adult pig bladder using immunohistochemistry.  
AQP1 immunoreactivity was present in the lamina propria, localised to endothelial 
cells in capillaries and arterioles (Figure 2.7A). AQP1 negative control using a 
peptide control (Table 2.2) showed no labelling in the bladder (Figure 2.7B) 
suggestion that the antibody used is specific in detecting AQP1. Positive control 
experiments using rat kidney cortex demonstrated localisation of AQP1 to proximal 
tubules (Figure 2.7C, peptide control, Figure 2.7D).   
AQP3 labelling was detected throughout the urothelium (Figure 2.8A, negative 
control using a peptide control, Figure 2.8B). The positive control experiments in rat 
kidney medulla demonstrated AQP3 labelling in the collecting tubules (Figure 2.8C, 
peptide control, Figure 2.8D). 
AQP9 labelling was identified in the upper layers of the urothelium which would 
include umbrella and intermediate cells (Figure 2.9A, peptide control, Figure 2.9B). 
The positive control experiments using rat liver demonstrated AQP9 labelling in the 
hepatic lobules (Figure 2.9C, peptide control, Figure 2.9D).  
AQP11 labelling was also detected throughout the urothelial layer (Figure 2.10A, 
peptide control, Figure 2.10B). A positive control shows labelling in rat kidney cortex 
(Figure 2.10C, peptide control, Figure 2.10D). 
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Figure 2.7 Immunoperoxidase labelling of AQP1 in pig bladder and positive 
control tissue, rat kidney. 
Rabbit polyclonal anti-AQP1 antibody was used at a dilution of 1:1000 to detect AQP1 
in pig mucosa tissue section. A: bladder mucosa with AQP1 immunoreactivity in the 
lamina propria. The inset shows a small blood vessel immediately below the 
urothelium at a larger magnification. B: mucosa, peptide negative control.  C: AQP1 
immunoreactivity in rat kidney; apical and basolateral membranes of cells of the 
proximal tubule and descending thin limb. D: rat kidney, peptide negative control. U, 
urothelium; LP, lamina propria; G, glomerulus, PT, proximal tubule. Bladder mucosa, 
representative image of n=12; kidney, representative image of n=3. 
 
 
 
82 
 
 
Figure 2.8 Immunoperoxidase labelling of AQP3 in pig bladder and positive 
control tissue, rat kidney medulla.  
Rabbit polyclonal anti-AQP3 antibody was used at a dilution of 1:1000 to detect AQP3 
in pig mucosa strip. A: bladder mucosa with AQP3 immunoreactivity in the urothelium, 
the inset shows the urothelium at a larger magnification. B: mucosa, peptide negative 
control. C: AQP3 labelling in rat kidney medulla; collecting duct cells; D: rat kidney, 
peptide control. U, urothelium; LP, lamina propria; G, glomerulus, CD, collecting duct. 
Bladder mucosa, representative image of n=12; kidney, representative image of n=3. 
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Figure 2.9 Immunoperoxidase labelling of AQP9 in pig bladder and positive 
control tissue, rat liver 
Rabbit polyclonal anti-AQP9 antibody was used at a dilution of 1:1000 to detect AQP9 
in pig mucosa strip. A: bladder mucosa with AQP9 immunoreactivity in the urothelium. 
The inset shows the urothelium at a larger magnification. The dotted line demonstrates 
the boundary between the urothelium and the suburothelium region. B: mucosa, 
peptide control. C: AQP9 labelling in rat liver; perivascular hepatocytes, D: rat liver, 
peptide negative control. U, urothelium; LP, lamina propria; CV, central vein; HL, 
hepatic lobule. Bladder mucosa, representative image of n=12; kidney, representative 
image of n=3. 
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Figure 2.10 Immunoperoxidase labelling of AQP11 in pig bladder and positive 
control tissue, rat kidney 
Rabbit polyclonal anti-AQP11 antibody was used at a dilution of 1:1500 to detect 
AQP11 in pig mucosa strip. A: bladder mucosa with AQP11 immunoreactivity in the 
urothelium. The inset shows the urothelium at a larger magnification. B: mucosa, 
peptide control. C: AQP11 labelling in rat kidney medulla intracellularly in the proximal 
tubule. D: rat kidney, peptide negative control. U, urothelium; LP, lamina proria; G, 
glomerulus, PT, proximal tubule. Bladder mucosa, representative image of n=12; 
kidney, representative image of n=3. 
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2.5 Discussion 
 
2.5.1 Expression of AQPs in the Urinary Bladder  
The main aim of this study was to determine the expression profile of AQPs in the 
adult pig bladder whether it can be used as a model to describe human bladder 
function. mRNA expression and protein production of AQP1, AQP3, AQP9 and AQP11 
were observed in the urothelial and suburothelial layers of pig bladder. However, 
AQP4, AQP7 which are reported to be expressed in human (Rubenwulf et al., 2009) 
and AQP2, AQP5, AQP6, AQP8 and AQP10 were not detected. 
AQP1 was confined to lamina propria blood vessels and not to the urothelium (Fig 2.3 
& 2.7) as observed in rat bladder and ureter (Spector et al., 2002). The functional role 
of AQP1 in proximal tubular and the descending limb of the loop of Henlé epithelium 
is to mediate water fluxes (Boassa et al., 2006). AQP1 is also found in blood vessels 
of many tissues, where it may also gate K+ channel activity (Boassa et al., 2006). 
AQP1 multifunctional channel suggests it is a potential therapeutic target for 
pathological conditions involving altered fluid homeostasis as well as in mice airways 
and lungs where it facilitates osmotic water transport across alveolar microvascular 
endothelium (Verkman, 2002). However, AQP1 knockout in transgenic mice had no 
impact on alveolar fluid absorption, impaired humidification or lung CO2 transport 
(Song et al., 2001; Yang et al., 2000; Fang et al., 2002). Similarly, deletion of AQP1 in 
the microvascular endothelial cells of salivary gland in mice had no effect on the 
secretion of saliva (Ma et al., 1999). It appears that AQP1 has limited physiological 
function in fluid movement in the endothelium, but its functional role in the 
microvasculature of the bladder mucosa is unknown. AQP2, the subtype responsible 
for AVP mediated water fluxes of the distal tubule and collecting duct of the nephron 
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in human was absent in pig bladder mucosa. Whiles AQP2 has been identified in rat 
bladder (Spector et al., 2009), similar to this study AQP2 is absent in human bladder.  
AQP3 was expressed in the urothelium of pig urinary bladder, consistent with data 
from human and rat bladder urothelium (Spector et al., 2002; Rubenwolf et al., 2009). 
Rubenwolf et al. (2009) also reported that AQP3 was located especially at the 
intercellular borders of basal and intermediate cells, but in the pig bladder it was 
demonstrated that distribution was homogeneous throughout the urothelium (Fig 2.3 
& 2.8). AQP3 transports several neutrally-charged solutes, including water, glycerol, 
urea and H2O2 (Hara-Chikuma et al., 2015). Distribution of AQP3 on both apical and 
basolateral membranes of bladder urothelium suggests bidirectional movement of 
water and solutes. AQP3 expression is responsive to changes of local osmolality 
(Spector et al., 2002). Exposure of human urothelial cells to hyperosmolar NaCl (500 
mosm/kg) solutions increased AQP3 expression, as well as increased water fluxes 
(Rubenwulf et al., 2012). These suggest that AQP3 expression and translocation to 
the plasma membrane is part of a mechanism to regulate urothelial cell osmolarity and 
volume during increased osmotic stress as caused by exposure to urine of variable 
osmolality. AQP3 is a member of the aquaglyceroporin family and thus also transports 
urea and other solutes (Litman et al., 2009). Based on the similarities in the function 
of AQP3 and urea transporter B, which has also been found in the urothelium (Timmer 
et al., 2001; Yang et al., 2002; Dong et al., 2013), it may be postulated that AQP3 also 
facilitates the transfer of urea across the bladder urothelium. 
AQP9 was detected more on the apical surface of the pig urothelium, i.e. umbrella and 
intermediate cells (Fig 2.3 & 2.9). Basal cells differentiate into intermediate and 
umbrella cells (Papafotiou et al., 2016) and other studies have shown that AQP9 
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expression is also evident in differentiated keratinocytes (Sugiyama et al., 2001), 
freshly isolated urothelium and differentiated urothelial cultures (seen as urothelial 
cells expressing ZO-1 and Claudin-4 to tight junction complex) (Rubenwolf et al., 
2009), whereas AQP3 is localised in both differentiated and proliferating urothelial 
cells (Rubenwolf et al., 2009). These data including this current study suggest that 
whiles AQP3 expression is required throughout the different cell types of the urothelial 
cells, AQP9 expression is mostly seen in differentiated cells (umbrella cells) located in 
the lumen of the bladder where it may serve to be important for modifying urine. AQP9 
also belongs to the aquaglyceroporin family and is involved in glycerol influx and urea 
efflux during increased liver gluconeogenesis (Carbrey et al., 2003). A 3D-structural 
analysis of APQ9 showed a larger pore size compared to other AQPs and can explain 
its ability to transport larger molecules such as lactate, purines and pyrimidines 
(Tsukaguchi et al., 1998; Viadiu et al., 2007). Thus, AQP9 could modify the final 
composition of urine by facilitating transport of various solutes across the bladder 
urothelium. 
AQP11 was identified throughout the urothelium (Fig 2.3 & 2.10) and its expression 
has been reported in different mammalian tissues including: rat testis, mouse brain 
and kidney (Yeung et al., 2010; Koike et al., 2016). AQP11 is mainly present in the 
endoplasmic reticulum and only a fraction migrates to the cell membrane to facilitate 
glycerol and water transport (Morishita et al., 2005; Madeira et al., 2014; Ikeda et al., 
2011). AQP11 expression has also been shown in human adipocytes where it 
functions as a water and glycerol channel (Madeira et al., 2014). Thus, AQP11 may 
act as a water and glycerol transporter in bladder urothelium under osmotic stress. 
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2.5.2 Potential Regulatory Mechanism Mediating AQP Expression 
and Function in Bladder Urothelium 
 
2.5.2.1 Expression of TRP Channels in Pig Urinary Bladder  
Various studies have demonstrated that the expression/ function/ translocation of 
AQPs in different cell types is dependent on an increase in intracellular calcium levels 
(Benfenati et al., 2011; Jo et al., 2015). This increase in intracellular Ca2+ levels seems 
to be dependent on activation of various Ca2+ channels expressed in the cell 
membrane rather than elevation of intracellular calcium levels. One of the key families 
of ion channels responsible for mediating the flux of Ca2+ from extracellular space to 
the intracellular space in response to osmotic/ chemical or mechanical stresses are 
the TRP channels 
TRPV4 mRNA expression was found in both mucosa and urothelium whilst TRPC4 
expression was limited to the mucosa (Fig 2.5). Previous studies have demonstrated 
that different subtypes of TRP channels such as TRPV1, TRPV2, TRPV4, TRM4, 
TRPM8 and TRPA1, are expressed in the urinary bladder of rats, pigs and humans 
(Vahabi et al., 2013; Anderson, 2019) in the urothelial cells similar to this current study. 
TRPC4 was found to be expressed in the submucosa.TRPC4 have also been 
identified in the vascular endothelial cells (Kim et al., 2012).Therefore the identification 
of TRPC4 could suggest that in pig bladder, TRPC4 is also expressed in vascular 
endothelial cells.  
Currently, no studies have reported an interaction between TRP channels and AQPs 
in the urinary bladder, however, a few studies have reported an interaction between 
TRP channels and AQPs in different tissues and cell lines (Benfenati et al., 2011; Jo 
et al., 2015; Conner et al., 2012). TRPC1, also part of the canonical family as TRPC4 
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is shown to regulate AQP1 translocation to the plasma membrane in rat astrocytes 
(Conner et al., 2012) therefore the identification of AQP1 in blood vessels capillaries 
and endothelial cells in the suburothelial and the expression of TRPC4 in the lamina 
propria could suggest that TRPC1 is involved in regulating AQP1 translocation.  
The presence of different types of TRP channels detected in pig urinary bladder in this 
study in addition to the clear association of TRP channels in various subtypes of AQP 
regulation suggest that TRP cahnnels could also regulate AQP channels in pig urinary 
bladder.  These channels could be further explored as part of future work in AQP 
regulation in the bladder.  
2.5.2.2 Expression of ER-1 in Pig Urinary Bladder 
In this study, the expression of ER-1 was detected in the mucosa and the urothelium 
of the female pig bladders (Figure 2.5). The association between oestrogen receptors 
and AQPs, in particular AQP1, AQP3, and AQP9 have been characterised extensively 
in other tissues (Jablonski et al., 2003; Kim et al., 2010; Oliveira et al., 2005). 
Oestrogen receptor response element has been identified in the promoter region of 
AQP3 gene and oestrogen has been demonstrated to directly upregulate AQP3 
expression by activating oestrogen response element found within AQP3 gene (Huang 
et al., 2015). In rat efferent ductile epithelium and the initial segment of the epididymis, 
oestrogen and 5α- dihydrotestosterone were found to upregulate AQP9 expression 
(Oliveira et al., 2005). Similarly, an increase water permeability was observed in 
mouse uterus (expressing AQP2 and AQP3) treated with oestrogen (Jablonski et al., 
2003). These studies collectively demonstrate that changes in estrogen levels impact 
AQP expression and function. In the current study, female pig bladder were used 
throughout the experiment and transcripts for ER-1 was identified in the urinary 
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bladder. ER receptors are also found in human bladder (Losif et al., 1981), since 
estrogen is shown to upregulate AQPs expression, the identification of ER in pig 
bladder could suggest a potential mechanism for estrogen mediated up and down 
regulation of AQP expression depending on the reproductive cycle of the pig. Further 
studies to investigate the protein levels, localisation and interaction of ER-1 with AQPs 
in bladder urothelium are required.  
2.5.2.3 Expression of ENaC in Pig Urinary Bladder  
ENaCs are major regulatory channels of Na+ and water reabsorption (Butterworth, 
2010) and paracellular transport of water across cell membrane in response to Na+ 
transport has been established (Tripathi and Boulpaep, 1989). In some cell types, 
constitutive expression of AQPs in the plasma membrane has been reported and thus 
we hypothesised that in addition to paracellular movement of water in response to Na+  
transport,  transcellular water transport facilitated by constitutively expressed AQPs 
can occur in the event of increase in Na+ transport. Therefore the expression of the 
different subtypes of ENaC channels in the urinary bladder was explored 
Three homologous ENaC subunits were identified in the pig urinary bladder. ENaC β 
and ENaC γ were identified in the mucosa and urothelium whilst ENaC α subunit was 
only found in the urothelium (Figure 2.5). 
 In a study investigating the distribution of electrolytes and water transport pathways 
in human cortical distal nephron, AQP3 and AQP2 were found to be co-localized with 
ENaCs within the same cells of the cortical collecting duct (Biner et al., 2002) 
suggesting a possible direct or indirect interaction between AQP2 AQP3 and ENaC 
channels. In mammalian urinary bladder, ENaC isoforms (α-, β-, and γ-ENaC) are also 
present in the apical plasma membrane and function as trans-epithelial sodium 
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reabsorption channels (Smith et al., 1998). Stretch of the bladder in response to 
increasing urinary volume or aldosterone levels caused an increase in the number of 
ENaCs in the apical membrane of rabbit urinary bladder urothelium (Smith et al., 
1998). Rabbit bladder urothelium has the ability to reabsorption up to ~80 µmol/h of 
Na+, indicating that the urothelium is involved in modifying the final concentration of 
urine (Smith et al., 1998). Currently, no studies have reported the involvement of ENaC 
in AQPs function or expression. However, ENaC could indirectly influence AQPs’ 
function via the reabsorption of Na+ to regulate urothelial cell volume. This assumption 
is in line with studies by Rubenwolf et al. (2012), where they demonstrated that an 
increase in the  osmolarity of tissue culture medium achieved through increasing the 
concentration of NaCl up to 500 mosm/kg caused an increase in AQP3 expression 
(Rubenwulf et al., 2012).The general principle of Na+ reabsorption is the movement of 
water alongside Na+. Therefore, an increase in Na+ reabsorption will cause changes 
in extracellular and intracellular osmolarity. These changes could initiate water 
reabsorption mediated by active transport through AQP channels or passive diffusion 
to regulate osmolarity. 
 
2.5.3 Control Experiments Implemented in this Study 
In this study, it was important to determine the expression profile of AQPs in both the 
urothelial and suburothelial layers as AQPs localisation in the different layers of the 
bladder wall could help detemine their physiological role in water homeostasis. 
Therefore, in order to ensure that both urothelial and mucosa samples obtained from 
the pig bladder were not contaminated with cells from other layers of the bladder wall, 
various  markers such as  vWF and SMMHC were used ensure that the urothelial 
samples did not have any cross contamination from the suburothelial layer. SMMHC 
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are smooth muscle cells specific markers (Lu et al., 2011; Sadegh et al., 2012). 
SMMHC expression was seen in the mucosa only in this study (Fig 2.5). The 
expression of SMMHC in mucosa was expected as mucosa contains muscularis 
mucosa which are smooth muscle cells. Urothelial samples containing SMMHC bands 
were excluded from the experiment. vWF is an endothelial specific marker (Zanetta et 
al., 2000) was used as a control to check the urothelial samples for cross 
contamination with vascular endothelial cells. vWF was identified in the mucosa but 
not the urothelium samples as the mucosa contains a rich network of capillaries and 
arterioles (Fig 2.5). Urothelial samples positive for vWF were excluded from all the 
experiments.  
Also, to ensure that the urothelial and mucosa samples extracted contained all the 
different cell layers in particular the umbrella cells as these are known to easily 
dissociate with minimum shear stress (Carattino et al., 2013), which could have 
happened during transport of the bladder, the expression of terminally differentiating 
urothelial markers such as Claudin-2 and Caludin-4, uroplakin (Smith et al., 2015) 
were investigated in all samples. Uroplakin, Claudin-2, Claudin-4 mRNA was detected 
in the bladder urothelium and mucosa (as the mucosa also contains the urothelial 
layer), demonstrating that all layers of the bladder urothelium were indeed present in 
the samples and were not dissociated during the dissection technique.  
These controlled experiments before each experiment demonstrated that no cross 
contamination was introduced to the different samples. Moreover, they confirm that 
the isolated cell extract were indeed of urothelial and mucosa cells. Therefore the data 
generated was reliable. 
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2.6 Summary 
 
Four different AQP mRNA’s (AQP1, AQP3, AQP9, and AQP11) were detected in adult 
pig bladder, suggesting that AQPs may regulate urothelium cell volume and also 
determine the final urine composition. Changes to the extracellular osmolality of 
urothelium cells may also generate membrane stress, and release various transmitters 
from the bladder urothelium that affect bladder contractility and sensory nerve 
transduction. However, the exact role of AQPs in mediating the sensory and contractile 
functions of the bladder wall, and the mechanisms by which their expression and 
function in the bladder is regulated is unknown.TRPC4, TRPV4, ER-1 and ENaC 
transcript was detected in pig urinary bladder. These proteins have previously been 
shown to be directly or indirectly involved in regulating AQP expression and function 
in other tissue types. Therefore, they may also be important in modulating AQP 
function in the urinary bladder. The exact role of AQPs in mediating the sensory and 
contractile functions of the bladder wall, and the mechanisms by which their 
expression and function in the bladder is regulated is unclear and remains to be 
elucidated. 
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Figure 2.11 A proposed model for the regulation of rapid cellular water flow.  
Regulation of osmolarity through influx of AQP channels in conjunction with solute channels such as ENaC. 1) Continue adjustment of intracellular 
osmolarity in response to small changes in extracellular environment is achieved through transcellular influx of solutes such as sodium through ENaC 
and water through constitutively expressed AQP channels. 2) In the event of rapid osmotic changes caused by influx of water through AQP channels 
leading to cell swelling, 3) TRP channels are activated to allow extracellular calcium entry and as a result triggers additional AQPs translocation to the 
plasma membrane 4, 5, 6, 7). The translocation to the plasma membrane is believed to be along microtubules which is dependent on the activation of 
calmodulin (CaM) followed by AQP protein phosphorylation and insertion in the cell membrane. To increase the amount of plasma membrane AQPs,  
5) AQP synthesis is initiated in response to prolonged extracellular osmotic challenges ( such as trauma) or hormonal changes such as oestrogen 
leading to the activation of oestrogen response element, for example in the promoter region of AQP3.  The increased amount of AQPs in the cell 
membrane facilitate water entry or exit from the cell to maintain cellular homeostasis 8). Adapted from Conner et al., 2012.  
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Chapter 3 
 
Measurement of D2O Fluxes Across 
Pig Urinary Bladder Mucosa  
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3.1 Introduction  
 
The tightness of the urothelial barrier is important for a healthy bladder function as 
disruption of this barrier has been associated with various urothelial bladder disorders 
such as interstitial cystitis and bladder pain syndrome (Parsons, 2010; Jiang and Kuo., 
2017). Various techniques such as real time  transepithelial electrical  resistance 
(TEER) measurement with microinjection of fluorescently-labelled molecules imaged 
with epifluorescent microscope (Hill et al., 2017),   impedance spectroscopy and 
conductance scanning (Krug et al., 2009) TEER measurement with epithelial volt ohm 
meter chop-stick electrodes the TEER (Srinivasan et al., 2015) or the Ussing chamber 
technique (Li et al., 2004) have been used in the laboratory to study the barrier function 
of various tissues (Li et al., 2004; Clark,2009). Out of these various techniques, the 
Ussing chamber system is frequently used in measuring TEER of many epithelial 
tissues. The Ussing chamber system is widely used to measure paracellular and 
transcellular movement of ions across tissues, including intestinal transport during the 
processes of homeostasis, damage (Li et al., 2004; Clark, 2009) and restitution 
(Riegler et al., 2000).   
 
3.1.1 History of the Ussing Chamber 
 
The Ussing chamber was originally designed around 1950 by Hans Ussing to measure 
the short-circuit current as an indicator of net ion transport across frog skin (Ussing 
and Zerahn, 1951). Prior to the development of the Ussing chamber, Na+  transport 
influx across the frog skin was established to be higher than the  efflux of Na+ using 
double labelling with Na+ isotopes (Levi and Ussing, 1949). The Ussing chamber 
allowed the first investigation of ion (Na+) transport physiology of an epithelium.  
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Ussing chamber uses a biological membrane, across which salts and water are 
transported, to separate two chambers containing test solutions (Li et al., 2004). If the 
composition and volume of solutions in the two chambers is identical paracellular 
movements would be minimised if the electrical potential gradient across the 
membrane was also set to zero by an external voltage-clamp. (Clarke et al., 2009).  .  
This external current is termed the short-circuit current (Isc). Therefore, by eliminating 
transepithelial diffusion forces (osmotic and electrochemical gradients), the movement 
of ions as measured by isotopic tracers or the Isc in the Ussing chamber is due to active 
transport (Clarke et al., 2009). 
The Ussing chamber method also enables continuous validation of the integrity and 
viability of the tissue or cells by measuring electrophysiological parameters such as 
transepithelial electrical resistance (R), transmembrane potential difference (Vte) and 
short circuit current (Isc) using the following equation (Li et al., 2004): 
 
 
Equation 3.1 
 
 
3.1.2 Ussing Chamber Experiments in the Urinary Bladder 
 
The Ussing chamber system has been used to characterise the transport properties 
of bladder urothelium in different species (Miyake et al., 2013; Mani et al., 2013; 
Burshtein et al., 2013; Arnold et al., 2019). With rabbit urinary bladder, the Ussing 
 
Rte
Vte
Isc
=
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chamber was used to measure water, urea, ammonia and H+ permeability of the 
urothelium (Negrete et al., 1996). 
A study investigated the effects of cAMP on epithelial Na+ channel activity in rabbit 
bladder by measuring the amiloride-sensitive short-circuit current across bladders 
mounted in Ussing chambers (Burton et al., 2000). In this study, they discovered that 
cAMP stimulates the insertion of new Na+ channels into the apical membrane of the 
rabbit bladder urothelium.  
Ussing chamber has also been a valuable technique in measuring water transport 
across the urinary bladder urothelium using urothelial cells established on permeable 
Snapwell™ to measure radioisotopic flux of [3H] water (Rubenwulf et al., 2012). 
Rubenwolf et al. (2012) have previously looked at AQPs responsiveness to changes 
in osmolarity using in vitro-differentiated normal human urothelial cell culture systems 
in hemi-chambers (Rubenwulf et al., (2012). In their study, they demonstrated that 
changes in osmolarity in particular increase in NaCI causes increase water and urea 
movement across the urinary bladder. AQP blockade with HgCl2 resulted in decreased 
water and urea flux. No other study have reported the use of Ussing chamber in the 
study of urinary bladder since however, these studies previous collectively 
demonstrate that Ussing chamber is a powerful tool to investigate urinary bladder 
urothelium. 
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3.1.3 The use of D2O in Measuring Transurothelial Water Movement 
 
D2O (heavy water) is used as a moderator in nuclear reactors. Its biological effects 
have both “solvent isotope effects,” those due to the special properties of D2O as a 
solvent, and “deuterium isotope effects” (DIE), which result when D replaces H in many 
biological molecules have been studied extensively (Kushner et al., 1999). D2O has a 
low toxicity toward mammals and therefore widely used in research for measuring 
water movement in humans and animals.   
Since H2O is thought to interact with specific amino acid residues Phe-56 and Agr-195 
in AQP pore via hydrogen bonding (Mamonov et al., 2007;Miloshevsky and Jordan, 
2004) to allow H2O to be transported across membranes, D2O which has similar 
properties as H2O, might interact with AQPs in a similar way (Mamonov et al., 2007).   
Previously, D2O permeability through AQPs such AQP1 has been studied to determine 
whether AQP1 selectivity to water is limited to H2O only and not other heavier water 
such as D2O. It was demonstrated that D2O permeability through AQP1 is similar to 
that of H2O (Mamonov et al., 2007). Therefore, D2O was used as a maker to determine 
water movement in this study  
3.1.4    Potential AQP Inhibitors 
 
A number of ions and molecules have been tested as AQP inhibitors (Jeyaseelan et 
al., 2006). However, the existing compounds are non-specific and can block   
numerous transporters, channels and enzymes. Therefore they cannot be considered 
as specific inhibitors of AQP channels and the effect on water movement is secondary 
to altered ion transport. Heavy metal compounds such as gold and silver or mercury 
chloride were the first to be identified as non-selective AQPs inhibitors (Savage and 
Stroud 2007).  
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HgCl2 was used in this current Ussing chamber experiment as it is commonly used to 
inhibit AQP channels in a variety of tissues and cells. HgCl2 has previously been 
demonstrated to reduce water transport in the red blood cell membrane by inhibiting 
AQP channels (Preston et al., 1993). This selective inhibition subsequently allowed 
for aquaporin isolation, cloning, membrane transport characterization, and mercury 
sensitivity mutational analysis (Savage and Stroud 2007). The purpose of this study 
was to determine the role of AQPs in mediating water flux across the bladder 
urothelium, therefore, the effect of HgCl2, specific AQP inhibitor on D2O movement 
across the pig bladder urothelium was assessed. (Preston et al., 1993; Rubenwulf et 
al., 2012)  
The need for an effective and specific AQP inhibitor is important in studying the 
functional role of AQP channels in mediating water and solute transport. In addition to 
this, AQP specific inhibitors are important as AQPs have been implicated in a variety 
of diseases such as nephrogenic diabetes insipidus and polycystic kidneys (Morishita., 
2005; Loonen et al., 2008) including disorders in the urinary bladder urothelium such 
as bladder outlet obstruction (BOO) (Kim et al., 2010).  
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3.2 Aims of the Study 
 
Little is known about the functionality of AQPs in the urinary bladder. The aim of this 
study was to investigate the potential role of AQPs in mediating water transport across 
pig bladder urothelium in response to osmotic stress 
3.2.1 Objectives of the D2O flux experiments were: 
· To determine the rate of water (D2O) flux from apical to basolateral chambers 
across pig bladder mucosa strip 
· To determine is the rate of water flux was dependent on the transmembrane 
osmotic gradient 
· To determine if the rate of water flux was dependent on functional aquaporin 
channels - this was done by using the non-selective aquaporin inhibitor 300 µM 
HgCl2 
· To determine if the rate of water flux was dependent different osmotic gradient 
- this was done by exposing the basolateral and apical side of the tissue to 
different osmotic solutions containing D2O on the apical side in the presence of 
HgCl2. 
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3.3 METHODS 
 
3.3.1 Tissue Preparation for Ussing Chamber Experiments 
 
Female pig (Sus scrofa domestica) bladders were obtained from a local abattoir. Whole 
bladders were placed in PBS for transportation on ice. From each bladder, two paired 
strips of circular orientated mucosa were dissected from the bladder dome at room 
temperature using dissection forceps and fine-tip pointed stainless steel scissors with 
curved blades. One mucosal strip was used for control experiments and the other one 
was used to investigate the effect of HgCl2 on movement of D2O.  
 The paired tissue sections were immediately stretched and mounted on a 14.6 mm 
by 5.0 mm rectangular chamber and secured by six fine needles located at the edges 
of the chamber. Chambers containing tissue sections were placed in an Ussing 
chamber system. Twelve pairs of mucosal strips from twelve different bladders were 
used for Ussing chamber experiments. 
 
3.3.2 The Structure of an Ussing Chamber System 
 
An Ussing chamber supports an epithelial membrane in such a way that each side of 
the membrane is isolated and faces a separate chamber-half (Figure 3.1). The Ussing 
chamber system used in this study was made from a solid acrylic block cut into 
cylindrical halves. Each half consisted of a hollow chamber open at one end, so that 
when the two halves were brought together a single chamber was formed. A parafilm 
O-ring fitted into a groove at the open end of each half-chamber to ensure a watertight 
seal. When an experimental tissue preparation was stretched across the hole the only 
connection between the two chambers was via the preparation itself (Figure 3.1). Each 
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half of the chamber had several ports: for connection to a water-jacketed circulation 
system; for introduction and drainage of superfusing solution; and for making 
electrical connections to the system. Ports to measure transmembrane potential 
were closest to the tissue while ports for current injection electrodes were furthest 
from the tissue (Figure 3.1). Electrical connections were made with Ag-AgCl pellet 
electrodes that fitted into the ports. The electrodes were connected to a high input 
impedance amplifier to record the potential difference and pass current. The voltage 
and current electrodes made contact with the superfusing solution via 2% agar bridges 
filled with 3 M KCl through Luer ports. The remaining ports allowed superfusing fluid 
to make contact with the two faces of the epithelial membrane preparation.   
The face of one chamber-half was imbedded with sharp stainless-steel pins which 
mated with corresponding holes in the other chamber-half face. These pins puncture 
the preparation to hold it in place across the hole (radius 5 mm) in each half-chamber. 
A modified Krebs solution (Table 3.2) superfused the tissue from reservoirs on each 
side of the chamber. Each horizontal reservoir arm had an inlet and outlet port for 
access to the water jacket. Water at the desired temperature was pumped through a 
jacket from a water bath (37ºC). Each reservoir had a separate air/gas inlet to drive 
the circulation system, in these experiments 95% O2/5% CO2 was used to maintain a 
constant pH of 7.40±0.05. 
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Figure 3.1: The Ussing chamber  
Schematic diagram of an Ussing chamber. The Ussing consisted of two chambers to allow the tissue to be placed inbetween 
the chambers. The guide pins ensure the tissue is held in place and alignment dots allow the chambers to be assembled in the 
right orientation. Each half-chamber has voltage and current electrode connecting ports to pass current and measure the 
transmembrane potential. Additional ports in the chamber allows constant perfusion of the tissue preparation with experimental 
solution and 95% O2 and 5% CO2 to ensure a steady oxygen perfusing to tissue. Other ports serve to enable fluid sampling. 
The chamber is a clear acrylic that allows the observation of the experimental progress. (Adapted from WPI, 2015) 
 
Position of the mucosal tissue between the 
two chambers 
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Figure 3.2 The Ussing chamber system: A) Representative image of an assembled Ussing chamber system used in this experiment. 
The Ussing chamber system consisted of oxygen regulating clamp; to regulate the flow of oxygen to the tissue preparation, circulating 
water bath; to water jacket internal tissue buffer and maintain desired temperature at 37ºC, tissue section; pig bladder mucosa tissue 
preparation used to determine the rate of D2O movement, internal tissue buffer; to provide a physiological condition for the tissue to stay 
viable, fluid out/fluid in; ports that allow internal tissue buffer to circulate in and from the tissue, voltage electrode/current electrode; to 
allow TER measurement. B) Representative image of pig mucosa tissue preparation used during the experiments. 
 
 
 
A 
B 
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3.3.4 Noise and Offset Voltage Control 
 
The chambers, superfusing solutions and solid agar bridges of 3M KCl in 2% agar 
were prepared before each experiment. The Ussing chamber was assembled (Figure 
3.2) without any tissue and the whole system was flushed with Krebs solution).  
A watertight system was established (without tissue preparation) with superfusate in 
the central chamber and the temperature of the circulating water bath was adjusted to 
37ºC. Current and voltage electrodes were inserted into each half-chamber to test for 
intrinsic noise and any voltage offsets (Figure 3.2). The electrodes were connected to 
a commercial system (Model: U9500/U9520. WPI UK) to inject current and record 
potential difference and to test for intrinsic noise and any voltage offsets. Noise and 
offsets generally arose from bubbles in the agar bridges connecting the current/voltage 
electrodes to the superfusate; bubbles were removed by gently tapping the agar 
bridges. The potential difference (p.d.) between the two voltage electrodes was 
measured and should have been <0.1 mV; when greater agar bridges were again 
cleaned until the p.d. was acceptable. Current pulses, I, were then injected (<0.1 mA) 
and the p.d. (V) recorded; the resistance of the superfusate-filled chamber, R, was 
calculated from the relationship R=V/I. The value of V was then offset to 0 mV by 
passing a current from the control system.   
 
3.3.5 The Ussing Chamber Experimental Set Up 
 
After noise and offset corrections were carried out as described above, the two 
separate chambers, one chamber for control experiment and the other chamber for 
HgCI2 treatment, were disconnected from the superfusate solution and a sheet of two 
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paired mucosa was stretched across the mouth of the central chamber of one half-cell 
and then connected to the second half-cell both chambers were filled with superfusate. 
At this time, the system was checked visually for leaks. After reassembly of the system, 
each reservoir was filled with the same volume of modified Krebs superfusate (20 ml) 
to maintain equal hydrostatic pressure across the preparation. Ballooning of the 
preparation into one half-chamber indicated unequal hydrostatic pressure between the 
two half-chambers. Agar bridges previously prepared with their respective electrodes, 
were inserted in the wells of the two half chambers to record the potential difference 
across the preparation. The current electrodes were then inserted in preparation for 
the measurement of transmembrane resistance. The chamber was again checked for 
leakages and the time of the chamber assembly was recorded. The system was then 
allowed to equilibrate for an hour to recover from the mounting procedure until an 
acceptable value of transmembrane potential was recorded. The respective chambers 
facing the apical and baso-lateral faces of the mucosa membranes was carefully 
recorded and are henceforth referred to as the apical and baso-lateral chambers. 
 
3.3.6 Transient Epithelial Electrical Resistance Measurement 
 
The electrical resistance of the tissue preparation was measured under voltage-clamp 
conditions using EVC400 and EVC3 preamplifiers which is part of the commercial 
system. The measurement of the electrical resistance was only performed for the initial 
tissues used in the experiment to establish a tight urothelial barrier.  The short-circuit 
current (Isc) is that required to offset the existing transmembrane potential to 0 mV. 
The transmembrane potential (Vte) of the preparation was initially recorded in current-
clamp mode. Current was then passed in voltage-clamp mode to offset Vte to 0 mV 
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and the value of Isc recorded. The transmembrane resistance, rte, was than calculated 
from Ohm’s Law: 
 
Equation 3.2          
𝑟𝑡𝑒 =
𝑉𝑡𝑒
𝐼𝑠𝑐
 
 
To normalise resistance, (Ω,cm-1) values to be independent of membrane area values 
were normalised to specific resistances  (Ω.cm) by the relation:  
 
Equation 3.                                       
𝑅𝑡𝑒=𝑟𝑡𝑒 . 𝐴 
 
Where A is the cross-sectional area of the preparation covering the hole between the 
two-half chambers. 
 
3.3.7 Establishing the Optimum Time for D2O Flux Measurements 
Across Pig Bladder Mucosa 
 
Initially, to determine the optimum time scale for measuring D2O concentration on the 
basolateral side of the mucosal membrane, samples were taken i) during 6 hours of 
initial equilibration (samples were taken every hour) ii) during 13 hours of equilibration 
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(samples taken every hour after the 6th hour) after 19 hours of equilibration (samples 
were taken every 10 mins for 1 hour) and iii)  
 
3.3.7.1. Measurement of Transmembrane D2O Fluxes for Six Hours 
 
The reservoirs supplying the apical and the basolateral half chambers were both filled 
with 20 ml PBS for each experiment, a tissue preparation was mounted between the 
chambers and was allowed to equilibrate for an hour. Subsequently, the apical 
chamber reservoir was emptied and loaded with an hypotonic solution but dissolved 
in water containing 40% deuterium oxide, (D2O).  The basolateral membrane of the 
reservoir was loaded with a hypertonic solution without D2O. Samples (1ml) of 
superfusate were taken from the basolateral chamber every 1h over a period of six 
hours, and the concentration of D2O was determined. 
In order to maintain the transmembrane hydrostatic pressure across the mucosal 
membrane, an equal volume of fluid was also taken at each sampling time point from 
the apical reservoir.  
 
3.3.7.2. Measurement of Transmembrane D2O Fluxes for 20 Hours 
 
Similar method described above was used for 20 hours experiment. The reservoirs 
supplying the apical and the basolateral half chambers were both filled with 20 ml PBS 
for each experiment, a tissue preparation was mounted and was allowed to equilibrate 
for an hour. Subsequently, the apical chamber reservoir was emptied and loaded with 
an hypotonic solution but dissolved in water containing 40% D2O. The basolateral 
membrane of the reservoir was loaded with a similar hypertonic solution but without 
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D2O. The system was allowed to equilibrate overnight (19 hours) and then a 1 ml 
sample of superfusate was taken from the basolateral chamber every 10 min over a 
period of 1 hour for analysis of D2O content. 
 An equal volume was also taken each time from the apical reservoir to maintain the 
transmembrane hydrostatic pressure. The measurement of D2O in the basolateral 
sample showed high amount of D2O detection however the changes in D2O 
concentration overtime with each sample remained the same suggesting that the 
concentration had plateaux. Therefore, a decision was made to look at the period of 
D2O movement between the two time points  
3.3.7.3 Measurement of Transmembrane D2O Fluxes for 13 Hours 
 
Similar method described above was used for 13 hours experiment. The reservoirs 
supplying the apical and the basolateral half chambers were both filled with 20 ml PBS 
for each experiment, a tissue preparation was mounted and was allowed to equilibrate 
for an hour. Subsequently, the apical chamber reservoir was emptied and loaded with 
an hypotonic solution but dissolved in water containing 40% D2O. The basolateral 
membrane of the reservoir was loaded with a similar hypertonic solution but without 
D2O. The system was allowed to equilibrate for 5 hours and then a 1 ml sample of 
superfusate was taken from the basolateral chamber every 1 h over a period of eight 
hours for analysis of D2O content. 
 An equal volume was also taken each time from the apical reservoir to maintain the 
transmembrane hydrostatic pressure. A gradual increase in D2O diffusion rate was 
observed in this time period and therefore, all the subsequent experiments were done 
performed within this time point.  
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3.3.7.3 Measurement of Transmembrane D2O Fluxes 
 
The same experiment described above in the 13 hours was used for this experiment. 
The reservoirs supplying the apical and the basolateral half chambers were both filled 
with 20 ml PBS for each experiment, a tissue preparation was mounted and was 
allowed to equilibrate for an hour. Both apical and basolateral sided on each chamber 
were subsequently emptied and washed with PBS 5 times and the apical half chamber 
and the basolateral half chamber was loaded with the following solution gradient 
separately: 
 Hypertonic on the basolateral/Hypotonic on the apical 
 Isotonic on the basolateral/Hypertonic on the apical 
 Isotonic on the basolateral/Hypotonic on the apical 
 Isotonic on the basolateral/Isotonic on the apical 
 
The system was allowed to equilibrate for five hours and then a 1 ml sample of 
superfusate was taken from the basolateral chamber every hour over a period of eight 
hours for analysis of D2O content. An equal volume was also taken each time from the 
apical reservoir to maintain the transmembrane hydrostatic pressure. At the end of 
each experiment, 3% v/w Evans Blue dye diluted in PBS was added to the apical 
reservoir to test for any leaks between the two half-chambers via the preparation for 
an hour to determine the integrity of the tissue preparation (Figure 3.3). Samples 
collected from leaking tissue preparations were excluded from the data analysis. This 
experimental set up served as a control.  
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Experimental Set Up Tissue 
Incubation Period 
(h) 
Sample 
Collection 
Duration  
Volume of 
sample collection 
each time (ml) 
Measurement of 
Transmembrane D2O 
Fluxes for Six Hours 
 
 
1 5h 1 
Measurement of 
Transmembrane D2O 
Fluxes for 20 Hours 
 
19 Every 10m for 1h 1 
  
Measurement of 
Transmembrane D2O 
Fluxes for 13 Hours 
 
5 8h 1 
 
 
 
 
 
 
Table 3.8: Establishing the optimum time for D2O flux measurement across pig 
bladder mucosa. To determine the optimum time and incubation period needed for 
D2O flux measurement, three different experimental set up protocols indicated below 
were applied.  
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3.3.7.4 Measurement of Transmembrane D2O Fluxes in the Presence of 
HgCl2 
 
To determine whether the movement of D2O was attributed to passive diffusion or the 
presence of AQP channels in the urinary bladder, a second using chamber system 
was set up where AQP channels are inhibited with HgCl2. The exact same approach 
was used. The reservoirs supplying the apical and the basolateral half chambers were 
both filled with 20 ml PBS for each experiment, a tissue preparation was mounted and 
was allowed to equilibrate for an hour. 
The apical and side on each chamber was subsequently emptied and washed with 
PBS 5 times, 20 ml PBS containing 300uM HgCl2 was loaded to the apical side of the 
tissue for an hour. Both apical and basolateral sided on each chamber were 
subsequently emptied and washed with PBS 5 times and the apical half chamber and 
the basolateral half chamber was loaded with the following solution gradient 
separately: 
 Hypertonic on the basolateral/Hypotonic on the apical 
 Isotonic on the basolateral/Hypertonic on the apical 
 Isotonic on the basolateral/Hypotonic on the apical 
 Isotonic on the basolateral/Isotonic on the apical 
The system was allowed to equilibrate for five hours and then a 1 ml sample of 
superfusate was taken from the basolateral chamber every hour over a period of eight 
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hours for analysis of D2O content. An equal volume was also taken each time from the 
apical reservoir to maintain the transmembrane hydrostatic pressure. At the end of 
each experiment, 3% v/w Evans Blue dye diluted in PBS was added to the apical 
reservoir to test for any leaks between the two half-chambers via the preparation for 
an hour to determine the integrity of the tissue preparation (Figure 3.3). Samples 
collected from leaking tissue preparations were excluded from the data analysis. 
 
 
Table 3.2 Krebs buffer solutes. Composition of solutions used to measure the 
influence of osmotic pressure on transmembrane D2O flux Hypotonic solution; 
96mOsM, Hypertonic solution; 407mOsM, Isotonic solution 283mOsM;   
 
 
 
 
 
 
 
Chemicals  
(mmol/l)   
NaCI D Glucose NaHCo3 KCI MgSo4 KH2PO4 CaCl2 Tris 
base 
Sucrose  
Hypotonic   47 12 25 4.6 2.4 1.2 2.6 0 0 
Isotonic  47 12 25 4.6 2.4 1.2 2.6 71 0 
Hypertonic   94 12 25 4.6 24 1.2 2.6 0 160 
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Figure 3.3 Tissue integrity assessment using Evans Blue dye. A) Close up image of the Ussing chamber with urinary 
bladder mucosa tissue preparation. 3% Evans Blue dye diluted in PBS was loaded on the apical reservoir/half chamber. 
A) No visible movement of Evans Blue dye detected on the basolateral half chamber after 1 hour. B) Movement of Evans 
Blue dye was detected on the basolateral half chamber after 10 minutes indicating leaking tissue preparation.  
A B 
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3.3.8 Infrared Detection of D2O and Calculation of Flux Rate  
 
Sample (1 ml each) collected from the basolateral side of the chamber were loaded 
on fourier-transform infrared spectroscopy reader and the sample were analysed using 
a Fourier-transform infrared spectrometer (FT-IR spectrometer) peak signals detected 
around a wavenumber of 2501 cm-1 were interpreted as D2O values. Figure 3.5 shows 
a spectrometer reading of D2O solution of known concentrations. A standard curve of 
concentration (0.4%, 0.5%, 1%, 2%, 6% is this v/v) against wave length was generated 
(Figure 3.5). The relationship between peak amplitude and D2O concentration was 
linear and fitted to a straight-line equation:  
                                                       y = mx + c 
 
where y = optical density @ 2501 cm wavelength); m = gradient of the relationship; c 
a non-zero intercept constant; x = D2O percentage.  
The change in concentration of D2O on the basolateral side of the mucosa over time, 
in the presence and absence of HgCl2, was used to estimate the permeability 
(diffusion) coefficient (PD) using the equation:   
                                                      PD = ᶲ/(A.∆C)    
Where ᶲ is the flux of the tracer across the membrane and is calculated from the net 
increase of the tracer in the basolateral surface, A is the area of the apical membrane, 
and ∆C is the concentration gradient for the D2O across the membrane 
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3.3.9 Statistical Analyses  
 
All data are presented as mean ± standard error of the mean (SEM) of three repeats 
(n=3). The number of separate experiments from different animals are denoted as n. 
Comparisons between the total D2O diffusion, HgCl2 dependent D2O diffusion and 
HgCl2 independent D2O diffusion used repeated measures analysis of variance 
(ANOVA) with post-hoc tests (Newman-keuls test) for any differences between pairs 
of conditions. 
The rate of D2O diffusion amongst the different tonicities was compared using one-
way ANOVA followed by a post hoc test (Tuckeys test). Straight-line fits used an 
iterative algorithm to calculate the best-fit values of slope and intercept. p<0.05. All 
analyses were performed in GraphPad Prism. 
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Figure 3.4 Representative graph of known D2Ostandard cencentrations against peak height in absorbance. A 
standard curve of concentration against absorbance for D2O was generated. The relationship between absorbance on the 
y axis and D2O concentration ((%) 0, 0.4, 0.5, 1, 2, 6) on the x axiswas linear and fitted to a straight-line equation.  
 
 
y = 0.0377x - 0.0058
R² = 0.9985
0
0.05
0.1
0.15
0.2
0.25
0 1 2 3 4 5 6 7
A
b
s
o
rb
a
n
c
e
 (
A
) 
% D2O concentration
119 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
12 07 17 standard  0.005 hyper buffer used in dilution 
12 07 17 standard  0.01 hyper buffer used in dilution
12 07 17 standard  0.5 hyper buffer used in dilution
12 07 17 standard  1% hyper buffer used in dilution
12 07 17 standard  2% hyper buffer used in dilution
12 07 17 standard  6% hyper buffer used in dilution
Name
Sample 276 By Administrator Date Wednesday, July 12 2017
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Figure 3.5 The fourier-transform infrared spectroscopy (FT-IR) spectrum of D2O 
Experime t l sam les of differe t D2O concentrations w r  an lysed using a PerkElmer FT-IR spectrometer. D2O peak was 
detected at 2500 cm-1 wavenumber region. Wavenumberof 2500 cm-1 were interpreted as D2O values.  
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3.4 RESULTS 
 
3.4.1 Establishing transient epithelial resistance (TER) and the 
Optimum Time for D2O Flux measurements across pig bladder 
mucosa 
 
To determine the tightness of the dissected mucosa strip, the permeability properties 
of 5 mucosa constructs of bladder were determined by TER measurements. The mean 
TER was 1303.4 Ω.cm2, indicating a ‘tight’ urothelium. Once a tight barrier was 
established, the TER was not measured for subsequent experiments. 
To determine optimum time scale for measuring D2O movement across pig bladder 
urothelium, the concentration of D2O on the basolateral side was measured under 
maximum osmotic gradient (i.e. hypotonic solution on the apical side and the 
hypertonic solution on the basolateral side) over 3 time scales: 6 hours, 13 hours and 
20 hours.  
Experiments were performed initially where samples was taken every 1 h for six hours. 
However, the concentration of D2O was too low for detection (Fig 3.6). Therefore, a 
longer experimental time was chosen. Tissue was allowed to incubate overnight (19 
hrs) and samples were collected every 10 min for 1 hour on the 20th hour (Figure 3.7). 
Although the movement of D2O was detected, there was no change in the 
concentration of D2O over time in these samples. Therefore, a decision was made to 
allow the tissue to equilibrate for five hours and samples taken every hour after the 
sixth hour for an additional eight hours. This resulted in a total of 13 hours experiment 
with five hours tissue equilibration time and eight hours sampling time.   
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Figure 3.6. Measurement of transmembrane D2O flux for six hours  
Graph represent three different repeats of six hours experiment of D2O against time. Small quantities of D2O was 
detected over the period of six hours with an increase in D2O concentration with each hour of sampling.  
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Figure 3.7. Measurement of transmembrane D2O flux for 1 hour after 19 hours incubation time 
Graph represent one bladder strip of one hour experiment of %D2O against time. After 19 hours of incubation, samples 
were taken from the basolateral side every 10 minutes for one hour. Almost equal amount of D2O concentrations were 
detected with each sampling every 10 minutes for one hour.   
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3.4.2 Rate of D2O Diffusion when isotonic solutions was used at 
both basolateral and apical side of the tissue strip.   
 
In order to determine whether there was any basal diffusion of D2O across pig bladder 
mucosa in the absence of an osmotic gradient, both the apical and basolateral sides 
of the mucosa membrane were bathed in isotonic Krebs solution (Table 3.4). The 
concentration of D2O (% D2O) measured on the basolateral side of three mucosa 
membranes is shown in Table 3.4. No D2O movement was detected across the first 
mucosa sample (Table. 3.4).  Very low concentrations of D2O were detected from the 
6th to 8th hour on the basolateral side of the second mucosa sample. No D2O 
movement was detected across the third mucosa sample (Table. 3.4). This data 
demonstrates that there was hardly a driving force for D2O movement across the 
barrier without an osmotic gradient even though concentration gradient for D2O was 
present.  
As the movement of D2O was minimal when both the apical and basolateral sides of 
the mucosa membrane were exposed to isotonic solution, a concentration gradient 
was created across the mucosa membrane by bathing the apical and basolateral side 
of the tissue with solutions of different osmolarity.  
Statistical analysis could not be performed due to the absence of sample detection.  
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Time    %D2O movement 
        Bladder 1 
%D2O movement 
     Bladder 2 
 %D2O movement 
         Bladder 3 
1 0 
 
0 0 
2 0 
 
0 0 
3 0 
 
0 0 
4 0 
 
0 0 
5 0 
 
0 0 
6 0 
 
0.33 0 
7 0 
 
0.41 0 
8 0 
 
0.53 0 
 
Table 3.4 Concentration of D2O measured on the basolateral side of the mucosa when both apical and 
basolateral sides of the membrane were bathed in isotonic solution.  
As a control, isotonic Krebs solution was loaded on the basolateral and apical sides of the membrane in three different 
repeat experiments with three different samples. Movement of D2O was not detected in the first and third repeat. 
Movement of D2O was detected in the second repeat at the 6th 7th and 8th hours.  
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3.4.3 Calculation of D2O Diffusion Rate in Absence and Presence of 
HgCl2  
 
To determine the diffusion rate of D2O across the pig urinary bladder mucosa in the 
presence and absence of HgCl2, the concentration of D2O on the basolateral side of 
pig bladder mucosa strips mounted in Ussing chambers was measured over eight 
hours (after five hours of equilibration). The rate of diffusion under different osmotic 
conditions in the absence and presence of HgCl2 was calculated 
 
3.4.3.1. Hypertonic Solution on the Basolateral Side and Hypotonic 
Solution on the Apical Side 
 
In this experiment, the basolateral side of the mucosa strip was bathed in hypertonic 
solution and the apical side was bathed in hypotonic solution, aim to maximise the 
osmotic gradient created across the mucosa  
The linear regression analysis of D2O concentration against time in the absence (total 
D2O movement, n=3) and presence of HgCl2 (HgCl2-independent D2O movement n=3; 
Figure 3.8) was used to calculate the D2O diffusion rate across each mucosal strip. 
(Table 3.5) The HgCl2-independent D2O concentration at each time point was 
subtracted from the total D2O concentration to determine the HgCl2 dependent D2O 
movement and the diffusion rate (Figure 3.8 and Table 3.5) 
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Figure 3.8 Linear regression analysis of D2O concentration against time in presence and absence of HgCl2 with hypotonic solution 
on the apical and hypertonic solution on the basolateral side of pig bladder mucosa. A, B and C) Linear regression analysis of total D2O 
concentration against time in 3 mucosa strips. G, H and I) Linear regression analysis of D2O concentration against time in presence of HgCl2 
(HgCl2-independent D2O movement) in 3 mucosa strips. The HgCl2-independent D2O concentration at each time point was subtracted from 
the total D2O concentration at that time point in paired mucosa strips to determine the HgCl2 dependent (AQP dependent) D2O concentrations 
D, E and F) Linear regression analysis of HgCl2 dependent D2O concentration against time. The diffusion rate was calculated using % D2O 
over time from these graphs   
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Conditions 
 
Rate of diffusion (slope of the linear 
regression analysis) 
Bladder strip 1   
Total movement   
 
0.3982 
HgCl2 independent D2O movement   
 
0.1737 
HgCl2 dependent D2O  movement   0.2245 
Bladder strip 2   
Total movement   
 
0.2206 
HgCl2 independent D2O movement   
 
0.1392 
HgCl2 dependent D2O  movement  0.0815 
Bladder strip 3   
Total movement   
 
0.3667 
HgCl2 independent D2O movement   
 
0.1336 
HgCl2 dependent D2O  movement   
 
0.2331 
 
 
Table 3.5 The rate of diffusion of total, HgCl2 dependent, HgCl2 independent D2O movement for 
each repeat 
The slopes for total D2O movement, HgCl2 dependent D2O movement and HgCl2 independent D2O 
movement for hypotonic solution on the apical and hypertonic on basolateral  
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A comparison between the total, HgCl2 dependent and HgCl2 independent D2O 
diffusion rates is presented in Figure 3.9. There was a noticeable, but a non-significant 
(p = 0.0664) reduction in D2O diffusion rate when the tissue was treated with 300µM 
HgCl2, a non-selective AQP inhibitor (Figure 3.9)  There was also no significant 
difference  (p = 0.0664) between the HgCl2 dependent and HgCl2 independent D2O 
diffusion rates.   (Figure 3.9). 
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Figure 3.9. Comparison of the mean D2O diffusion rates in absence and presence of HgCl2 with hypotonic solution on the apical and 
hypertonic solution on the basolateral side of the pig bladder mucosa strip.  
There was no significant difference between the total, HgCl2 dependent and HgCl2 independent D2O diffusion rates. The different D2O diffusion 
rates were compared using a repeated measures one-way ANOVA followed by a Newman-Kleus post-hoc test. p value=0.0664, Data are expressed 
as mean ± SEM of 3 independent repeats (n=3).  
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3.4.4 Calculation of D2O Diffusion Rate in Absence and Presence of 
HgCl2  
 
To determine the diffusion rate of D2O across the pig urinary bladder mucosa in the 
presence and absence of HgCl2, the concentration of D2O on the basolateral side of 
pig bladder mucosa strips mounted in Ussing chambers was measured over eight 
hours (after five hours of equilibration). The rate of diffusion under different osmotic 
conditions in the absence and presence of HgCl2 was calculated 
 
3.4.4.1. Isotonic Solution on the Basolateral Side and Hypotonic Solution 
on the Apical Side 
 
In this experiment, the basolateral side of the mucosa strip was bathed in isotonic 
solution and the apical side was bathed in hypotonic solution, aim to simulate the 
osmotic gradient created across the mucosa in over hydrated condition. 
The linear regression analysis of D2O concentration against time in the absence (total 
D2O movement, n=3) and presence of HgCl2 (HgCl2-independent D2O movement n=3; 
Figure 3.10) was used to calculate the D2O diffusion rate across each mucosal strip. 
(Table 3.6) The HgCl2-independent D2O concentration at each time point was 
subtracted from the total D2O concentration to determine the HgCl2 dependent D2O 
movement and the diffusion rate (Figure 3.10 and Table 3.6)
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Figure 3.10 Linear regression analysis of D2O concentration against time in presence and absence of HgCl2 with hypotonic solution 
on the apical and isotonic solution on the basolateral side of pig bladder mucosa. A, B and C) Linear regression analysis of total D2O 
concentration against time in 3 mucosa strips. G, H and I) Linear regression analysis of D2O concentration against time in presence of HgCl2 
(HgCl2-independent D2O movement) in 3 mucosa strips. The HgCl2-independent D2O concentration at each time point was subtracted from 
the total D2O concentration at that time point in paired mucosa strips to determine the HgCl2 dependent (AQP dependent) D2O concentrations 
D, E and F) Linear regression analysis of HgCl2 dependent D2O concentration against time. The diffusion rate was calculated using % D2O 
over time from these graphs   
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 Conditions 
 
Rate of diffusion (slope of 
the linear regression 
analysis) 
Bladder strip 1  
Total movement   
 
0.2508 
HgCl2 independent D2O movement   
 
0.0537 
HgCl2 dependent D2O  movement   
 
0.1971 
Bladder strip 2  
Total movement   
 
0.3241 
HgCl2 independent D2O movement   
 
  
0.1847 
HgCl2 dependent D2O  movement   
 
0.1394 
Bladder strip 3  
Total movement   
 
0.4962 
HgCl2 independent D2O movement   
 
0.1603 
HgCl2 dependent D2O  movement   
 
0.3358 
Table 3.6 the rate of diffusion of total, HgCl2 dependent, HgCl2 independent D2O movement for 
each repeat. The slopes for total D2O movement, HgCl2 dependent D2O movement and HgCl2 D2O 
independent movement for hypotonic solution on the apical and isotonic on basolateral with 
representative equilibration time show the length of duration before D2O could be sampled.  
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A comparison between the total, HgCl2 dependent and HgCl2 independent D2O 
diffusion rates is presented in Figure 3.11. There was a noticeable, but a non-
significant (p=0.0645) reduction in D2O diffusion rate when the tissue was treated with 
300µM HgCl2, a non-selective AQP inhibitor (Figure 3.11)  There was also no 
significant difference (p=0.0645) between the HgCl2 dependent and HgCl2 
independent D2O diffusion rates.   (Figure 3.11). 
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Figure 3.11 Comparison of the mean D2O diffusion rates in absence and presence of HgCl2 with hypotonic solution on the 
apical and isotonic solution on the basolateral side of the pig bladder mucosa strip.  
There was no significant difference between the total, HgCl2 dependent and HgCl2 independent D2O diffusion rates. The different D2O 
diffusion rates were compared using a repeated measures one-way ANOVA followed by a Newman-Kleus post-hoc test. p value=0.0645, 
Data are expressed as mean ± SEM of 3 independent repeats (n=3). Data are expressed as mean ± SEM of 3 independent repeats. 
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3.4.5 Calculation of D2O Diffusion Rate in Absence and Presence of 
HgCl2  
 
To determine the diffusion rate of D2O across the pig urinary bladder mucosa in the 
presence and absence of HgCl2, the concentration of D2O on the basolateral side of 
pig bladder mucosa strips mounted in Ussing chambers was measured over eight 
hours (after five hours of equilibration). The rate of diffusion under different osmotic 
conditions in the absence and presence of HgCl2 was calculated. 
 
3.4.5.1. Isotonic Solution on the Basolateral Side and Hypertonic 
Solution on the Apical Side 
 
In this experiment, the basolateral side of the mucosa strip was bathed in isotonic 
solution and the apical side was bathed in hypertonic solution, aim to simulate the 
osmotic gradient created across the mucosa in severely dehydrated condition. 
The linear regression analysis of D2O concentration against time in the absence (total 
D2O movement, n=3) and presence of HgCl2 (HgCl2-independent D2O movement n=3; 
Figure 3.12) was used to calculate the D2O diffusion rate across each mucosal strip. 
(Table 3.7) The HgCl2-independent D2O concentration at each time point was 
subtracted from the total D2O concentration to determine the HgCl2 dependent D2O 
movement and the diffusion rate (Figure 3.12 and Table 3.7)
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Figure 3.12 Linear regression analysis of D2O concentration against time in presence and absence of HgCl2 with hypertonic solution on the 
apical and isotonic solution on the basolateral side of pig bladder mucosa. A, B and C) Linear regression analysis of total D2O concentration 
against time in 3 mucosa strips. D, E and F) Linear regression analysis of D2O concentration against time in presence of HgCl2 (AQP-independent 
D2O movement) in 3 mucosa strips. The HgCl2-independent D2O concentration at each time point was subtracted from the total D2O concentration at 
that time point in paired mucosa strips to determine the HgCl2 dependent (AQP dependent) D2O concentrations G, H and I) Linear regression analysis 
of HgCl2 dependent D2O concentration against time. The diffusion rate was calculated using % D2O over time from these graphs    
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Conditions 
 
Rate of diffusion (slope 
of the linear regression 
analysis) 
Bladder strip 1   
Total movement   
 
0.2225 
HgCl2 dependent D2O  movement   
 
0.1608 
HgCl2 independent D2O movement   
 
0.0617 
Bladder strip 2   
Total movement   
 
0.2906 
HgCl2 dependent D2O  movement  
  
0.1837 
HgCl2 independent D2O movement   
 
0.1068 
Bladder strip 3   
Total movement   
 
0.2087 
HgCl2 dependent D2O  movement   
 
0.1039 
HgCl2 independent D2O movement   
 
0.1049 
Table 3.7 the rate of diffusion of total, HgCl2 dependent, HgCl2 independent D2O movement for 
each repeat. The slopes for total D2O movement, HgCl2 dependent D2O movement and HgCl2 D2O 
independent movement for hypotonic solution on the apical and isotonic on basolateral with 
representative equilibration time show the length of duration before D2O could be sampled.  
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A comparison between the total, HgCl2 dependent and HgCl2 independent D2O 
diffusion rates is presented in Figure 3.13. There was a significant difference 
(p=0.0263) between the total versus HgCl2 dependent and independent D2O diffusion 
rates (Figure 3.13).  However, there was also no significant difference (p=0.0263) 
between HgCl2 dependent versus HgCl2 independent D2O diffusion rates (Figure 3.13)   
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Figure 3.13 Comparison of the mean D2O diffusion rates in absence and presence of HgCl2 with hypertonic solution on the apical 
and isotonic solution on the basolateral side of the pig bladder mucosa strip.  
There was a significant difference between the total versus HgCl2 dependent and HgCl2 independent D2O diffusion rates. There was no 
significant difference between the HgCl2 dependent versus HgCl2 independent D2O diffusion rates. The mean D2O diffusion rates were 
compared using a repeated measures one-way ANOVA followed by a Newman-Kleus post-hoc test. *p<0.05, Data are expressed as mean 
± SEM of 3 independent repeats (n=3).  
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3.4.6 Comparison of Total, HgCI2 Dependent and HgCl2 independent 
D2O Diffusion Rates across Pig Bladder Mucosa under 
Different Osmotic Conditions 
 
The calculated mean D2O diffusion rates (total, HgCl2 dependent and HgCl2 
independent) were compared between mucosa strips subjected to different osmotic 
conditions (Figure 3.14). There were no significant differences (p=0.3558) detected 
when comparing the total D2O diffusion rates between hypotonic apical/ hypertonic 
basolateral versus hypertonic apical/isotonic basolateral versus hypotonic apical/ 
isotonic basolateral treatments (Figure 3.14A). There were also no significant 
differences (p=0.5537) in HgCl2 dependent D2O diffusion rates between hypotonic 
apical/ hypertonic basolateral versus hypertonic apical/isotonic basolateral versus 
hypotonic apical/ isotonic basolateral treatments (Figure 3.14B). There were also no 
significant differences (p=0.3306) in HgCl2 independent D2O diffusion rates between 
hypotonic apical/ hypertonic basolateral versus hypertonic apical/isotonic basolateral 
versus hypotonic apical/ isotonic basolateral treatments (Figure 3.14C). 
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Figure 3.14 Comparison of mean total, HgCI2 dependent and HgCl2 independent D2O diffusion rates across pig bladder mucosa 
under different osmotic conditions A) Comparison of mean total D2O diffusion rates between different treatments, B) A Comparison 
of mean HgCl2 dependent D2O diffusion rates between different treatments, C) Comparison of mean  HgCl2 independent D2O diffusion 
rates between different treatments,. D2O diffusion rates were compared by one-way ANOVA followed by a Tuckey’s post hoc test 
(n=3).Data are presented as mean+/- SEM 
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3.5 Discussion 
 
The bidirectional movement of water and solutes has been demonstrated across the 
bladder urothelium of various species (Cahill et al., 2003; Englund 1959; Levinsky and 
Berliner 1959; Shafik et al., 2006; Shafik et al., 2005; Shafik et al., 2004; Walser et al., 
1988). However, no studies so far have investigated the movement of water across 
pig bladder urothelium.  In this study, movement of water across pig bladder mucosa 
mounted in an Ussing chamber setup was detected using isotopically labelled water 
(D2O). However, this movement was only detected when the mucosa was subjected 
to an osmotic gradient, achieved by bathing the apical and basolateral sides of the 
mucosa in different osmotic solutions. The movement of D2O was very low or nearly 
undetectable in absence of an osmotic gradient (when both apical and basolateral 
sides of the mucosa were bathed in isotonic solution), although a concentration 
gradient for D2O existed across the mucosa membrane. This could suggest that 
without an osmotic gradient, there was not a strong enough driving force for movement 
of D2O across the mucosa membrane.  The low transurothelial D2O flux under isotonic 
conditions could be due to the special properties of the urothelial cells. These cells 
contain junctional complexes which is a zone of attachment between adjacent 
urothelial cells and is located at the intersection of their apical and lateral membranes 
(Khandelwal et al., 2009). The zone of attachment includes tight junctions and 
adherens junctions, both of which form continuous belts around the cell, as well as 
desmosomes (structure that allows adjacent cell to be attached) (Khandelwal et al., 
2009). Claudins also play an important role in regulating paracellular transport 
(Montalbetti et al., 2015). These proteins provide a mechanism to limit paracellular 
water and ion flow across the uroepithelial tissue (Khandelwal et al., 2009). 
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By introducing the mucosa strip to an osmotic gradient (achieved by bathing the apical 
and basolateral sides of the mucosa with different osmotic solutions) movement of 
D2O was detected after nearly 6 hours of equilibration. Many studies have reported 
that changes in osmotic gradient causes increase water fluxes which is facilitated by 
AQPs (Yasui et al., 2008; Benfenati et al., 2011; Rubenwulf et al., 2012; Kitchen et al., 
2015). Also, several studies have demonstrated that AQPs are translocated from the 
intracellular compartment to cell membrane when osmotic gradient is created between 
intracellular and extracellular osmolarity (Benfenati et al., 2011; Kitchen et al., 2015). 
This suggesting that AQPs are involved in restoring the changes in osmolarity.  
It was observed in this study that 6 hours equilibration time was needed before D2O 
could be detected on the basolatareal side.  Studies that have looked at AQP mediated 
water fluxes and AQP translocation to the cells membrane have all reported different 
time of duration  before water fluxes of AQP trafficking could be detected (Yasui et al. 
,2008; Conner et al., 2010; Garcia et al., 2001; Kitchen et al., 2015). An explanation 
for the variation in time amongst all these experiments including this current study 
could suggest different signalling processes and pathways for both AQP protein 
phosphorylation and AQP protein synthesis in different cell lines and tissues.   
 
3.5.1 AQP dependent D2O movement across pig bladder urothelium 
 
In this current study, D2O movement across pig bladder mucosa under three different 
osmotic conditions was demonstrated: (i) hypotonic solution on the apical side and 
hypertonic solution on the basolateral side of the mucosa membrane; (ii) hypertonic 
solution on the apical side and isotonic solution basolateral; (iii) hypotonic solution on 
the apical side and isotonic solution on the basolateral.   
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The movement of D2O observed in all three conditions is believed to be transcellular 
D2O movement facilitated by AQP channels. This conclusion was drawn by the 
observation that when the mucosa strip was exposed to HgCl2, which is known as 
AQP selective inhibitor, a noticeable reduction in D2O movement was seen. Rubenwulf 
et al (2012) has also reported similar finding. They demonstrated that AQPs contribute 
to transurothelial permeability in vitro and the transurothelial permeability was 
modulated by exposing cells to 500mosm/kg NaCl supplemented medium for 48 hours 
(Rubenwulf et al., 2012). Movement of water and urea was detected after 25 minutes 
which was sustained for six hours. AQPs function was abolished when urothelial cells 
were exposed to HgCl2 (Rubenwulf et al., 2012). Their study in addition to this current 
study suggest that AQPs present in the urinary bladder urothelium are able to respond 
to the continuous changes in osmolarity and as a result, water is transported through 
AQP channels across the urothelium. 
 In this current study, there was no significant difference in the movement of D2O 
between hypotonic/isotonic, hypertonic/hypotonic and hypotonic/hypertonic 
experimental set up in the presence and absence of HgCl2. This finding reported 
herein was considered in the light of some limitations. A key limitation in this study was 
the sample size. Three reapeats were performed for each experimental set up and the 
calculated diffusion rate values for two repeats were similar with the third value 
showing a large deviation. Due to the small sample size, interpretation of the results, 
in particular confidence interval and p-value may not demonstrate the true effect and 
as a result, false positive or false negative conclusion can be made. Therefore, these 
results were interpreted with caution and will served as groundwork for larger 
confirmatory studies where the sample number is larger (six or above) to generate 
more accurate and reliable results.    
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AQPs are inhibited by ‘mercury salts’ and other metal ion inhibitors but few other and 
more specific, organic AQP inhibitors have been defined (Brooks et al., 2000; Huber 
et al., 2007; Huber et al., 2009; Migliati et al., 2009; Mola et al., 2009). All AQPs 
channels are structurally comparative (Nesverovs et al., 2019) and thus similar 
mechanisms of inhibition of AQPs identified in pig urinary bladder is likely. Though 
HgCl2 inhibition of AQPs in this study and in Rubenwulf et al., (2012) study was seen, 
previous studies have also shown that water movement occurs through channels other 
than AQPs and some of these channels are not inhibited by HgCl2. Therefore, in this 
study, a second transcellular mechanism for D2O movement other than AQPs needs 
to be considered. 
3.5.2 Other possible channels involved in D2O transport 
 
The absence of complete inhibition of D2O movement with HgCl2 in this current study 
has been attributed to paracellular transport of D2O but studies have shown that 
transcellular movement of water can be mediated by available surface channels other 
than AQPs (Fischbarg et al., 1990; Fischbarg et al., 1990; Solomon et al., 1983) 
Transport of water across the plasma membrane are in part controlled by additional 
proteins located in the membrane that may include ion pumps, ion channels and ion 
exchange proteins as well as transient receptor potential (TRP) channels. It has been 
demonstrated that water transport also occurs through certain membrane transport 
proteins such as the glucose transporter (Fischbarg et al., 1990) and Cl- channel 
(Solomon et al., 1983). Glucose transporters and Cl- channels are found in most 
mammalian cells including urinary bladder urothelial cells (Haines, 1994). These 
channels transport only small amounts of water, firstly as there are few channels in 
the membrane and secondly because the gating of these Cl- channels open briefly 
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(Haines, 1994). However they provide another possible explanation for D2O 
movement independent of AQP water channel and passive diffusion. 
3.5.3 Comparison of mean Total, HgCI2 Dependent and HgCl2 
independent D2O Diffusion Rates across Pig Bladder Mucosa 
under Different Osmotic Conditions 
Previous studies have reported that transurothelial permeability is modulated by NaCl 
(Rubenwulf et al., 2012). Therefore, because changes in solutes were introduced in 
the solution used in this experiment where NaCl was normal in hypertonic solution but 
it was halved for isotonic solution and hypotonic solution, AQP mediated D2O diffusion 
rates between the different treatments conditions used above were compared. The 
two experimental conditions (i) isotonic condition on the basolateral side, hypotonic 
condition on the apical side; ii) isotonic condition on the basolateral side, hypertonic 
condition on the apical side were design to in part simulate the physiological condition 
of mammals. No significant differences were seen between these two conditions. 
Rubenwulf et al., (2012) study reported a significant increase in water and urea flux 
across an osmotic gradient when urothelial cells were exposed to hypertonic 
conditions. Their studies did not include hypotonic solution studies (Rubenwulf et al., 
2012). In their study, AQP3 expression was also upregulated by increased osmolality 
(Rubenwulf et al., 2012). The observation in this current study does not reflect the 
same findings observed in Rubenwulf et al., (2012) studies, because, here we 
demonstrated that both hypertonic and hypotonic caused increase movement of D2O. 
Earlier studies done by Presten et al. (1992) showed that transfection of AQPs in 
Laevis oocytes that were exposed to hypotonic medium resulted in immediate swelling 
(Preston et al., 1992; Agre, 2006).  
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Moreover, HEK293 cells exposed to hypotonic solution (107-125 mOsm/kg) for one 
hour caused AQP1 to translocate to the cell membrane which eventually caused an 
increase in cell volume after 30 seconds of hypotonic solution exposure, suggesting 
that hypotonic solutions could be involved in the immediate translocation of AQPs to 
the cells membrane as an immediate response to regulate intracellular and 
extracellular fluid homeostasis and to balance the osmotic stress exposed to cells. 
Therefore, in this study, the increase diffusion rate in of D2O hypertonic and hypotonic 
solution could be due to increase AQP trafficking to the plasma membrane to regulate 
the urothelial cell volume exposed to in particular hypotonic shock.    
In addition, previous studies have shown that AQP proteins in urothelial cells are 
located surrounding both the apical and basolateral membrane of the cells (Rubenwulf 
et al., 2009), suggesting that although water permeates from the apical luminal side of 
the umbrella cells, regulatory volume decrease in the urothelial cells may occur via 
basolateral movement of water back to the systemic circulation to achieve homeostatic 
balance. While existing data have not reported AQP-mediated water movement to the 
systemic circulation, a body of data prior to the discovery of AQPs have shown that 
bidirectional fluid movement across mammalian urinary bladder urothelium occurs 
(Hohlbrugger 1987; Levinsky and Berliner, 1959; Rapoport et al., 1960; Turnbull and 
Fellow, 1972; Walser et al., 1988).  
This study demonstrates consistant water movment between all mucosa strips after 5 
hours incubation with various tonicity when a gradient was created between the apical 
and basolateral side. This study adds on to the existing knowledge on emerging roles 
of the urinary bladder urothelium in regulating urinary bladder function.  
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Chapter 4 
 
Investigating the Effect of Tonicity on 
AQP3 Localisation  
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4.1 Introduction 
 
Similar to many other proteins, regulation of AQP abundance and function can be 
achieved by several mechanisms: 1) direct regulation of AQP gene expression or 
protein degradation 2) altering the number of AQP proteins present in the cell 
membrane via exo- or endocytosis (Balkom et al., 2002, Nedvetsky et al., 2009) and 
3), by altering the gating of AQP channels via conformational changes where AQP 
channels are opened and closed (Sorensen et al., 2013; Reichow et al., 2013; Kalman 
et al., 2008). Regulation of cellular osmolarity to maintain osmotic homeostasis despite 
the influence of external factors can be achieved through short-term and long-term 
regulation of AQPs, (Halsey et al., 2018). Most AQPs were previously considered to 
be constitutively expressed in the plasma membrane of various cells (Verkman, 2011). 
This assumption was largely based on the fact that the first AQP protein discovered 
(AQP1) was identified in the membrane of erythrocytes (Preaston et al.,1992). 
Moreover, because earlier studies investigating AQPs reported AQPs expression on 
membrane of different cells, AQPs were predominantly referred to as  “constitutively” 
expressed plasma membrane channels with the exception of AQP2 and AQP6 
(Verkman., 2005) AQP2 and AQP6 studies showed that these channels reside in the 
membrane (Yasui et al., 1999; Verkman, 2005). However, emerging studies shows 
that subcellular localisation of various AQPs are observed in some tissues and these 
AQPs are translocated to the plasma membrane in response to external stimuli such 
as changes in osmolarity  (Gradilone et al., 2005; Calamita et al., 2005; Conner et al., 
2012; Huebert, et al., 2002). Changes in osmolarity in HEK293 cells showed that 
AQP1 can be trafficked reversibly to the plasma membrane in response to altered 
tonicity (Conner et al., 2010). This process was identified to be mediated by PKC and 
microtubule. Membrane localisation of AQP1 was found to increase in a time 
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dependent manner when HEK293 cells were exposed to diluted DMEM (Conner et al., 
2010). They demonstrated that membrane localization of AQP1, was 26 ± 3% in 
control experiment exposed to non-diluted DMEM. Following replacement of DMEM 
with diluted DMEM, the relative level of membrane expression in the same cells was 
77 ± 2% (Conner et al., 2010). The increase in AQP1 abundance in the cell membrane 
induced by hypotonic solution occurred over a span of 10 secs demonstrating rapid 
intracellular signalling process in AQP1 translocation to the membrane. When the 
HEK293 cells were removed from diluted DMEM and placed in normal DMEM, these 
HEK293 cells showed a cytoplasmic expression profile for AQP1 similar to that initially 
observed in the non-diluted DMEM (relative level of membrane expression of 26 ± 3%) 
(Conner et al., 2010) suggesting a rapid reversible trafficking of AQP1 to membrane 
in response to osmotic stress (hypotonic) and internalisation of AQP1 from the 
membrane upon removal of osmotic stress. 
A different study also investigated AQP3 localisation in keratinocyte and found AQP3 
cytoplasmic localisation. AQP3 was translocated to the cell membrane of cultured 
human keratinocytes following a 2 h osmotic stress with 200 µM sorbitol (Garcia et al., 
2011). The study further revealed that AQP3 was localized near the plasma membrane 
shortly after an osmotic stress, but that the effect was no longer observed 24h after 
removal of the osmotic stress (Garcia et al., 2011) demonstrating similar reversible 
trafficking of AQP3 in response to hypertonicity.  These two studies also demonstrate 
that both hypotonic and hypertonic solution causes trafficking of AQP and that 
changes in osmolarity is a key factor in regulating AQP trafficking.  
Subcellular localisation of AQP and trafficking of AQP to the plasma membrane as a 
response to external influence other than changes in osmolarity has also been 
reported for AQP4. AQP4 is known to be highly expressed in glial cells of the central 
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nervous system and facilitates the osmotically driven pathological brain swelling 
associated with stroke and traumatic brain injury. Cell surface expression of AQP4 
was demonstrated to be rapidly and reversibly regulated in response to changes of 
tonicity in primary cortical rat astrocytes and in transfected HEK293 cells (Kitchen et 
al., 2015). AQP4 membrane localization increased 2.7-fold after ten min of hypotonic 
challenge at 85 mosM/kg of H2O  but did not change significantly after ten min of 
hypotonic challenge with another hypotonic solution of 140 mosM/kg of H2O (Kitchen 
et al., 2015) Demonstrating that hypotonic condition can induce sub cellular 
localisation of AQP4 to traffic to the membrane. The translocation mechanism was 
found to involve PKA activation, influx of extracellular calcium, and activation of 
calmodulin (Kitchen et al., 2015). 
Epinephrine has also been found to translocation of AQP3 from the cytoplasmic 
fraction to the plasma membrane in Caco-2 cells within 60 min. Epinephrine induced 
membrane trafficking of AQP3 was found to be mediated through the signal pathway 
GqPCR–PLC–PKC in Caco-2 cells (Yasui et al., 2008). Though, the primary signal in 
this study was not changes in osmolarity, this study demonstrate subcellular 
localisation of AQP3 and perhaps epinephrine induces AQP3 synthesis and trafficking 
to the plasma membrane.  
AQPs identified in the urothelium of human urinary bladder cells lines showed increase 
transurothelial water movement upon exposure to hypertonic solution. Furthermore, 
the expression of AQP3 was found to be increased in hypertonic solution as a result 
of increased NaCl (Rubenwulf et al., 2012). Although this study did not focus on AQP3 
trafficking but rather increased AQP3 protein levels, the study further support the 
influence of changes in osmolarity on AQP. 
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It is interesting to note that these studies collectively reported that translocation of 
AQPs to the plasma membrane was observed at different time points. Kitchen et al., 
(2015) showed hypotonic induced AQP4 trafficking to the membrane in ten min, Gracia 
et al., (2011) showed hypertonic induced AQP1 trafficking to the membrane in 2 hrs, 
Yasui et al., (2008) showed epinephrine induced AQP3 trafficking to the membrane in 
one h and Conner et al., (2010) demonstrated hypotonic induced AQP1 trafficking to 
the membrane in ten sec. The time variation observed in these studies could suggest 
different intracellular signalling pathways. Moreover, while these studies collectively 
shows AQP trafficking as a result of changes in osmolarity, considering osmotic induce 
AQP synthesis as reported by Rubenwulf et al., (2012) followed by AQP trafficking to 
the plasma membrane in some of these studies could also explain the variation in time 
for AQPs translocation to the plasma membrane reported by the different studies.   
Although these studies have demonstrated that changes in osmolarity is involved in 
AQP function, expression and translocation, the mechanism by which AQPs that have 
been identified in the urinary bladder are regulated is still unknown. To date, no studies 
have reported if increase or decrease osmolarity results in AQP gating or translocation 
in the urinary bladder. In chapter 2, AQP1, 3, 9 and 11 were identified in the urinary 
bladder of pig urothelium with AQP1 expressed in the suburothelial area and AQP3, 9 
and 11 in the urothelial cells. Here, AQP3 appeared to be most abundantly expressed 
in the urothelial cells, therefore, a decision was made to investigate the osmotic effect 
on AQP3 in the urinary bladder. 
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4.2  Aims of the Study 
 
Hypotonic effect on AQPs localisation have been reported in other studies in different 
tissues. Though AQP3 expression in response to hypertonicity have been reported in 
Normal Human Urothelial (NHU) cell line, the effect of hypertonic and hypotonic 
solution on AQP3 localisation within urothelial cell has not been reported. Therefore, 
this chapter is to identify the effect of hypotonic and hypertonic solution on AQP3 
localisation. 
4.2.1 Specific objectives  
 
· To Isolate urothelial cells from pig bladder containing all the different population 
of urothelial cells (umbrella cells, intermediate cells, basal cells) 
· To determine the localisation of AQP3 within urothelial cells  in untreated cells 
using immunochemical experiments 
· To determine the localisation of AQP3 within treated urothelial cells using 
immunohistochemistry 
·  
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4.2 Methods  
 
4.2.1 Tissue Preparation  
Female pig (Sus scrofa domestica) bladders were obtained as previously described. 
The bladder was immediately filled with 20 ml Hank's Balanced Salt Solution (HBSS) 
digestion buffer that consisted of 1% HBSS, 5 mM EDTA and 10 mM hepes (pH was 
adjusted to 7.4 using sodium bicarbonate) for transportation. From each whole bladder 
dome, the trigone region was dissected off the bladder body and was then folded 
inside out so that the urothelium was facing outwards. The bladder base was sealed 
with a 22 G 2 inches syringe needle and submerged in 100 ml HBSS digestion buffer 
 
4.2.2 Isolation of Cells from the Urinary Bladder Urothelium 
 
Urothelial cells were isolated from the whole bladder of five different pigs by gentle 
titration during the incubation time where the tissue was submerged in 100 ml of HBSS 
digestion buffer for one hour at RT. After gentle titration, a cell scrapper was used to 
scrape off the urothelial cells to ensure maximum collection of basal cells. The whole 
bladder was discarded and the collected cells suspended in HBSS digestion buffer 
was initially allowed to sit in a 50 ml falcon tube for 1 min to remove the bottom heavy 
debris followed by 25 min to allow the cells to set at the bottom. About 80 ml of the top 
HBSS digestion buffer was gently removed ensuring the bottom HBSS digesting buffer 
containing the cells was not disturbed. The cell suspension was centrifuge at 600g for 
five min. Clear lysate liquid at the top was removed and the cell pellet at the bottom 
was resuspended in 1 ml of PBS.  
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4.2.3 Cell Counting 
 
A sample was taken from each preparation and counted using an improved Neubauer 
haemocytometer stage. The percentage of viable cells was visually determined by the 
proportion excluding Trypan blue (0.4 % solution) purchase from ThermoFisher 
scientific (UK): 100 μl added to a 100 μl sample of the cell suspension. The three 
urothelial cell population large (umbrella cells), medium (intermediate cells) and small-
sized (basal cells) assessed visually with each experiment to ensure all of the different 
cell populations were present.  
 
4.2.4 Treatment of Isolated Urothelial Cells 
The isolated pig bladder urothelial cells were suspended in PBS. The cell suspension 
in PBS was subsequently divided into 15 ml falcon tube containing 10 ml of 407 
mosM/kg hypertonic, 96 mOsM/kg hypotonic and  289 mOsM/kg isotonic solutions with 
the composition described (table 3.2) at RT.  Additional 15 ml falcon tubes were made 
containing duplicate of the hypertonic, hypotonic and isotonic solution. Isotonic 
solution served as a negative control as it had a physiological osmolarity of 289 
mOsM/kg. Isolated urothelial cells in 407 mosM/kg hypertonic and 96 mOsM/kg 
hypotonic was allowed to incubate for 4 and 5 hrs at RT. 4th  and 5th  hours incubation 
time was chosen because in chapter 3, movement of water (D2O) was observed after 
the 5th  hour (Figure 3.6). The 4th hour incubation time was included to determine 
whether an ealier time point will show any significant differences in AQP3 staining 
profile compared to the 5th hour time point. Cells in 289 mOsM/kg isotonic solution were 
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allowed to incubate for five hours. These control cells in isotonic solution are further 
referred to as non-treated cells. 
 
4.2.5 Immunocytochemistry 
 
After each incubation period with 407 mosM/kg hypertonic 96 mOsM/kg hypotonic 289 
mOsM/kg isotonic and a negative control Krebs solution, isolated cell suspensions 
were centrifuge at 600 g for five min and then washed three times with PBS followed 
by fixing with 250-500 μl of ice-cold methanol, depending on the cell density, for ten 
min. The cell suspension were washed three times with PBS and centrifuged at 600 g 
for five min each time. The cells were then incubated with 100 mM glycine (pH 8.5 in 
PBS) followed by incubation with 10% foetal bovine serum (FBS) in PBS for 5 min. 
The cells were permeabilised with 0.2% Triton X-100 in PBS for 20 min, then washed 
3x with PBS. Cell suspension was incubated with 3% BSA in PBS at RT for one hour 
to block non-specific binding sites. With the exception of the negative control cells, all 
the cells were then incubated with Cytokeratin 7 primary antibody raised in mouse, 
and AQP3 primary antibody raised in rabbit (cytokeratin 7, 1:1000, AQP3 1:500, 
prepared in 3% BSA/PBS) separately for 1 hour each at room temperature with each 
antibody. The cells were then washed 3x 5 min with PBS. Secondary antibodies, Alexa 
Fluor 488 goat anti-rabbit (dilution) and Alexa Fluor 647 donkey anti-mouse (dilution), 
were prepared in 3% BSA/PBS and then added to all the samples including the 
negative control cells and incubated for one hour for each secondary antibody at room 
temperature. Excess secondary antibodies were removed by 3x 5 min PBS washing 
after incubation and the cell suspension was incubated with DAPI nuclear stain for ten 
min. Excess DAPI was removed by washing cell suspension 3x with PBS. 20 µl of 
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labelled cell suspension were placed on slides and mounted using VECTASHIELD® 
Antifade Mounting Medium. Imaging was performed using Nikon Ti Eclipse x 40 
magnification.  
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4.3 Results 
 
4.3.1 AQP3 Localisation in Non-Treated Pig Urinary Bladder 
Urothelial Cells  
 
 
The expression of AQP3 in isolated primary urothelial cells were investigated in non-
treated cells where the cells were incubated in 289 mOsM/kg isotonic solution for five 
hours. Immuno staining with anti-AQP3 antibody demonstrated cytoplasmic 
localisation of AQP3 with distinct localisation around the nucleus. DAPI was used to 
stain the nucleus and is shown in blue. Figure 4.1 is a representative image of non-
treated primary urothelial cells (n=3) all displaying a similar intracellular localisation 
profile.  
The ratio of urothelial cells containing AQP3 and cells which did not contain AQP3 was 
not quantified due to the blurriness of some areas of the prepared slide. Therefore, 
accurate quantification could not be done.  
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A
-ve control
AQP3 subcellular localization and expression primary pig urothelial
cells.
Immunocytochemistry showing expression profiles of endogenous AQP3 in
non-treated pig urothelial cells which does not show AQP3 trafficking to plasma
membrane. All images shown are a single representation contributing to
repeated experiment of n=4
Figure 4.1 AQP3 immunofluorescence labelling of non-treated isolated pig urothelial cells 
 
Isolated urothelial cells kept in 289 mOsM/kg isotonic solution for five hours were stained with rabbit polyclonal anti-AQP3 
antibody in 1:500 dilution, and DAPI nucleuse stain. A) AQP3 was detected throughout the cytoplasm of the isolated 
urothelial cells, with distinct localisation around the nucleus. –ve control is in the absence of AQP3 primary antibody. The 
images shown above are representative of three independent experiments.  
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4.3.2 AQP3 localisation/ Immunofluorescence Labelling in Isolated 
Pig Urothelial Cells Following Four Hours Incubation in 
Hypotponic Krebs Solution 
 
To test the effect of hypotonicity on AQP3 localisation, urothelial cells isolated from 
pig bladders were incubated in hypotonic Krebs solution for four hours. Cytokeratin 7, 
urothelial specific marker, was used to identify the isolated urothelial cells. 
Immunostaining with an anti-AQP3 antibody suggested increased trafficking and 
plasma membrane localization of AQP3 following incubation of isolated urothelial cells 
in hypotonic solution. Figure 4.2 is a representative image of four hours treatment of 
primary urothelial cells (n=3) all displaying a similar intracellular localisation profile.  
The ratio of urothelial cells containing AQP3 and cells which did not contain AQP3 was 
not quantified due to the blurriness of some areas of the prepared slide. Therefore, 
accurate quantification could not be done.  
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Figure 4.2 AQP3 immunofluorescence labelling in isolated pig urothelial cells following incubation with hypotonic Krebs 
solution  
Isolated urothelial cells kept in 96 mOsM/kg hypotonic Krebs solution for four hours were stained with rabbit polyclonal anti-AQP3 (red) 
antibody in 1:500 dilution, mouse monoclonal anti-cytokeratin 7 (green) antibody in 1:1000 dilution and DAPI (blue). A&B) AQP3 labelling 
suggested increased trafficking and plasma membrane localisation. –ve control is in the absence of AQP3 primary antibody. Figures are 
representative of three independent experiments.   
 repeated experiments of n=3  
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Figure 2. Immunolocalisation and expression of AQP3 in response to hypotonic Krebs solution.
A&B) Immunofluorescence labelling of isolated primary urothelial cells from pig urinary bladder shows
AQP3within the cytoplasm and membrane. Primary cells exposure to hypotonic Krebs solution with
osmolalities of 96 mosM/kg for 4 hours resulted in AQP3 trafficking to the cell membrane. Cytokeratin was
used as urothelial specific marker and dapi was used to identify the nucleus. –ve control is in the absence of
AQP3 and cytokeratin primary antiboby. All images shown are a single representation contributing to
repeated experiment of n=3 Scale bar: 20 µM
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4.3.3 AQP3 Localisation/ Immunofluorescence Labelling in Isolated 
Pig Urothelial Cells Following Five Hours Incubation in 
Hypotponic Krebs Solution  
 
To test the effect of hypotonicity on AQP3 localisation, urothelial cells isolated from 
pig bladders were incubated in hypotonic Krebs solution for five hours.  Cytokeratin 7, 
urothelial specific marker, was used to identify the isolated urothelial cells. 
Immunostaining with an anti-AQP3 antibody suggested increased trafficking and 
plasma membrane localization of AQP3 following incubation of isolated urothelial cells 
in hypotonic solution. Figure 4.3 is a representative image of five hours treatment of 
primary urothelial cells (n=3) all displaying a similar intracellular localisation profile 
The ratio of urothelial cells containing AQP3 and urothelial cells which did not contain 
AQP3 was not quantified due to the blurriness of some areas of the prepared slide. 
Therefore, accurate quantification could not be done.  
 
 
 
 
163 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DAPI AQP3Cytokeratin 7 Merged
20µm 20µm20µm
20µm 20µm 20µm 20µm
20µm
A
B
20µm20µm20µm20µm
-ve control
Figure 3. Immunolocalisation and expression of AQP3 in response to hypotonic Krebs solution. 
A&B) Immunofluorescence labelling of isolated primary urothelial cells from pig urinary bladder shows
AQP3within the cytoplasm and membrane. Primary cells exposure to hypotonic Krebs solution with
osmolalities of 96 mosM/kg for 5 hours resulted in AQP3 trafficking to the cell membrane. Cytokeratin was
used as urothelial specific marker and dapi was used to identify the nucleus. –ve control is in the absence
of AQP3 and cytokeratin primary antibody. All images shown are a single representation contributing to
repeated experiment of n=3 Scale bar: 20 µM
Figure 4.3 AQP3 immunofluorescence labelling in isolated pig urothelial cells following incubation with hypotonic Krebs 
solution 
Isolated urothelial cells kept in 96 mOsM/kg hypotonic Krebs solution for five hours were stained with rabbit polyclonal anti-AQP3 
(red) antibody in 1:500 dilution, mouse monoclonal anti-cytokeratin 7 (green) antibody in 1:1000 dilution and DAPI (blue). A&B) 
AQP3 labelling suggested increased trafficking and plasma embrane loc lisatio . –ve control is in the absence of AQP3 primary 
antibody. Figures are representative of three independent experiments.   
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4.3.4 AQP3 Localisation/ Immunofluorescence Labelling in Isolated 
Pig Urothelial Cells Following Four Hours Incubation in 
Hypertonic Krebs Solution  
 
To test the effect of hypertonicity on AQP3 localisation, urothelial cells isolated from 
pig bladders were incubated in hypertonic Krebs solution for four hours.  Cytokeratin 
7, urothelial specific marker, was used to identify the isolated urothelial cells. 
Immunostaining with an anti-AQP3 antibody suggested increased trafficking and 
plasma membrane localization of AQP3 following incubation of isolated urothelial cells 
in hypertonic solution. Figure 4.3 is a representative image of four hours treatment of 
primary urothelial cells (n=3) all displaying a similar intracellular localisation profile 
The ratio of urothelial cells containing AQP3 and urothelial cells which did not contain 
AQP3 was not quantified due to the blurriness of some areas of the prepared slide. 
Therefore, accurate quantification could not be done.  
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Figure 4. Immunolocalisation and expression of AQP3 in response to hypertonic Krebs solution. 
A&B) Immunofluorescence labelling of isolated primary urothelial cells from pig urinary bladder shows
AQP3 within the cytoplasm and membrane. Primary cells exposure to hypotonic Krebs solution with
osmolalities of 407 mosM/kg for 4 hours resulted in AQP3 trafficking to the cell membrane. Cytokeratin was
used as urothelial specific marker and dapi was used to identify the nucleus. –ve control is in the absence
of AQP3 and cytokeratin primary antibody. All images shown are a single representation contributing to
repeated experiment of n=3 Scale bar: 20 µM
Figure 4.4 AQP3 immunofluorescence labelling in isolated pig urothelial cells following incubation with hypertonic Krebs 
solution 
Isolated urothelial cells kept in 407 mosM/kg hypertonic Krebs solution for four hours were stained with rabbit polyclonal anti-AQP3 (red) 
antibody in 1:500 dilution, mouse monoclonal anti-cytokeratin 7 (green) antibody in 1:1000 dilution and DAPI (blue). A&B) AQP3 labelling 
suggested increased trafficking and plasma membrane localisation. –ve control is in the absence of AQP3 primary antibody. Figures are 
representative of three independent experiments.   
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4.3.5 AQP3 Localisation/ Immunofluorescence Labelling in Isolated 
Pig Urothelial Cells following five Hours Incubation in 
Hypertonic Krebs Solution  
 
To test the effect of hypertonicity on AQP3 localisation, urothelial cells isolated from 
pig bladders were incubated in hypertonic Krebs solution for five hours.  Cytokeratin 
7, urothelial specific marker, was used to identify the isolated urothelial cells. 
Immunostaining with an anti-AQP3 antibody suggested increased trafficking and 
plasma membrane localization of AQP3 following incubation of isolated urothelial cells 
in hypertonic solution. Figure 4.3 is a representative image of five hours treatment of 
primary urothelial cells (n=3) all displaying a similar intracellular localisation profile 
The ratio of urothelial cells containing AQP3 and urothelial cells which did not contain 
AQP3 was not quantified due to the blurriness of some areas of the prepared slide. 
Therefore, accurate quantification could not be done.  
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Figure 5. Immunolocalisation and expression of AQP3 in response to hypertonic Krebs solution. 
A&B) Immunofluorescence labelling of isolated primary urothelial cells from pig urinary bladder shows
AQP3 within the cytoplasm and membrane. Primary cells exposure to hypotonic Krebs solution with
osmolalities of 407 mosM/kg for 5 hours resulted in AQP3 trafficking to the cell membrane. Cytokeratin was
used as urothelial specific marker and dapi was used to identify the nucleus. –ve control is in the absence
of AQP3 and cytokeratin primary antibody. All images shown are a single representation contributing to
repeated experiment of n=3 Scale bar: 20 µM
Figure 4.5 AQP3 immunofluorescence labelling in isolated pig urothelial cells following incubation with hypertonic Krebs 
solution  
Isolated urothelial cells kept in 407 mosM/kg hypertonic Krebs solution for five hours were stained with rabbit polyclonal anti-AQP3 
(red) antibody in 1:500 dilution, mouse monoclonal anti-cytokeratin 7 (green) antibody in 1:1000 and DAPI (blue). A&B) AQP3 
labelling suggested increased trafficking and plasma membrane localisation. –ve control is in the absence of AQP3 primary 
antibody. Figur s are representative of three independent experiments.   
repeated experiments of n=3 
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4.4 Discussion  
 
In this study, different AQPs; AQP3, AQP9 and AQP11 have been identified in pig 
urinary bladder and they are presented in Chapter 2 results section. Out of these 
identified AQPs, AQP3 expression and protein levels in all the 3 different cell types of 
the urothelium was the most abundant. Because of this, AQP3 was chosen as the 
protein to investigate.  
Urinary bladder urothelium is exposed to urine at different levels of osmolarity. AQP3, 
part of the aquaglycerolporin family and expressed by the urinary bladder urothelium, 
is continuously exposed to various urine tonicity. AQP3 exposed to different tonicity in 
the urinary bladder could play an important role in responding to the bladder content 
and in turn trigger urothelial mediated signalling processes to regulate the bladder 
function.  
AQP3 is a water/glycerol/urea channel abundant in different tissues in the human body 
such as the kidney, skin, and the urinary bladder (Damiano et al., 2001; Spector et al., 
2002; Pavlovic-Djuranovic et al., 2006; Hara and Verkman, 2001; Boury-Jomot et al., 
2006) In view of the functional importance of AQP3 in transporting water, as well as 
solutes, such as glycerol and urea, the effect of different osmolarity on AQP 3 
regulation was examined.  
In the current study, isolated urothelial cells were exposed to isotonic Krebs solution 
and immune staining with anti-AQP3 antibody demonstrated cytoplasmic localisation 
of AQP3 with distinct localisation around the nucleus. This expression pattern of AQPs 
around the nucleus has also been identified in another study investigating AQP3 in 
MDCK cell lines (Arnspang et al., 2013). AQP3 tagged with enhanced green 
fluorescent protein showed AQP3 localisation within the cytoplasm of the cells 
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(Arnspang et al., 2013). Similar distinct pattern of AQP3 localisation around the 
nucleus was observed. MDCK cells were stained with Golgi marker G58 K and an 
overlay of both AQP3 tagged and Golgi staining showed colocalisation (Arnspang et 
al., 2013). Considerable evidence show that the Golgi complex (Rodriguez-Boulan et 
al., 2005) regulate sorting of apical and basolateral membrane proteins into separate 
vesicles in the exocytic and endocytic (recycling) pathways. Because the AQP3 
localisation profile in Arnspang et al., (2013) study shows similar AQP3 localisation in 
the isotonic urothelial cells in this study, It could be assumed that localisation of AQP3 
around the nucleus could imply AQP3 localisation in the Golgi. Further studies are 
required for AQP3 double labelling with Golgi specific markers to confirm this 
assumption.   
The effect of hypotonicity and hypertonicity on AQP3 localisation was examined in this 
study. Four and five hours as experimental time points were chosen because we found 
in chapter 3 that movement of water (D2O) was mostly observed after five hours 
(Figure 3.6). Moreover, in chapter 3, traces of D2O  was seen in some of the 
experimental set up after four hours therefore, the fourth hour time point was included 
to determine whether there was a difference in AQP3 trafficking at fifth and fourth hour. 
AQP3 labelling suggested increased trafficking and plasma membrane localisation in 
urothelial cells exposed to both hypotonic and hypertonic solution for four or five hours. 
No differences were oberserved in AQP3 staining profile between the fourth and fifth 
hour time points.  Two separate studies have reported similar findings in different cells 
types showing that both hypertonic and hypotonic solution causes AQP3 trafficking to 
the plasma membrane (Matsuzaki et al., 2001; Garcia et al., 2011). 
Matsuzaki et al., (2001) investigated the effect of hypertonicity on AQP3 expression in 
MDCK epithelial cells by exposing the cells to hypertonic medium containing raffinose 
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or NaCl. Northern blot and immunoblot analyses revealed that the amounts of AQP3 
mRNA and AQP3 protein, respectively, were markedly increased by exposure of cells 
to hypertonicity (Matsuzaki et al., 2001). In addition to the increased expression of 
AQP3, Immunofluorescence and immunoelectron microscopy also demonstrated that 
the abundance of AQP3 protein was increased in cells incubated in hypertonic medium 
for 24 h and that the protein was localized at the basolateral plasma membrane 
(Matsuzaki et al., 2001).  Garcia et al., 2001 also demonstrated that 
Immunofluorescence staining of AQP3 in NHK cells revealed a cytoplasmic 
localization of AQP3 in a controls state when cells were not exposed to hypotonicity. 
Increased membrane staining was observed in cells that were treated with hypotonic 
osmotic stress (Garcia et al., 2001) 
These two studies suggest that both hypotonicity and hypertonicity causes AQP3 
translocation, which is in agreement with this current studies as AQP3 translocation 
was seen in pig bladder urothelial cells when exposed to both hypertonic and 
hypotonic Krebs solution. This is not surprising as hypotonicity and hypertonicity are 
both considered to be a form of osmotic stress. Most cells have the ability to regulated 
external osmotic stresses by modifying cell volume. 
The ability to control cell volume is essential for cellular function of every cell (Lang et 
al., 1998; Wehner et al., 2003; Hoffmann et al., 2009).  The mechanisms involved 
controlling cell volume include cell membrane proteins such as ion channels, 
transporters, ionic pumps and cytoskeletal proteins and AQPs (Conner et al., 2012; 
Day et al., 2013). Hypotonic or hypertonic disturbances in cell volume activate several 
signalling pathways, resulting in adaptive and protective effects in cells (Hoffmann et 
al., 2009). Following an osmotic shock, changes in the volume of cells show two 
dynamic phases. In the first one, which lasts a few seconds to minutes, water rushes 
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osmotically across the plasma membrane primarily through paracellular water 
diffusion. In the second phase, the cell undergoes a process of volume regulation; 
induced cell swelling is followed by regulatory volume decrease (RVD), and induced 
cell shrinking is followed by regulatory volume increase (RVI) (Lang et al., 1998; 
Hoffmann et al., 2009). In view of this current study and existing studies of hypotonic 
and hypertonic effect on AQP3 trafficking, it could be suggested that in the event of 
hypertonic osmotic stress, urothelium cells respond by initiating RVI mechanism to 
offset the shrinking of the urothelial cell caused by the increase in tonicity, whereas in 
the event of hypotinic osmotic stress, urothelial cells respond by initiating RVD 
mechanism to offset the increase in cell volume caused by the decrease tonicity. 
Therefore, this process of RVD and RVI could initiate AQP3 translocation to the 
plasma membrane of the urothelial cell in restoring urothelial cell volume. 
The signalling pathways associated with regulatory volume control (RVC) appear to 
be cell-type dependent. The involvement of AQPs in RVC as a result of osmotic stress 
has been reported previously in other cells.  
A study looking at mice fertility found that the sperm of AQP3 −/− mice did not undergo 
their normal RVD process, and these mice exhibited reduced fertility (Chen et al., 
2011; Chen and Duan, 2011). Normally, sperm encounter reduced extracellular 
osmolality (hypotonicity) which is believed to be a signal that activates sperm mortility 
(Chen and Duan, 2011). This hypotonic stress also causes the sperm to swell which 
if not corrected by RVD process, results is impaired fertility caused by excessive 
bending of the sperm tail with the uterus (Chen et al., 2011). If AQP3 was simply acting 
passively as a water channel, RVD would not be stopped in AQP3 −/− mice but rather 
the timescale for which the cell reaches osmotic equilibrium would be 
increased. Another study done in human and murine salivary gland cells 
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demonstrated that TRPV4 has a functional interaction with AQP5: in AQP5 knockout 
cells, the hypotonicity-induced calcium influx through TRPV4 was attenuated and 
subsequent RVD was abolished. Hypotonicity also increased cell surface expression 
of both TRPV4 and AQP5 and increased their co-localisation (Liu et al., 2006). 
These studies shows that AQP3 is involved in RVC. Therefore, in urothelial cells, 
prolong exposure to hypotonic or hypertonic solution, which reflect urine content 
depending on the hydration status of the individual, could initiate AQP3 translocation 
to the plasma membrane to regulate urothelial cell volume. 
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Chapter 5 
 
Overall discussion conclusion, and 
future work  
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5.1 Overall Discussion and Conclusion 
 
In recent decades, one of the major forces driving lower urinary tract (LUT) research 
has been the aim of discovering potential new cellular targets for treatment of 
debilitating conditions such as nocturia. The consequence of these studies has been 
emergence of new insights into physiological function of the urinary bladder.  
The main current treatments for nocturia are vasopressin V2 receptor agonist, 
Diuretics, selective α1 adrenoceptor antagonists, antimuscarinics and many other 
which stimulate water reabsorption, reduce salt and water load, reduce activity in 
afferent pathways of micturition or reduce the generation of bladder afferent activity 
and frequency of voiding (Andersson and Kerrebroeck , 2018). These drugs do not 
directly treat nocturia but target other bladder disorder such as overactive bladder 
(OAB) and benign prostatic hyperplasia (BPH). However, a new concept of bladder 
urine absorption to increase the functional capacity of the bladder to avoid nocturia 
has been proposed (Watanabe and Azuma, 2015). By increasing fluid reabsorption, 
the need for waking up at night can be reduced significantly and as a result lead to 
alleviating nocturia symptoms.  
It is now clear that bladder is not simply a storage bag that fills and empties with urine, 
it has an active role in regulating its own function, altering the final composition of urine 
stored in bladder and sensing the changes in its local environment (Birder, 2010). 
The bladder urothelium and the suburothelial layers have been the subject of many 
studies so far especially in terms of their role in regulating the sensory function of the 
bladder (Birder, 2010; Birder and Andersson 2013). However, there is a clear lack of 
understanding on the role of these layers in altering the final composition of urine. The 
bidirectional movement of water and solutes across the urothelium has been 
175 
 
demonstrated in various studies (Hohlbrugger, 1987; Levinsky and Berliner 1959; 
Rapoport et al., 1960 Walser et al., 1988). However there are very limited studies 
which have looked at the mechanism through which this bidirectional movement is 
achieved. The discovery of AQPs in the bladder urothelium has provided the 
researches with a new target to further investigate this phenomenon. However, there 
are very limited studies in this area. 
To date, only six studies have been reported on the relationship between AQPs and 
the mammalian urinary bladder; in rats and bears (Spector et al., 2002; Spector et al., 
2015; Kim et al., 2012) and in isolated human cells and cell lines (Rubenwulf et al., 
2009; Rubenwulf et al., 2012; Rubenwulf et al., 2014). Out of these studies, only four 
studies have focused on the expression profile of AQPs in the urinary bladder (Spector 
et al., 2002; Spector et al., 2015; Rubenwulf et al., 2009). Rubenwulf et al. (2009) 
identified AQPs in the urinary bladder using freshly isolated urothelial cells and NHU 
cell lines and identified AQP 3, 4, 7, 9 and 11. (Spector et al. (2002) reported the 
expression of AQP1, 2, 3 in rat urinary bladders using isolated cells and they also 
demonstrated that dehydration causes an increase in AQP expression (Spector et al., 
2002). A subsequent study demonstrated that hibernating bears urinary bladder 
urothelium contain AQP1 and 3, however their exact localisation was not reported. 
Therefore in an attempt to further elucidate the role of AQPs in altering the final 
composition of urine, this study aimed to investigate the expression and possible 
function of these channels in adult pig urinary bladder, a close model to human bladder 
function (Parson et el., 2012). In the initial stages of the current  study, (Chapter 2) the 
expression of AQP subtypes was investigated in pig urothelium and suburothelium.  
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Briefly, in this study, AQP 1 was identified in the arterioles and capillary in the lamina 
propria which was confined in the mucosa area. This is in line with the studies that 
have reported AQP expression in the urinary bladder (Spector et al., 2002; Rubenwulf 
et al., 2012). AQP3 was found evenly distributed across the urothelial in all 3 different 
cell types (Umbrella, intermediate and basal cells). However, Rubenwolf et al. (2009) 
reported that AQP3 was located especially at the intercellular borders of basal and 
intermediate cells. The variation in AQP3 distribution in these species could be due to 
the presence of orthodox AQPs such as AQP4 in NHU cells which was found in all 
three different urothelial cells types (Rubenwulf et al., 2009). This could suggest that 
the need for water transport in NHU cells may be much greater than the need for 
solutes transport. AQP9 was detected more on the apical surface of the pig urothelium, 
i.e. umbrella and intermediate cells. In NHU cell lines, AQP9 mRNA expression was 
identified but no immunoreactivity was found for AQP9. Rubenwulf et al., (2009) were 
unsuccessful in identifying AQP11 protein levels in NHU cells due to the lack of 
suitable antibodies, this study was able to identify AQP11 protein throughout the 
urothelium. 
Interestingly, the majority of AQPs identified in pig urinary bladder consist of 
aquaglyceroporins (AQP3, 9 and 11) which, unlike AQP1, are found in the urothelial 
cells that are exposed to components in urine. It is also interesting to note that, out of 
all the different subtypes of AQPs currently identified in the urinary bladder of 
mammals, AQP3 appears to be present in all the different studies which could indicate 
the crucial role of AQP3 in the urinary bladder. The orthodox AQPs, AQP1, AQP2, 
AQP4, AQP5, AQP6, which are known to primarily facilitate water could not be 
identified in in pig bladder urothelium which suggests that the need for water in addition 
to solute reabsorption is much greater than water only. Reabsorption of urea from 
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urine during the passage of urine from the kidney to the bladder and in the bladder 
has been reported in other studies. A number of in vivo studies have suggested that 
many urinary constituents, including water, urea and various ions are reabsorbed 
through the epithelial (urothelial) lining under certain circumstances (Hohlbrugger, 
1987; Levinsky and Berliner 1959; Rapoport et al., 1960; Walser et al., 1988). 
Rubenwulf et al. (2012) has demonstrated that urea and water in the urinary bladder 
is reabsorbed by AQPs. Therefore, this study proposed that the expression of AQP3, 
AQP9 and possibly AQP11 are responsible for water and urea reabsorption and that 
AQP3, AQP9 and AQP11 function is not limited only in the reabsorption of urea and 
water but also the loss of other solutes that have previously been reported before the 
discovery of AQPs. The reabsorption and reutilization of urine nitrogenous wastes 
(urea, creatinine) is critical for survival in hibernating animals, the advantages of such 
transport in non-hibernating mammals remains to be clarified. Other studies have 
proposed that urea and creatinine reabsorption across the urinary bladder is 
subsequently metabolised and the nitrogen moiety is utilized for protein synthesis in 
conditions such as low protein, starvation pregnancy and growth in children (Spector 
et al., 2007). On the other hand, it is also possible that the lower urinary tract 
urothelium is involved in the pathophysiology of “prerenal azotemia,” a condition 
defined by relatively high serum levels of urea nitrogen in the state of dehydration and 
previously believed to be caused by urea reabsorption in the renal proximal tubule and 
collecting duct only.  
Since there are currently very limited studies which have looked at AQPs possible 
regulatory mechanism in the bladder, the expression of potential regulatory proteins 
in the pig urinary bladder was investigated. There are many potential receptors and 
channels that have been shown to be involved in mediating the function, expression 
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and translocation of AQPs in other tissue types. From these, it was decided to focus 
on a few of these channels and receptors including TRPC1, TRPV4, ER-2, ENaC, AG-
2 to confirm the expression of these channels and receptors in pig urinary bladder. 
TRPV4 (found in the urothelium) and TRPC1 (found in the mucosa) have not been 
reported to be expressed pig urinary bladder. Channels such as TRP channels are 
reported to work directly with AQPs in a synergistic manner by allowing influx of 
calcium ions in respond to external triggers leading to intracellular signalling cascade 
which eventually cause AQPs to be trafficked to the membrane (Conner et al., 2010; 
Day et al., 2013; Benfenati et al., 2011). AG-2 receptor (found in the mucosa) has 
previously been demonstrated in pig bladder but no studies have been done on AG-2 
potential interaction with AQP channels (Ilieva et al., 2008). ENAC channels (found 
mucosa an urotheial layer) are proposed to indirectly influence AQP function by 
allowing movement of ions across urothelial cells and in turn initiating AQPs to regulate 
cell volume via a mechanism known as RVC. Therefore, these potential AQP 
regulatory channels investigated in pig urinary bladder and their presence confirmed 
could potentially regulate AQP function and expression.  
After identifying AQPs subtypes and potential receptors and channels which could 
regulate these water channels, the second and third objectives of this study were to 
investigate whether there is evidence of water movement across the pig bladder 
urothelium and if AQPs were potentially involved in mediating this movement given 
that no studies have looked at pig bladder and there are very limited studies that have 
investigating water movement across the bladder urothelium  Also, to investigate 
changes in the effect of tonicity on AQP3 localisation in isolated urothelial cells. 
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AQP3 was investigate because its expression was the most abundant in this study 
and it has also been found in all the studies done on AQPs in mammalian bladders 
(Spector et al., 2002; Rubenwolf et al., 2009). 
Since AQP proteins are continuously exposed to changes in urine osmolarity for 
prolong periods of time, it was hypothesised that AQPs could respond to the changes 
in osmolarity. For the first time, using an Ussing chamber device, it could be 
demonstrated that both a hypertonic solution and a hypotonic solution could cause the  
movement of D2O across pig urinary bladder mucosa when an osmotic gradient was 
created, where the basolateral side of the mucosa tissue was exposed to isotonic 
solution and the apical side of the mucosa was exposed to hypertonic or hypotonic 
solution. The movement of D2O is thought to predominantly be mediated by AQP 
channels. This was demonstrated when the movement of D2O was noticeably reduced 
after inhibition of AQPs with HgCl2, a nonspecific AQP inhibitor. Moreover, this study 
has also demonstrated for the first time in pig urinary bladder that when urothelial cells 
are exposed to either hypertonic or hypotonic solutions, AQP3 is trafficked to the 
plasma membrane, indicating that both hypertonic and hypotonic solutions activate 
AQPs to function and they are translocated to the membrane as demonstrated with 
AQP3. This observation is important because of the environmental conditions of 
urothelial cells. Over the course of a day, urothelial cells are exposed to both 
hypertonic and hypotonic solution on more than one occasion and these cells must 
adapt to the changes in tonicity each time. While paracellular movement of water 
occurs as a mechanism to regulate this offset in osmotic imbalance, the rate of 
paracellular movement of water alone is insignificant to restore the osmotic changes 
in a limited amount of time (Day et al., 2014). AQPs are proposed to regulate this offset 
through a common passive mechanism and also cell volume regulation (CVR). AQPs 
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regulation and cellular distribution varies significantly between systems, specifically in 
constituent tissues and cells like kidney (Day et al., 2014). This variation in AQP 
distribution has also been demonstrated in this study for AQP1, 3, 9 and 11 but in 
particular for AQP3 and AQP9 in urothelial cells. CVR is an important mechanism 
component of AQP-mediated transcellular water movement. CVR involves regulatory 
volume decrease (RVD), typically in response to hypotonic induced cell swelling and 
regulatory volume increase (RVI), predominantly in response to hypertonic induced 
cell shrinking (Cacace et al., 2014). The mechanism involved in these responses are 
not fully understood but because this process is cell-type dependent, it is unlikely that 
there is a single mechanism for CVR. Most cells in the human body has a CVR 
mechanism to respond to osmotic changes and some cells such as the urothelium 
cells could have complex CVR mechanisms due to changes in urine osmolarity. As 
demonstrated in Chapter 3, hypertonic and hypotonic solution both caused movement 
of D2O and both modulated tonicity, but also caused AQP3 trafficking as demonstrated 
in Chapter 4. Therefore, it is hypothesized that trafficking of AQP3 to the plasma 
membrane and the movement of D2O could be an important CVR mechanism in the 
urothelial cells to regulate intracellular osmolarity which is required during both 
hypertonic and hypotonic conditions (Figure 5.1). This hypothesis is further supported 
by the observation that when the mucosa strip was exposed to isotonic solution on the 
basolateral side and isotonic solution on the apical side, small quantities of D2O was 
observed on the basolateral side which was lower than that observed when osmotic 
gradient was created. Also, when isolated urothelial cells were exposed to PBS 
isotonic solution, AQP3 was found to be localised within the urothelial cell, suggesting 
that in an isotonic environment, the need for RVI and RVD was not required. The 
trafficking of AQP3 in response to both hypertonic and isotonic solution has been 
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reported by two different studies, but both demonstrated the opposite tonicity effects 
on AQP3 (Garcia et al., 2001; Matsuzaki et al., 2001). 
It is important to a acknowledge that Rubenwulf et al. (2012) demonstrated increase 
water fluxes in NHU cells as well as an increase in AQP3 expression in hypertonic 
condition (500 mOsm/kg). Although water fluxes in hypotonic solution was not reported 
in their study, increase water fluxes seen in hypertonic solution is in line with this 
current study. They further demonstrated that hypotonic condition (215 mosm/kg) 
caused a decreased expression of AQP3 by 30% relative to the control. The decrease 
in AQP3 protein levels reflects a decrease in AQP3 protein synthesis or increased 
turnover and not necessary AQP3 trafficking. This distinction is key as the RVC 
mechanism in urothelial cells is essential in hypertonic as well as hypotonic conditions 
and thus in their study, available AQP3 within the cytoplasm could be trafficked to the 
membrane as demonstrated with AQP3 in this study.  
Whether the movement of D2O in this study merely reflects a CVR mechanism to offset 
osmotic balance or the movement of D2O is reabsorbed back into the systemic 
circulation remains to be clarified. However, the use of mucosa strips in this study, 
where AQP1 resides in endothelial cells and capillaries in the lamina propria as 
reported in Chapter 2, could suggest a possible D2O reabsorption to the systemic 
circulation.  
 
.  
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Figure 5.1: Proposed solute transport pathways mediating CVR in Urothelial cells  A) Represents the pathways for RVD in urothelial 
cells: the activation of K+ channels allows efflux of K+ from the cell and subsequent water loss by osmosis either through AQPs or directly 
through the lipid bilayer biophysical data demonstrates that AQP expression can increase membrane water permeability by up to ~ 50 fold. 
Movement of K+ out of the cell is dependent on the concentration gradient but to maintain the electrostatic membrane potential, volume-
regulated anion channel(s) (VRAC) simultaneously move anions (mainly Cl− during RVD) out of the cell, which could be activated by tyrosine 
kinases. Four K+-Cl− co-transporters (KCCs), known to be activated by cell swelling, are possibly involved in this process.  
B) Represents the pathways for RVI in urothelial cells: The activation of Na+-H+ exchangers and Na+-K+-2Cl− co-transporters (NKCCs) 
causes cellular influx of Na+ and subsequent volume increase by osmotic movement of water.The Na+-H+ exchange pump, NHE1, is known 
to be activated by cell shrinkage, which may be mediated by binding of calmodulin to its carboxy-terminus. The co-transporter, NKCC1, is 
known to be activated by cell shrinkage, potentially through lysine-deficient protein kinase 1 (WNK1) and proline/alanine-rich protein kinase 
(SPAK) signalling. Amiloride-sensitive non-selective cation channels (NSCCs) may also play a role. Adapted from Day et al. (2014). 
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To date, no model has been proposed for AQP intracellular signalling pathways with 
tonicity as a trigger in the urinary bladder urothelium.  
Three possible models can be hypothesised for trafficking and function of AQPs in 
bladder urothelium based on the evidence gathered from this study and other studies 
on the bladder as well as studies on other tissues  
 
First model: this model is based on a study by Conner et al. (2012) who proposed a 
model for HEK293 cell lines. In HEK293 cell lines, Conner et al. (2012) demonstrated 
that AQP1 exposure to hypotonicity translocated to the cell membrane, a process that 
is mediated by the influx of calcium ions through TRPC1. Inhibition of 
mechanosensitive TRPC1 prevented hypotonicity-induced AQP1 translocation. Based 
on these findings, a model for AQP1 regulation in HEK293 was proposed. Influx of 
water by osmosis and/or through constitutively expressed AQPs channels causes cell 
swelling and induces extracellular calcium ion entry through TRP channels, and as a 
result triggers AQP translocation to the membrane. They demonstrated that AQP1 
translocation is dependent on calmodulin (CaM) activation and AQP1 phosphorylation 
by PKC. Water then exit the cell to maintain cellular homeostasis (Conner et al., 2012). 
In this current study, it has clearly been demonstrated that AQP 1, 3, 9 and 11 are 
present in the urinary bladder and that AQP3 is trafficked to the plasma membrane 
upon exposure to both hypertonic and hypotonic solution. Also, in this study, it was 
demonstrated that TRPV4, a mechanosensitive ion channel, is also expressed in pig 
urothelial cells (Figure 4). Moreover, existing data have shown that AQP 1, 3 and 9 
contain several putative phosphorylation sites for PKC, PKA (Yasui et al., 2008; 
Nesverova et al., 2019). In addition, expression of AQP 3 and AQP 9 is shown to be 
regulated by oleic acid through the PI3K/Akt and p38 MAPK signalling pathways. 
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Therefore based on existing data and this current data, the model presented in Figure 
5.2 is proposed.  
Second model: TRPM8 is the only TRP channels that is reported to detect small 
changes in osmolality, (Quallo et al., 2015). Increasing osmolality evokes 
depolarization and action potential firing in TRPM8-expressing sensory neurons, 
whereas inhibition of TRPM8 evokes hyperpolarization (Quallo et al., 2015). TRPM8 
expression has also been demonstrated in pig urinary bladders (Vahabi et al., 2013). 
Whereas in proposed model one, constitutively expressed AQPs in cell membrane 
initially allows influx of water leading to stretch and which is followed by an influx of 
calcium ions, in this second model, it is proposed that changes in external osmolarity 
is detected by TRPC8 which causes an influx of calcium ions, and as a result trigger 
AQP trafficking to the plasma membrane (Figure 5.2).  
Third model: This model is based on RVC mechanisms. Ion channels, such as the 
Na+-K+ pump,  help to maintain an osmotic balance across the mammalian cell 
membrane by keeping the intracellular concentration of Na+ low (Pirahanchi et al., 
2019). In addition to this, reabsorption of urea and other solutes can lead to changes 
in intracellular and extracellular osmolarity (Schafer, 2004). Therefore, unlike the 
proposed model one or model two, in this third model, it is hypothesised that in addition 
to passive diffusion, constitutively expressed AQPs are involved in continuously 
regulating cell volume by fine tuning of intra- and extracellular osmotic changes. 
Constitutively expressed AQPs respond to small changes in osmolarity and evoke a 
mechanism known as RVD/RVI to regulate urothelial cells by allowing bidirectional 
movement of water and solutes.   
In this proposed pathway, TRP channels activation of AQPs trafficking is only important 
during extreme increase in intra- and extracellular osmotic changes (Figure 5.2).  
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Figure 5.2: Proposed mechanism for AQPs regulation 
 
Proposed model 1: Osmotic changes in extracellular environment causes an influx of H2O to the cell via constitutively expressed AQPs, the influx of H2O causes 
the cell to stretch. TRP channels present respond to the stretch caused by an increased in intracellular water. Calcuim ion influx via the TRP channels result in 
phosphorylation of AQPs stored in vesicles and trafficking to the cell membrane by protein kinases or AQPs (AQP3/9) synthesis via P13K/Akt and P38 MAPK. 
When equilibrium is achieved, signalling feedback loop result in down regulation of AQPs expression and de-phosphorylation of AQPs. 
 Proposed model 2:  unlike pathway 1, TRPM8 detect changes in extracellular osmolarity and this leads to influx in calcium to the intracellular space. This is 
then followed by Influx of water by osmosis and/or through constitutively expressed AQP channels or leads to cell swelling and as a result induces intracellular 
calcium entry through TRP channels, thereby triggering AQPs translocation. This translocation along microtubules is dependent on calmodulin (CaM) activation 
and AQP phosphorylation by PKC/PKA. Water subsequently enters or exits the cell to maintain cellular homeostasis. 
Proposed model 3: Ion channels such as Na+-K+ pump helps maintain an osmotic balance across the cell membrane by keeping the intracellular concentration 
of Na+ low. Osmotic changes in extracellular environment causes reabsorption of urea and other solutes and as a result changes in intracellular and osmolarity. 
This causes constitutively expressed AQPs to allow the permeability of water (bidirectional). These changes are performed continuously in fine-tuning intra and 
extracellular osmotic changes via as a form of osmosis. TRP channels activation of AQPs is only important during extreme increase in intra and extracellular 
osmotic changes.  
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To conclude, knowledge on the mechanisms of water and solute movement across 
the urothelium is limited and research in this area can help identify novel targets. We 
have identify AQPs expression for the first time in adult pig bladder urothelium and we 
have also demonstrated that these AQP channels are functional in the urinary bladder 
when osmotic gradient is created. We have also demonstrated that AQP3 is trafficked 
to the membrane after exposure to hypotonic, hypertonic solutions. The presence of 
AQPs in the urinary bladder can be seen as a new therapeutic target where AQPs can 
reabsorb water across the bladder urothelium at night as a mechanism to treat 
Nocturia. Further studies are required to investigate hypotonic and hypertonic 
intracellular signalling involved in AQPs function, expression and translocation.  
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5.2 FUTURE WORK 
 
This thesis provides evidence that AQPs are present in the urinary bladder of pigs and 
also demonstrates that AQPs are function in pig urinary bladder. Furthermore, this 
thesis shows that the function of these AQPs in mediating water across the urinary 
bladder could be through trafficking of AQPs, in particular AQP3 to the plasma 
membrane of urothelial cells. In addition, several regulatory proteins that have been 
demonstrated to regulate AQPs function in other studies have been demonstrated in 
this study. To investigate this further, the following experiments could be considered: 
 Identification of AQP3 localisation around the nucleus in urothelial cells using 
cellular organelle markers using AQP3-GFP tagged/EM staining 
Investigating the intracellular signalling pathway involved in AQP3 trafficking  
 Establish and optimise isolated urothelial cell cultures from pig urothelium for 
intracellular signalling experiments.   
 Exposure of urothelial cells to hypertonic, hypotonic and isotonic Krebs solution 
followed by inhibition of phospholipase C and PKC and calphostine C 
respectively and examination of AQP3 cytosolic and plasma membrane fraction 
proteins levels to determine AQP trafficking. 
 Activation of PKC, and phospholipase C to observe AQP3 cytosolic and 
membrane fraction changes. 
 Measurement of intracellular Ca2+ using Till photonics-polychrome IV 
spectrofluorimeter and Olympic microscope and Metaflour imaging system to 
measure fluorescence traces after urothelial exposure to hypertonic, hypotonic 
Krebs solution. 
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 Pharmacological activation and inhibition of TRPV4 and measurement of AQP3 
membrane fraction to determine whether an increase in intracellular calcium 
ions is through TRPV4 after urothelial cells exposure to hypertonic, hypotonic 
and isotonic solution. 
 Investigating the role of AQPs in the release of mediators such as ATP by 
urothelial cells and bladder contraction. 
 Instillation of D2O in dehydrated, well-hydrated and over-hydrated pig urinary 
bladders and sampling of blood to determine reabsorption of D2O back into the 
systemic circulation under all three conditions. 
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